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General introduction and outline of the thesis
Neuropsychiatric and neurological disorders constitute a major health problem in Europe, 
and their impact on public health and society is increasing with the aging of the 
population. According to the Strategic Research Agenda of the European Platform on 
Innovative Medicines (IMI) (http://www.imi.europa.eu/), one of the most important 
bottlenecks for finding more effective drugs for brain disorders is the development of 
model systems that translate to human pathology and are predictive of clinical efficacy. 
The World Health Organization estimated in 2006 that neurological disorders, ranging 
from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion 
people worldwide (World Health Organization. The world health report 2006 − working 
together for health: World Health Organization, 2006). Neurologic disorders and cerebro-
vascular disease combined represent 7.1% of the total global burden of disease measured 
in DALY (disability-adjusted life-years) for all causes and ages (Chin & Vora, 2014). 
One particularly relevant neurological disorder in the framework of the foregoing concerns is 
Huntington disease (HD). HD is an autosomal-dominantly inherited, fatal, neurodegenerative 
disorder. Its prevalence is estimated highest in Europe and populations of European 
descent (P. S. Harper, 1992). The average frequency of affected persons in Europe, North 
America and Australia amounts to a minimum of 6 per 100,000 (Pringsheim et al., 2012) 
and varies greatly geographically as a result of ethnicity, local migration and past immigration 
patterns. HD symptoms comprise adult-onset personality changes, generalized motor 
dysfunctions, and cognitive decline. The peak age of adult-onset HD is between 35 and 50 
years. A small percentage of patients (10%) develop symptoms before age 20. Animal 
models of neurological disorders are essential for the assessment of new preventive 
interventions and therapeutic options (Cenci, Whishaw, & Schallert, 2002). Accordingly, 
part of that research effort involves identifying suitable animal models that provide a valid 
representation of the pathological and behavioral profile of the human disease and that 
can serve for the identification of therapeutic candidates and novel approaches to therapy 
(P. Kumar, Kalonia, & Kumar, 2010; Pouladi, Morton, & Hayden, 2013; Ross & Tabrizi, 2011). 
Among mammalian species, rats were the first animals used for scientific purposes and 
have been considered for decades as a key model organism in biomedical science, 
including neurological disorders and behavioral neuroscience (Cenci et al., 2002; Homberg, 
Wöhr, & Alenina, 2017). Accordingly, some complex behaviors and physiological processes 
that can be readily studied in rats are difficult or impossible to investigate in mice 
(Ellenbroek & Youn, 2016; Homberg et al., 2017). Comparative analyses of movements in 
rats and primates show homology of many motor patterns across species. Advances have 
been made in identifying rat equivalents of akinesia, tremor, postural deficits and 
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dyskinesia, which are relevant to neurological disorders (Cenci et al., 2002). Other practical 
advantages of rats include their larger size, which facilitates direct invasive procedures, 
such as blood and cerebrospinal fluid collections, repetitive physiological measurements 
and surgical manipulations. Whereas understanding disorder symptoms is important, 
even more important is the understanding of phenotypes that precede the full-blown 
disorder symptoms and their stability during the course of the disorder, so that possible 
therapies can be more effective in preventing further development of these disorders. 
This insight is mostly lacking in clinical studies, because prospective longitudinal studies 
are very time consuming and costly. The relatively short life span of experimental rodents 
allows us to overcome this limitation of clinical (human) studies.
 Recent progress in preclinical and clinical research on HD has been remarkable and is 
supported by a tight community of physicians, researchers, patients, and their families, 
creating a special dynamic that drives progress in the field (Reilmann, Leavitt, & Ross, 2014). 
HD has evolved into a model disease with the potential to treat CAG expansion carriers 
before manifestation of the disease, raising hopes for personalized preventive medicine. 
Hopefully, the collective efforts of the field will help pave the way to our ultimate goal 
–effective disease– modifying treatments for HD. 
Polyglutamine Diseases
Polyglutamine (polyQ) diseases are inherited, fatal neurodegenerative disorders caused 
by an expansion of a coding trinucleotide (CAG) repeat, which is translated to an 
abnormally elongated glutamine (Q) tract in the respective mutant proteins. There are 
nine known polyQ diseases: dentatorubral-pallidoluysian atrophy (DRPLA), Huntington 
disease (HD), spinal-bulbar muscular atrophy (SBMA), and six spinocerebellar ataxias (SCA1, 
2, 3, 6, 7, and 17). Except for SBMA, which is X-linked, members of this disease group are 
inherited in an autosomal dominant manner (Orr & Zoghbi, 2007). All the polyglutamine 
disorders share several common pathological features, including the nuclear accumulation 
and aggregation of the disease proteins (Weber, Sowa, Binder, & Hübener, 2014). Neuronal 
nuclear inclusions are considered to be a histopathological hallmark of the polyQ diseases 
and are even observed in disease brains in which normal polyQ proteins are predominantly 
expressed in the cytoplasm. Although the role of nuclear inclusions in pathology is not 
fully understood, it is clear that the inclusions result from the nuclear accumulation of 
polyQ-expanded proteins (Havel, Li, & Li, 2009). 
Natural history of Huntington Disease
Huntington disease (HD) is a neurodegenerative genetic disorder formally described for 
the first time in 1872 by George Huntington (Huntington’s Disease Collaborative Research 
Group, 1993). It is caused by an unstable, expanded CAG base triplets in the coding region 
of the IT15 gene (consequently later named Huntingtin gene, HTT) on chromosome 4p16 
(Huntington’s Disease Collaborative Research Group, 1993), which results in an abnormal 
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polyglutamine sequence in the huntingtin protein (htt) (Gusella et al., 1983; Ross & Tabrizi, 
2011). This disease is autosomal-dominantly inherited and has a broad impact on a person’s 
functional abilities and usually in movement, such as progressive motor abnormality and 
chorea, intellectual deterioration and psychiatric disorders, including severe depression 
(Walker, 2007). Since the original description, the name of this condition has been changed 
from Huntington Chorea to Huntington Disease to acknowledge the multiple non-motor 
symptoms faced by patients with this disease (Novak & Tabrizi, 2010). 
Symptoms
The symptoms of HD are the result of premature neuronal cell death, in particular in the 
striatum (Saudou & Humbert, 2016). After a variable ‘premanifest’ period, a prodromal 
phase characterized by subtle motor, cognitive and behavioural changes often precede a 
formal clinical diagnosis of motor onset by up to 15 years. Once signs and symptoms 
begin, they progress relentlessly over the course of the illness, which — with the exception 
of those patients with late-onset disease who may die of other causes — is fatal, with a 
median survival from motor onset of 18 years (Bates et al., 2015). 
 HD patients typically suffer from a triad of movement, psychiatric and cognitive 
symptoms. The onset of the symptoms, that can vary between individuals and affected 
members of the same family, usually occurs in mid-adulthood (30-40 years old), but the 
onset of disease may be earlier or later in life. The presence of 60 or more CAG repeats is 
associated with juvenile onset, typically manifesting with more severe symptoms including 
rigidity and a more rapid course of the disease (Huntington’s Disease Collaborative 
Research Group, 1993; Nance & Myers, 2001). For this reason, it is possible to divide HD into 
two phenotypes: juvenile (approximately 7% of individuals) and adult onset (Kirkwood, 
Su, Conneally, & Foroud, 2001). Declining cognitive functions, impairments of voluntary 
movements, awkward gait, slowed speech, bradykinesia, seizures and rigidity of limbs or 
trunk are the characteristic symptoms of juvenile HD (Kirkwood et al., 2001; Nance & Myers, 
2001). Later in the progression of the juvenile HD the voluntary movement abnormalities 
and cognitive decline worsen (Kirkwood et al., 2001). 
 In contrast to juvenile-onset HD, the diagnosis of adult-onset HD is typically 
involuntary motor abnormalities and chorea that often decrease in a late stage, when 
parkinsonism, dystonia and rigidity dominate. In the early stages patients have deficits in 
executive system functioning, short term memory and visuospatial functioning. Especially 
affected are executive functions which include planning, cognitive flexibility, abstract 
thinking, rule acquisition, initiating appropriate actions and inhibiting inappropriate 
actions. The later stages are characterized by bradykinesia, spasticity, dysarthria, dysphagia 
and incontinence (Kirkwood et al., 2001). In addition to motor abnormalities, cognitive 
decline and personality changes are part of HD, and, like motor impairments, cognition 
deteriorates gradually. Additionally, cognitive deficits progress to more widespread global 
subcortical dementia with apathy, impulsiveness, depression and antisocial and suicidal 
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behaviour. Depression and apathy may be an integral part of the disease process rather 
than a response to the debilitation, because they can occur several years before the motor 
abnormalities begin (Kingma, van Duijn, Timman, van der Mast, & Roos, 2008; Kirkwood 
et al., 2001). Less common are delusional depression or schizophrenia-like-psychosis, 
which might require psychiatric treatment (Bates et al., 2015).
 Beyond the well-established impairments of HD such as motor, neurocognitive and 
psychiatric symptoms, the presence of emotional disturbances have been documented. 
In particular it has been shown that HD patients have difficulty with the identification of 
the six classically basic facial emotional expression (Henley et al., 2012). Recent studies 
have shown that other than disgust also emotions like anger, fear or sadness (Johnson et 
al., 2007) are involved and this deficit might be already present at the pre-clinical stage. HD 
appears associated with generalized impairment in the detection and expression of 
emotions (Henley et al., 2012). An altered emotional processing can cause problems in the 
daily life and in the interpersonal relations, resulting in a negative impact in the social life 
(Vamos, Hambridge, Edwards, & Conaghan, 2017).
Present and future treatment of HD
To date, there is no cure for HD. Therapeutic strategies are designed in order to ameliorate 
the primary symptomatology and to improve the quality of life of patients (Handley, Naji, 
Dunnett, & Rosser, 2006). In order to improve the conditions of HD patients the current 
therapies use psychiatric agents for the control of behavioral symptoms, motor sedatives 
for the control of the chorea, cognitive enhancers and neuroprotective drugs (Kumar et al., 
2015). Commonly prescribed drugs to reduce involuntary movements are dopamine 
antagonists (e.g. haloperidol) or presynaptic dopamine depleters (e.g. tetrabenazine). 
Psychiatric symptoms are treated with antidepressants (e.g. carbamazepine), antipsychotics 
(e.g. clozapine), anxiolytics (e.g. benzodiazepine) or tranquilizers (e.g. chlorpromazine) 
(Videnovic, 2013). 
 Physiotherapy can be also useful to strengthen muscles or loosen rigidities, and 
speech language therapy can ameliorate speech and swallowing problems. In addition, 
psycho-social support can help patients and their family members to cope with the 
burden of HD. 
 Thus, therapeutic strategies for HD have been developed for basically every aspect 
discovered to be involved in the disease pathogenesis, and at least minor benefits have 
been demonstrated for a multitude of compounds and approaches in preclinical studies 
(Zuccato, Valenza, & Cattaneo, 2010). Unfortunately, promising candidates have so far 
failed to exert disease-modifying effects in clinical trials in HD patients (Nguyen & Cenci, 
2015). Among strategies such as enhancing mHTT degradation, improving neurotrophic 
support and reducing inflammation, the most promising therapeutic approach is the 
reduction of mHTT expression (Wild & Tabrizi, 2014). The single mutation and sole genetic 
cause responsible for HD enables the direct targeting of the inflicted protein on the tran-
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scriptional or translational level. RNA interference (S. Q. Harper et al., 2005; Stanek et al., 
2014), translational repression with antisense oligonucleotides (Carroll et al., 2011) and tran-
scriptional repression using zinc finger proteins (Garriga-Canut et al., 2012) have proven to 
be successful and beneficial in animal models. Delivery and distribution issues as well as 
allele-selectivity and -specificity constitute the major areas of research in this area (Wild & 
Tabrizi, 2014).
Genetics and neuropathology 
The mutant huntingtin (mhtt) protein is the result of the unstable CAG repeat in the HTT 
gene that causes a polyQ stretch near the N-terminus of the protein (Everett & Wood, 
2004). The N-terminal fragment represents the “toxic” species and the proteases that 
generate HTT fragments are caspase-3, caspase-6, calpains and matrix metalloproteinase 
10 (Sathasivam et al., 2013). The mutant htt protein undergoes proteolytic cleavage, 
misfolding and aggregation in all cells of the body (Cisbani & Cicchetti, 2012). This leads to 
impairments in transcription, axonal transport and mitochondrial function that cause 
atrophy due to massive neuronal loss (Hedreen & Folstein, 1995).
 The length of the CAG/polyglutamine repeat sequence is inversely correlated with 
the age of disease onset, thus determining whether an individual will develop HD (Duyao 
et al., 1993). In the normal population the polymorphic CAG repeat is between 6 and 35 
units, but the mutation becomes highly penetrant when the units are >40, provoking a 
disease process that inexorably leads to the onset of diagnostic motor signs (Huntington’s 
Disease Collaborative Research Group, 1993; Novak & Tabrizi, 2010). Repeats of 36-39 CAG 
units show reduced penetrance and are potentially unstable during inheritance, as some 
individuals have HD whereas others are not clinically diagnosed as having HD (Bates et al., 
2015; Novak & Tabrizi, 2010). Due to the instability of the gene during gametogenesis, 
so-called anticipation in the offspring can occur. This is referred to the phenomenon in 
which the inheritance of the mutant HTT allele through the male germ line often leads to 
a more severe clinical course than inheritance through the female germ line (Walker, 
2007). In general, children with HD show symptoms 8 years earlier than their fathers 
(Ranen et al., 1995). Importantly, the timing of onset of the motor signs is determined by 
the allele with the longer CAG repeat in a completely dominant manner. The second HTT 
allele (regardless of its length) does not alter the rate of the process that leads to clinical 
diagnosis. The pathogenetic mechanism of the CAG length dependence and allele dose 
independence is not known, but previous studies showed that the length of the CAG 
repeat, even in the normal range, correlates with measures in some cellular assays (for 
example, cellular energy charge or cellular adhesion assays) (Seong et al., 2005). This 
suggests that a gain of function that acts through augmentation or dysregulation of one 
or more normal functions of huntingtin might be involved (Bates et al., 2015). 
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HD: a basal ganglia disorder
Basal ganglia consist of four main interconnected nuclei: the striatum, the globus pallidus, 
the subthalamic nucleus and the substantia nigra (Pollack, 2001). The largest component 
is the striatum, and comprises two macroscopic nuclei, the caudate nucleus and the 
putamen (Yelnik, 2002). Both of them contain two different types of neurons: projection 
neurons and interneurons (respectively 90% and 10% of striatal neurons). The so called 
medium-sized spiny neurons (MSNs) are projections or striatofugal neurons, and they are 
all inhibitory neurons, using GABA as neurotransmitter (Lanciego, Luquin, & Obeso, 2012) 
The MSNs in the striatum receive information from incoming axons from the cerebral 
cortex. Striatofugal MSNs can also be divided according to their projections targets. The 
first group innervates the globus pallidus external nucleus and express dopamine subtype 2 
receptors (D2R), which inhibit intracellular adenyl-cyclase and give rise to the indirect 
pathway. In the second group striatal MSNs directly project to globus pallidus internal 
nucleus and subthalamic nucleus and contain dopamine receptor subtype 1 receptors 
(D1R) which activates adenyl-cyclase and give rise to the direct striatopallidal pathway 
(Lanciego et al., 2012). The striatum receives also a dopaminergic input from the substantia 
nigra pars compacta (Yelnik, 2002). The indirect pathway serves to modulate the 
disinhibitory actions of the direct pathway, which reduces tonic inhibition when activated. 
In patients with HD, MSNs projecting to the external segment of the globus pallidus 
degenerate, causing impairments in the pathway. This leads to an inappropriate activation 
of the upper motor neurons, resulting in undesired ballistic and choreic movements 
(Graybiel, 2000). 
 HD causes neuronal loss particularly in the striatum with about 57% loss of cross- 
sectional area from the caudate nucleus and about 65% loss of the putamen, while in the 
advanced cases there is also a loss of neurons in the thalamus, substantia nigra pars 
reticulata and in the subthalamic nucleus (Rubinsztein, 2002). The MSNs in the striatum 
that contain the neuropeptide encephalin and express the D2-subtype of dopamine 
receptor appear to be the most vulnerable neuronal population (Augood, Faull, Love, & 
Emson, 1996; Sapp et al., 1995). Accordingly, HD is defined as a basal ganglia disorder. The 
basal ganglia dysfunction leads to an abnormal reduction in tonic inhibition, and thereby 
to excessive excitability of the upper motor neurons (Shoulson & Young, 2011). 
Huntingtin protein
The huntingtin (htt) protein is a 348-kDa protein containing 3,144 amino acids. It is highly 
conserved from flies to mammals (Saudou & Humbert, 2016) and its normal function is not 
fully understood. The N-terminal region contains the expandable polyQ stretch and it is 
preceded by 17 amino acids that form an α-helical structure but can also adopt other 
conformations including α-helix, random coil and extended loop (Kim, Chelliah, Kim, 
Otwinowski, & Bezprozvanny, 2009) and it is followed by a proline-rich domain (PRD).  Both 
the polyQ stretch and the PRD are polymorphic in the human population. The proline-rich 
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domain, which is important for protein-protein interactions with tryptophan or Src 
homology 3 (SH3) domains, can be variable in the non-HD population (Harjes & Wanker, 
2003). Htt is also enriched in consensus sequences called huntingtin elongation factor 3, 
protein phosphatase 2A, and TOR 1 (HEAT) repeats that are organized into protein domains 
relevant for protein-protein interactions (Zuccato et al., 2010). It has been shown that the 
polyQ tract has an important role in binding the huntingtin protein to its large number of 
partners (Zuccato & Cattaneo, 2007). The protein might have a flexible or multifunctional 
structures that are able to assume specific conformations and activities depending on its 
binding partners, subcellular location, and time of maturation in a given cell type and 
tissue (Kim et al., 2009). 
 Htt contains three protease cleavage consensus sites that generate shorter fragments 
from the full-length HTT protein (Goldberg et al., 1996; Wellington et al., 1998). In addition 
to these three sites, there are an additional three caspase cleavage sites and two calpain 
cleavage sites N-terminal to the primary caspase cleavage sites (Kim et al., 2001). Both the 
wild-type and mutant forms of the HTT protein can be cleaved, producing fragments of 
varying length, function, and cellular localization (Lunkes et al., 2002; Ratovitski et al., 2007). 
Brain region-specific cleavage of HTT protein has also been described, suggesting that 
different fragment lengths may have cell-type-specific functions adding additional 
complexity to the function of this protein (Mende-Mueller, Toneff, Hwang, Chesselet, & 
Hook, 2001).
 Despite the association of mutant huntingtin with selective neurodegeneration in 
specific brain regions, HTT is ubiquitously expressed, at low levels, throughout the body 
(Van Raamsdonk et al., 2005). The normal functions of huntingtin are not fully understood, 
but some broad biological functions have been discovered (Saudou & Humbert, 2016). For 
instance, in vitro and in vivo studies have shown that the protein has a prosurvival role by 
blocking the formation of a functional apoptosome complex and the consequent 
activation of caspase-3 and caspase-9 (Rigamonti et al., 2001). Furthermore, huntingtin has 
a critical role in the development of the nervous system and influence the brain-derived 
neurotropic factor (BDNF) expression that is important for the survival of striatal neurons 
and for the activity of cortico-striatal synapses (Zuccato & Cattaneo, 2007). Huntingtin is 
associated with vesicle membranes and microtubules and also appears to be associated 
with clathrin through huntingtin-interacting protein. For these reasons, huntingtin might 
have a role in vesicle transport and synaptic function (Rubinsztein, 2002). Although a 
number of molecular dysfunctions have been correlated to the pathogenesis of HD, the 
specific biochemical functions of huntingtin protein remain largely unknown. 
Cell and animal models of HD 
Molecular aspects of HD have been studied intensely in mammalian cells including 
lymphoblasts (Trottier et al., 1995), fibroblasts (Persichetti et al., 1996), embryonic stem 
cells (Lu & Palacino, 2013; Metzler et al., 1999) and inducible pluripotent stem cells 
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(The HD iPSC Consortium, 2012) from HD patients and control subjects. In addition, cell 
lines (Ehrlich et al., 2001; Goldberg et al., 1996; Li, Cheng, Li, & Li, 1999; Li & Li, 1998; Trettel 
et al., 2000) and primary cell cultures (Saudou, Finkbeiner, Devys, & Greenberg, 1998) 
expressing mutant HTT (mHTT) with various lengths of the protein and polyQ tract have 
been used. In order to further understand the disease on organismic level, animal models 
of HD have been established. Small invertebrates such as worms and flies can be used to 
study the order and progression of molecular HD-related phenotypes, while larger, 
mammalian species such as mouse, rat, sheep, pig and monkey enable the analysis of 
systemic abnormalities and the interplay between cell populations in the body. Of these, 
rodent models certainly had the most impact on the evaluation of disease mechanisms 
as well as preclinical testing.
Invertebrate models of HD
The transgenic Caenorhabditis elegans model presents truncated amino-terminal fragments 
of mHTT between 57 to 171 amino acids in targeted neurons. Transgenic expression of 
mHTT in worms results in neuronal dysfunction and neurodegeneration (Faber, Alter, 
MacDonald, & Hart, 1999). The Drosophila melanogaster models use the USA-GAL4 system 
to drive the expression of full-length or truncated N-terminal fragments (65-548 amino 
acids) of mHTT in cellular populations. HD fly models show a progressive degenerative 
phenotype and motor abnormalities (Lee, Yoshihara, & Littleton, 2004).
Rodent models of HD
Up to now, rodents are the most commonly animal models used for HD and over 20 
different models have been created. The R6/1 and R6/2 mouse models expresses exon 1 of 
human HTT, respectively with 116 and 144 CAG repeats under the control of the human 
HTT promoter (Mangiarini et al., 1996). In particular, in the R6/2 mice the CAG repeat tract 
appeared to be unstable in the germ cells, and the transmissible CAG repeat expansions 
were greater than 400 CAGs. This means that in many colonies of R6/2 the size of expansion 
is greater than originally (Dragatsis et al., 2009). The N71-Q82 mouse model expresses a 
truncated HTT cDNA with 82 CAG repeats under the control of the mouse prion protein 
promoter (Schilling et al., 1999). All of the truncated N-terminal fragment models typically 
exhibit a rapid onset of symptoms, including motor and cognitive abnormalities, weight 
loss and a reduced lifespan. These symptoms are accompanied by a widespread and 
generalized degenerative phenotype (for a detailed review see Pouladi et al., 2013). 
 By knocking in a human HTT exon 1 with an expanded CAG repeats expansion in the 
endogenous mouse Htt gene locus, full length mHTT rodent model have been created. 
HdhQ111, CAG140 and HdhQ150 mouse models are genetically precise, with one or two 
copies of the mutant HD gene and temporally and spatially appropriate levels of mHTT 
expression (Heng, Tallaksen-Greene, Detloff, & Albin, 2007; Lin et al., 2001; Menalled, Sison, 
Dragatsis, Zeitlin, & Chesselet, 2003; Tallaksen-Greene, Crouse, Hunter, Detloff, & Albin, 
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2005; Wheeler et al., 2002). HdhQ111 and HdhQ150 show both a somatic instability of CAG 
repeats, HdhQ150 has the mouse proline-rich region, while the HdhQ11 and CAG140 mice 
have the human proline-rich region. Knock-in mice have been shown to develop 
neurological and neurodegenerative phenotypes (Hickey et al., 2008; Lerner, Trejo 
Martinez, Zhu, Chesselet, & Hickey, 2012; Menalled et al., 2003; Wheeler et al., 2002).
 Another group of full-length mHTT rodent models was generated using genomic-type 
constructs such as yeast artificial chromosomes (YACs) technology and bacterial artificial 
chromosomes (BACs) (Gray et al., 2009; Hodgson et al., 1999; Slow et al., 2003; Yu-Taeger et 
al., 2012). These models have human genomic mutant HTT transgenes, including all the 
introns and exons and the regulatory sequences up to 24 kb upstream and 117 kb 
downstream of the gene, ensuring appropriate temporal and tissue-specific expression of 
mHTT (Gray et al., 2009; Hodgson et al., 1999; Slow et al., 2003; Yu-Taeger et al., 2012). The 
YAC128 mice model expresses the transgene with 128 CAG repeats, while BACHD mice and 
rats express mutant HTT with 97 CAG repeats. Both YAC128 and BACHD rodent models 
develop progressive motor, cognitive and psychiatric symptoms, as well as selective 
striatal and cortical atrophy (Ehrnhoefer, Butland, Pouladi, & Hayden, 2009). Although 
these models share many phenotypic features, it is possible to find differences between 
neurochemical and aggregation phenotypes (Pouladi et al., 2012).
Large animal models of HD
Different large animal models of HD have been developed such as a non-human primate 
model (rhesus monkey, Macaca mulatta), a Tibetan miniature pig model, and a sheep 
model (Ovis aries). The first two models were generated using fragments of human HTT 
that included a CAG repeat expansion, while the sheep model uses the full-length human 
coding sequence of HTT that is expressed from a transgene. 
 The transgenic monkey was created by the injection of oocytes with lentiviruses 
expressing exon 1 of HTT carrying 84 CAG repeats, and the expression was controlled by 
the ubiquitin promoter (S.-H. Yang et al., 2008). The hallmark features of HD, including the 
presence of nuclear inclusions and neuropil aggregates, were observed in the brains of 
the symptomatic HD monkeys. The pathology was more similar to that observed in the 
R6/2 mouse rather than in human brain, this because both models contained a transgene 
with an N-terminal HTT fragment controlled by the ubiquitin promoter, that is upregulated 
in HD. 
 The transgenic HD sheep was created by micro-injection of a full-length human HTT 
cDNA containing 73 CAG repeats under the control of the human HTT promoter (Jacobsen 
et al., 2010). It has been reported that the brains of this showed characteristic inclusions at 
18 months of age, without showing the full HD phenotype. The Tibetan miniature pig 
model expressed the N-terminal of mHTT, containing a repeat of 105 glutamine residues 
and the expression of the construct was under the control of the cyclomegalovirus 
enhancer and chicken β-actin promoter (Yang et al., 2010). A large animal model recently 
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developed is the transgenic (tg) HD minipig (Baxa et al., 2013), which presents a stable 
expression of the N-terminal truncated form of human huntingtin transgene and is 
currently being tested in different motor, cognitive and behavioral tests (Schramke et al., 
2016; Schuldenzucker et al., 2017).
The urgency of a good animal model for the study of Huntington Disease 
Since the discovery of the HTT mutation 25 years ago, more than 13,000 papers have been 
published on HD, approximately half of which relate to attempts to model various aspects 
of the disease. As discussed in the previous section, different animal models have been 
established, elucidating important pathways that are disrupted in HD and providing 
important insights into the pathogenesis of this disease. These developments have been 
accompanied by the identification of several therapeutic candidates and novel approaches 
to therapy (Ross & Tabrizi, 2011). Over the past two decades 99 clinical trials have been 
performed in HD investigating 41 different compounds (McColgan & Tabrizi, 2017). 
However, the success rate is low, with only 3.5% of trials making from phase I to approval 
(Travessa, Rodrigues, Mestre, & Ferreira, 2017). Thus, despite the considerable progress in 
our understanding of the disease, an effective treatment that either prevents or slows the 
pace of HD remains out of reach. The slow rate of progression of HD often necessitates 
lengthy and therefore costly clinical trials. In addition, the number of patients with HD 
who are available to participate in such trials is limited, which means that a relatively small 
number of compounds can be tested every time. Thus, animal models will continue to 
have a role not only as a filter for test compounds before the initiation of human clinical 
trials but also as a means for identifying candidate compounds with therapeutic promise. 
The translational potential of an animal model of disease may be gauged on the basis of 
its construct, face and predictive validity (Belzung & Lemoine, 2011). Rodent models of HD 
are versatile, especially when considering the high number of established batteries of 
tests available that allow assessment of motor, cognitive and psychiatric-like features of 
the disease. Studies in rodents that emphasize careful behavioral analysis are being 
developed as effective and inexpensive models that complement clinical studies.
The BACHD rat model
The BACHD rat is the latest rat model of HD, and expresses the full length human 
huntingtin (fl-mhtt) with 97 CAG-CAA repeats under the control of the human HD 
promoter gene and all its regulatory elements to determine its similarity to the human 
condition (Gray et al., 2009; Yu-Taeger et al., 2012). The BACHD rat model is particularly 
relevant since it presents neuropathological and behavioral phenotypes reminiscent of 
symptoms seen among HD patients.
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Neuropathology 
Regional distribution pattern of mhtt-positive aggregates was investigated in BACHD rats, 
which exhibited widely distributed aggregates in all regions, with prominent expression 
in the neocortex and in limbic areas including nucleus accumbens, hippocampus, bed 
nucleus of the stria terminalis, and the amygdala. Very few aggregates were found in the 
dorsolateral caudate-putamen, the lateral globus pallidus, and the substantia nigra 
(Yu-Taeger et al., 2012). 
 Both the size and number of aggregates increased with age, showing the largest 
and most abundant aggregates in amygdala, in the CA3 region of the hippocampus, 
and in the cerebral cortex, indicating that aggregate formation continued to progress in 
these regions (Yu-Taeger et al., 2012). Moreover, dynamic PET scans in the striatum of 
BACHD rats presented a decrease in the striatal uptake of the D2-receptor antagonist [11C]
raclopride, showing a reduced dopamine receptor binding (Yu-Taeger et al., 2012).
Obesity
BACHD rats are obese and suffer from discrete developmental deficits. Although BACHD 
rats do not differ from WT rats in terms of body weight, they display several changes in 
body composition, carrying an excess amount of adipose tissue (Jansson, Clemens, Riess, 
& Nguyen, 2014). When assessing the motivation to lever push for a food reward, BACHD 
rats were found to be less motivated than WT rats, although this phenotype was 
dependent on the food deprivation strategy (Jansson et al., 2014). 
Gait and motor dysfunction
In order to measure forelimb and hindlimb motor coordination, BACHD rats have 
repeatedly been tested in the Rotarod test (Abada, Nguyen, Schreiber, & Ellenbroek, 2013; 
Clemens et al., 2015; Yu-Taeger et al., 2012), showing early impairments which progressively 
worsen over time. Altered activity in the PhenoMaster (TSE Systems, Germany) and in an 
open field test-like setup as well as abnormalities in unhindered walking gait have also 
been reported (Abada, Nguyen, Schreiber, et al., 2013; Yu-Taeger et al., 2012). Moreover, gait 
deficits have been investigated using the Catwalk system, showing that 12 months-aged 
BACHD rats exhibited shorter stride length, shorter stand and shorter front limb swing, 
with no differences in general walking speed. (Abada, Nguyen, Schreiber, et al., 2013). 
Lower rearing and ambulatory activity were observed with the PhenoMaster system at 3 
and 6 months of age (Yu-Taeger et al., 2012). In an open field test-like setup BACHD rats 
exhibited an initial hyperactivity followed by hypoactivity starting at 4 months of age 
(Abada, Nguyen, Schreiber, et al., 2013).
Cognition
In a fear conditioning set-up, BACHD rats exhibited associative memory deficits by 
4 months of age while an impairment of their reversal learning performance emerged at 
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6 months when rats were tested in a cross maze task (Abada, Nguyen, Ellenbroek, & 
Schreiber, 2013). In an object recognition task, BACHD animals presented intact object 
memory at 4 and 12 months of age. BACHD also showed a subtle deficit in prepulse 
inhibition of acoustic startle (Abada, Nguyen, Schreiber, et al., 2013). A recent study 
revealed an impaired performance in two Skinner box tests (delayed alternation and the 
delayed non-matching to position tests), indicating general problems with handling basic 
aspects of the tests, while short-term memory appeared to be intact (Clemensson, 
Clemensson, Riess, & Nguyen, 2017). 
Psychiatric endophenotypes
In the tail suspension test (TST), broadly used to measure depressive-like behavior, 
characteristic hindlimb clasping behavior has been observed in BACHD rats starting at 
three weeks of age (Yu-Taeger et al., 2012). Starting at 4 months of age, BACHD rats display 
also changes in emotionality as suggested by the decreased anxious-like behavior in the 
elevated plus maze (Yu-Taeger et al., 2012). At 4 months, BACHD rats exhibited behavioral 
hyper-reactivity to threats in social (social behavior test) and avoidance learning (signaled 
active avoidance, SAA) tasks. At 9 months of age, deficits in prepulse inhibition became 
evident as well (Abada, Nguyen, Schreiber, et al., 2013). 18 month-old BACHD rats made 
fewer choices during the Rat Gambling Task (RGT) and were less efficient in choosing 
advantageous options than younger animals (Adjeroud et al., 2015). 
Validity of the BACHD rat model for HD
In principle, the relevance of a given animal model of a human disease is often judged on 
the basis of three broad measures of validity: the animal model’s construct validity, face 
validity and predictive validity.
 Construct validity pertains to how closely the animal model reproduces the pathogenic 
lesion that underlies the disease in humans. For genetic diseases such Huntington disease, 
a model with high construct validity would reproduce the human mutation in the context 
of the full length human gene under the control of the gene’s endogenous promoter. 
Therefore, the construct validity of models expressing full-length human mutant 
huntingtin (HTT) is greater than those expressing full-length mouse mutant HTT (Pouladi 
et al., 2013). The BACHD rat model contains human genomic DNA spanning the full-length 
HTT gene with 97 CAG/CAA repeats, under the control of the HTT human promoter and 
including all regulatory elements (Yu-Taeger et al., 2012).
 Face validity refers to whether the overall phenotypes of a disease model, both 
behavioral deficits and neuropathology, faithfully recapitulate the symptoms and 
phenotypes associated with the human disease. For HD, animals with high face validity 
would reproduce progressive motor and cognitive deficits as well as psychiatric-like 
disturbances (Pouladi et al., 2013). As mentioned before, BACHD rats present motor, 
emotional and cognitive impairments resembling symptoms seen among HD patients 
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(Abada, Nguyen, Ellenbroek, et al., 2013; Abada, Nguyen, Schreiber, et al., 2013; Clemensson, 
Clemensson, Fabry, Riess, & Nguyen, 2017; Clemensson, Clemensson, Riess, et al., 2017; 
Lamirault et al., 2017; Manfré et al., 2016; Yu-Taeger et al., 2012). Furthermore, neuro-
anatomically and histologically, the models would display selective, age-dependent 
striatal and cortical neuronal loss and atrophy, nuclear inclusions and neuropil aggregates 
(Pouladi et al., 2013).
 Predictive validity is judged based on how closely improvements in response to 
treatment in the animal model parallel, or predict, improvements in patients. For treatable 
conditions, the predictive validity of an animal model may be tested, but for diseases like 
HD that are without an effective treatment, assessment of the predictive validity of an 
animal model is currently impossible (Pouladi et al., 2013).
Aim and outline of this thesis
Previous experiments have been already performed in this transgenic rat model, but they 
are lacking of information about important phenotypes preceding the onset of symptoms 
in BACHD rats. Despite the extensive use of the BACHD rat line in the last years (Abada, 
Nguyen, Ellenbroek, et al., 2013; Abada, Nguyen, Schreiber, et al., 2013; Clemensson, 
Clemensson, Fabry, et al., 2017; Clemensson, Clemensson, Riess, et al., 2017; Yu-Taeger et al., 
2012) the studies performed so far did not cover fine and gross motor function as well 
as psychiatric endophenotypes such as social behavior and impulsivity. 
 The investigation of the previously mentioned domains is necessary for the early 
detection of the first core symptoms of the disease and the monitoring of its development 
so that possible therapies can be more effective in preventing further development of 
neurodegeneration. 
Although patients and several HD mouse models have been found to present cognitive 
symptoms already before the start of any motor symptoms (Carter et al., 1999; Lichter & 
Hershey, 2010; Paulsen et al., 2001; Van Raamsdonk et al., 2005), this could not be 
demonstrated for the BACHD rat. Conversely, transgenic rats have repeatedly been found 
to show early impairments in the Rotarod test (Abada, Nguyen, Schreiber, et al., 2013; 
Clemens et al., 2015; Yu-Taeger et al., 2012) which progressively worsen over time (Abada, 
Nguyen, Schreiber, et al., 2013; Clemens et al., 2015; Yu-Taeger et al., 2012). Altered activity 
in the PhenoMaster (TSE Systems, Germany) and in an open field test-like setup as well as 
abnormalities in unhindered walking gait have also been reported (Abada, Nguyen, 
Schreiber, et al., 2013; Yu-Taeger et al., 2012). These findings suggest that a more in-depth 
investigation of various aspects of motor function in BACHD rats is needed. In chapter 2 
we further dissect the motor phenotype of this transgenic rat model of HD by combining 
traditional and modern paradigms, hypothesizing that this impairment might be due 
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to deficits in: 1) fine motor control; 2) muscle strength and/or endurance; 3) locomotor 
activity.
 Cognitive and psychiatric symptoms, including perseveration, lack of insight, 
 distractibility, impaired social life, anxiety and impulsivity, affect HD patients before motor 
symptoms (Dale & van Duijn, 2015; Novak & Tabrizi, 2010; Rosenblatt, 2007; Vamos et al., 
2017) and have thus an early deleterious impact on the quality of HD patient’s life. BACHD 
rats’ psychiatric phenotype has been only partly investigated indicating that the BACHD 
rat line requires further phenotyping to parallel their impairments to patients’ symptoms. 
In chapter 3, we focus on social behavior of BACHD rats as its changes are an important 
component of neuropsychiatric symptoms. Some aspects of social behavior have been 
partly examined in different rodent models of HD, showing altered social interaction 
(Nguyen et al., 2006; Pietropaolo, Delage, Cayzac, Crusio, & Cho, 2011; Wood & Morton, 
2015) and social preference (Pietropaolo et al., 2011), reduced social memory and 
recognition (Ciamei & Morton, 2008; Rudenko, Tkach, Berezin, & Bock, 2010) and even 
increased levels of aggression (Shelbourne et al., 1999), supporting the view of impaired 
social behavior also in various rodent models of HD. We therefore investigated different 
parameters of the social behavior repertoire. Additionally, gene expression analyses were 
performed to evaluate a potential involvement of D1 and D2 dopaminergic receptors and 
the contribution of brain-derived neurotrophic factor (BDNF) to the observed behavioral 
alterations.
 In chapter 4 we examined impulsivity traits in BACHD rats by using two different 
paradigms, the delay discounting task (DD), and the Differential Reinforcement of Low 
Rate of Responding task (DRL), to assess choice and action impulsivity, respectively. 
 In chapter 5 risk assessment and anxiety-like traits were characterized in a separate 
cohort of animals tested longitudinally, using the elevated plus maze and light-dark box. 
Additionally, an automated tool for assessing anxiety within a home cage-like environment 
allowed us to further investigate anxiety through an anxiety test “light spot” (LS). This 
home cage test provides the opportunity for in-depth analysis, making it a potentially 
useful tool for detecting subtle or complex anxiety-related traits.
 Finally, chapter 6 provides a general discussion and future perspectives regarding 
the results reported in this thesis.
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Chapter 2
Abstract
Rationale: Huntington disease (HD) is a progressive neurodegenerative disorder characterized 
by motor, cognitive and neuropsychiatric symptoms. HD is usually diagnosed by the 
appearance of motor deficits, resulting in skilled hand use disruption, gait abnormality, 
muscle wasting and choreatic movements. The BACHD transgenic rat model for HD 
represents a well-established transgenic rodent model of HD, offering the prospect of an 
in-depth characterization of the motor phenotype.
Objective: The present study aims to characterize different aspects of motor function in 
BACHD rats, combining classical paradigms with novel high-throughput behavioral 
phenotyping.
Methods: Wild-type and transgenic animals were tested longitudinally from 2 to 12 months 
of age. To measure fine motor control, rats were challenged with the pasta handling test 
and the pellet reaching test. To evaluate gross motor function, animals were assessed by 
using the holding bar and the grip strength tests. Spontaneous locomotor activity and 
circadian rhythmicity were assessed in an automated home-cage environment, namely 
the PhenoTyper. We then integrated existing classical methodologies to test motor 
function with automated home-cage assessment of motor performance.
Results: BACHD rats showed strong impairment in muscle endurance at 2 months of age. 
Altered circadian rhythmicity and locomotor activity were observed in transgenic animals. 
On the other hand, reaching behavior, forepaw dexterity and muscle strength were unaffected. 
Conclusions: The BACHD rat model exhibits certain features of HD patients, like muscle 
weakness and changes in circadian behavior. We have observed modest but clear-cut 
deficits in distinct motor phenotypes, thus confirming the validity of this transgenic rat 
model for treatment and drug discovery purposes.
Keywords: 
Huntington disease, polyglutamine disease, model characterization, motor function, transgenic 
rat, neurodegenerative disorders, fine motor control, automated home-cage monitoring.
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Introduction
Huntington disease (HD) is a severe autosomal dominant neurological disorder. Typically, 
onset of symptoms is during middle age and it consists of a triad of motor, cognitive and 
psychiatric symptoms (Walker, 2007). The motor symptoms of HD are varied and encompass 
involuntary movements such as chorea as well as impaired voluntary movements, which 
cause limb incoordination and impaired hand function (Novak and Tabrizi, 2010). These 
symptoms are worsened by loss of postural reflexes and their pattern tends to change 
over time, with chorea declining and dystonia, rigidity, and bradykinesia becoming more 
marked (Nguyen and Cenci, 2015; Novak and Tabrizi, 2010). Motoric symptoms are 
frequently involved in the cause of death, along with complications such as dysphagia 
and aspiration (Nguyen and Cenci, 2015; Walker, 2007). Typical latency from diagnosis to 
death is 20 years (Walker, 2007; Watt, 1990). The disease is caused by an expanded CAG 
mutation in the huntingtin (HTT) gene (Huntington’s Disease Collaborative Research 
Group, 1993), leading to initial atrophy and cell loss in the neostriatum (caudate nucleus 
and putamen in humans), then spreading to cortical areas and eventually affecting the 
whole brain (Vonsattel et al., 1985). Although disease progression is currently untreatable, 
efforts are aimed at identifying novel symptomatic, neuroprotective and reparative 
treatments (Frank, 2014). The latest drug approved for use in the United States, deutetra-
benazine, adds to the other drugs that can alleviate some of the choreic and psychiatric 
symptoms of HD (Frank, 2014; Frank et al., 2016). Part of that research effort involves 
identifying suitable animal models that provide a valid representation of the pathological 
and behavioral profile of the human disease and that can serve for the identification of 
therapeutic candidates and novel approaches to therapy (Kumar et al., 2010; Pouladi et al., 
2013; Ross and Tabrizi, 2011). Between mammalian species, rats were the first animals used 
for scientific purposes and have been considered for decades as a key model organism in 
biomedical science, including neurological disorders and behavioral neuroscience (Cenci 
et al., 2002; Homberg et al., 2017). Accordingly, some complex behaviors and physiological 
processes that can be readily studied in rats are difficult or impossible to investigate in 
mice (Ellenbroek and Youn, 2016; Homberg et al., 2017). Comparative analyses of movements 
in rats and primates show homology of many motor patterns across species. Advances 
have been made in identifying rat equivalents of akinesia, tremor, postural deficits and 
dyskinesia, which are relevant to neurological disorders (Cenci et al., 2002). 
 The BACHD rat is a recently generated transgenic rat model expressing full-length 
human mutant huntingtin (mHTT) and is currently being characterized in order to 
understand its advantages and limitations concerning modeling of HD. BACHD rats 
present a wide range of behavioral abnormalities reminiscent of the cognitive, emotional 
and motor alterations observed in HD patients (Abada et al., 2013a, 2013b; Clemens et al., 
2015; Clemensson et al., 2017a, 2017b; Jansson et al., 2014; Manfré et al., 2016; Yu-Taeger et 
al., 2012). Previous characterization studies in these rats showed the presence of emotional 
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alterations, as suggested by a decreased anxious-like behavior in the elevated plus maze 
(Yu-Taeger et al., 2012). BACHD rats also exhibited associative memory deficits in a fear 
conditioning setup, impairments of their reversal learning performance in a cross maze 
task (Abada et al., 2013a) as well as deficits in prepulse inhibition (Abada et al., 2013b). 
Furthermore, BACHD animals exhibited signs of fronto-striatal impairment in different 
Skinner box tasks for short term memory (Clemensson et al., 2017b) and an impulsive-like 
phenotype was shown in a delayed discounting paradigm and in the Differential 
Reinforcement of Low Rate of Responding task (Manfré et al., 2016). 
 Although patients and several HD mouse models have been found to present 
cognitive symptoms already before the start of any motor symptoms (Carter et al., 1999; 
Lichter and Hershey, 2010; Paulsen et al., 2001; Van Raamsdonk et al., 2005), this could not 
be demonstrated for the BACHD rat. Instead, BACHD rats have repeatedly been found to 
show early impairments in the Rotarod test (Abada et al., 2013b; Clemens et al., 2015; 
Yu-Taeger et al., 2012) which progressively worsens over time (Abada et al., 2013b; Clemens 
et al., 2015; Yu-Taeger et al., 2012). Altered activity in the PhenoMaster (TSE Systems, 
Germany) and in an open field test-like setup as well as abnormalities in unhindered 
walking gait have also been reported (Abada et al., 2013b; Yu-Taeger et al., 2012). These 
findings suggest that a more in-depth investigation of various aspects of motor function 
in BACHD rats is needed. Therefore, the aim of this study was to further dissect the motor 
phenotype of this transgenic rat model of HD by combining traditional and modern 
paradigms. We hypothesize that this impairment might be due to deficits in: 1) fine motor 
control; 2) muscle strength and/or endurance; 3) locomotor activity.
 One of the fine motor functions that is possible to investigate is skilled reaching (the 
conventional term for the reach-to-eat act), which is a form of prehension in which a hand 
is used to grasp a food item and place it into the mouth for eating (Alaverdashvili and 
Whishaw, 2013). Skilled reaching is an everyday activity for humans (Sacrey and Whishaw, 
2010). As mentioned earlier, rats serve as excellent models to reproduce deficits in motor 
ability, such as the ability to manipulate or reach various objects (Klein and Dunnett, 2012). 
Furthermore, manual dexterity is also a central daily activity and it is commonly disrupted 
by nervous system damage, often with permanent effects (Iwaniuk and Whishaw, 2000). 
Rodents use their forepaws in dexterous ways that are in some capacities homologous to 
humans (Cenci et al., 2002; Iwaniuk and Whishaw, 2000). Since HD patients have difficulties 
in manipulating and reaching objects, translating such behaviors to an animal model is of 
great interest, providing more information on a potential read-out for future treatments 
(Klein et al., 2012).
 Another cause that might underlie the motor deficits of BACHD animals is an 
impairment in gross motor function. HD patients and animal models of HD present signs 
of peripheral motor pathology, including gait abnormality and muscle wasting (De 
Aragão et al., 2016). Hence, characterizing this aspect in rodent models of progressive 
 neurodegenerative and muscle wasting diseases requires a battery of tests. Classical 
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behavioral assays such as the holding bar and the grip strength test are still of high value 
to assess muscle function and coordination (Brooks and Dunnett, 2009; Klein et al., 2012; 
Nguyen and Cenci, 2015). 
 A further aspect that can be evaluated concerns altered locomotor activity, since HD 
patients exhibit imbalance, trouble in walking, clumsiness and unsteadiness (Di Maio et al., 
1993). In previous studies, motor phenotypes in rodent models of  HD and Duchenne 
muscular dystrophy have been assessed using different setups, showing consistent results 
(Hara et al., 2002; Hickey et al., 2008). Accordingly, in the last decade there has been a 
concerted effort towards automating methods for continuous automated home-cage 
assessment and for measuring motor function (Bains et al., 2017; Chort et al., 2013; 
Vandeputte et al., 2010). Such technologies are aimed at capturing a wider range of 
behaviors and are free from experimenter bias through the possibility to house rodents in 
automated home-cage environments for extended periods of time and to measure 
voluntary activity without interference from the investigator (Schaefer and Claridge-
Chang, 2012). Here, BACHD and control rats were tested in an instrumented home-cage 
(PhenoTyper®, Noldus Information Technology) to monitor locomotor and circadian 
activity over time. 
 In the present study, we focused on tasks that may reveal subtle motor disturbances 
characteristic of human HD. To expand the repertoire of meaningful motor function tests, 
we combined classical behavioral paradigms with automated home-cage observations 
which allow high-throughput testing. The tests were performed at three different ages (2, 
7 and 12 months) to assess the onset and progression of specific motor symptoms and 
provide read-out parameters for future pre-clinical studies applying novel drugs for the 
treatment of HD.
Material and methods
Animals
Wild-type (WT) and transgenic (hemizygous BACHD; TG5 line) male rats carrying the 
mutant human huntingtin gene, under the control of the human huntingtin promoter 
and its regulatory elements were used. The transgene contained 97 CAG-CAA mix repeats, 
and additional 20 kb upstream and 50 kb downstream sequences ensured stability of the 
repeat length (Yu-Taeger et al., 2012). The construct has previously been used to generate 
the BACHD mouse (Gray et al., 2008). All animals were maintained on Sprague Dawley 
background and genotyped according to previously published protocols (Yu-Taeger et al., 
2012). As the study was a collaborative effort, two different cohorts have been used at 
University of Tuebingen (Tuebingen, Germany) for Experiment 1, and at Radboudumc 
(Nijmegen, The Netherlands) for Experiment 2. Each group of animals was subjected to a 
different battery of tests, as described in the study design section.
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 For Experiment 1, 12 BACHD rats and 12 WT rats were obtained from in-house breeding 
with hemizygous BACHD males from the TG5 line (Yu-Taeger et al., 2012) paired with WT 
females (Charles River, Germany). Rats were weaned at 21 days of age and housed in gen-
otype-matched groups of three rats per cage in type IV cages (38 x 55 cm) with high lids 
(24.5 cm from cage floor), containing wooden houses, nesting paper and wooden 
bedding material. All rats used for testing were handled on a daily basis. The animal facility 
kept 21–23°C, 55–10% humidity, and was set to a partially reversed light/dark cycle with 
lights on/off at 02:00/14:00 during summer, and 01:00/13:00 during winter. Food and water 
regimen is described in the study design section. All experiments were approved by the 
local ethics committee (Regierungspraesidium Tuebingen) and carried out in accordance 
with the German Animal Welfare Act and the guidelines of the Federation of European 
Laboratory Animal Science Associations, based on European Union legislation (Directive 
2010/63/EU). 
 For Experiment 2, 15 transgenic males were supplied from the original BACHD colony 
of Charles River (Wilmington, MA, USA) and an in-house breeding colony was preserved 
and maintained at Radboudumc (Nijmegen, The Netherlands) by cross-breeding these 
males with wild-type female rats (Charles River, Germany). WT and BACHD animals (n=12/
group) were weaned at 21 days of age and group-housed two per cage with littermates 
of the same genotype in type IV cages (38 x 55 cm) containing plastic houses, nesting 
paper and wooden bedding material. Cages were in a constant temperature-humidity 
room (19.5 °C - 54% humidity) with a regular 12 h light/dark cycle with lights on/off at 
8:00/20:00). Food and water were provided ad libitum. 
 Body weights were measured regularly throughout the study in both groups, and as 
seen with other cohorts of male BACHD rats, there was no difference in body weight 
between the genotypes (data not shown). It should be noted though that despite the 
unchanged body weight, BACHD rats have been reported to have a reduced bone and 
muscle mass and an increased fat mass from 3 months of age onwards (Jansson et al., 
2014) but these parameters could not be assessed in the present study.
 All experiments were positively evaluated by the Animal Ethics Committee (‘RU-DEC’, 
Nijmegen) and performed under a project license from the Central Committee on Animal 
Experiments (CCD, The Hague), in full compliance with the legal requirements of Dutch 
legislation on the use and protection of laboratory animals.  
Study Design
There were two experiments conducted for this study.
Experiment 1: Fine Motor Control
Prior to behavioral testing described below, all animals (2-month aged) were subjected to 
the Rotarod test (for detailed protocol see Clemens et al., 2015). This was done to ensure 
that BACHD rats exhibited the strong phenotype observed in previous studies (Abada et 
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al., 2013b; Clemens et al., 2015; Yu-Taeger et al., 2012) and to avoid having a group of rats 
not being representative for the model. After confirming the presence of the Rotarod 
impairment (data not shown), animals were divided in two groups (n=6/group) and 
longitudinally tested at 2, 7 and 12 months of age according to the following scheme. 
On any given day, one group was challenged with the pasta handling and the pellet 
reaching test, while the rats of the other group rested. Therefore, groups were assessed on 
alternating days until stable performance (10 sessions/age point for the pasta handling 
and 8 sessions/age point for the pellet reaching test). Unless otherwise noted, behavioral 
testing took place during the light phase to allow optimal visualization of fine movements. 
 During non-testing periods, all animals were given access to food and water ad libitum. 
Two weeks before each testing phase, daily food amount was progressively reduced until 
rats reached 85% of their respective free-feeding body weights. Afterwards, they were fed a 
daily ration in order to maintain this restriction level, taking normal growth into consideration. 
The animals were weighed every morning to assess food restriction levels and fed in their 
home-cages at 17:00 h. Following the testing periods, animals were again fed ad libitum.
 During scoring of both behavioral tests, the experimenters were blind to the rats’ 
genotypes, while this was not the case when the videos were gathered. After being tested 
at 12 months of age, all rats were used for additional food consumption tests published 
elsewhere (Clemensson et al., 2017a).
Experiment 2: Gross Motor Function and Locomotor Activity
Animals were divided in two groups of WT and BACHD (n=6/group) and longitudinally 
tested at 2, 7 and 12 months of age according to the following scheme. On day 1, rats were 
challenged with the holding bar test and subsequently housed in the PhenoTyper® cages 
for six consecutive days (day 1-6) to assess locomotor activity (de Visser et al., 2006). 
Animals were then taken out of the PhenoTyper® and socially housed for 48 hours (day 7-8) 
as resting period. On days 9-10, animals were, respectively, trained and tested for grip 
strength. All behavioral tests were performed during the light phase and carried out by a 
single experimenter, while another experimenter (blind to the rats’ genotype) was 
videotaping or scoring the behavior. 
Behavioral Procedures
Experiment 1: Tests for Fine Motor Control
Pasta handling test
The pasta-handling test was used to evaluate forepaw dexterity in the BACHD rats. This 
test has been found to be sensitive to a wide range of injuries and impairments (Allred et 
al., 2008, Tennant et al., 2010). Although the original protocols suggest using 7 cm-long 
spaghetti pieces, we have found that our rats eat in a hunched-over position, causing 
them to frequently break pasta pieces of such lengths. For the current study, the rats were 
therefore given strands of uncooked spaghetti (1.5 mm in width and 0.15 g/piece, Barilla, 
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Italy) that were cut to lengths of 5 cm. Prior to the first test occasion, rats were habituated 
to the pasta by placing 8 pieces into their social home-cages during 5 consecutive days. 
Afterwards, rats were given three habituation sessions in the test setup that was used. The 
test used a glass cage (28.5 x 29 x 29.5 cm) with mirrors on the floor and along two walls, 
which ensured a good view of the test animals. The sessions followed a similar structure 
during both, habituation and testing. At the start of each session, a rat was placed inside 
the setup. Afterwards, a single piece of spaghetti was dropped into the cage, and the rat 
was allowed to consume it. When the rat consumed the first piece, a new spaghetti piece 
was dropped into the cage. During habituation sessions, no video recordings were made, 
and the sessions ended either after consumption of two spaghetti pieces, or when 5 
minutes had elapsed. Rats that did not consume the first pasta piece within the set time 
limit were given an additional session at the end of the day, during dark phase, to promote 
habituation. After the habituation sessions, all rats were given ten test sessions, organized 
as described in the study design section. For these sessions, pasta pieces were filed down 
to achieve blunt edges and marked with an ultrafine tip marker at specific intervals (1 cm 
increments) in order to facilitate visualization of the movement of the pasta strand during 
eating. During each session, rats were given between 2 and 5 pasta pieces, depending on 
their behavior, with the aim to obtain two consumption videos of good quality from each 
rat. Sessions during which a rat broke the pasta piece were excluded and not counted as 
consumption video. A minimum of 20 consumption videos was gathered for each rat and 
test age. For occasions where the initial ten testing sessions were insufficient to achieve 
this, additional test sessions were given. Rats were videotaped with a handheld camera 
(Sony HD Handycam, Japan) positioned to optimize the view of paw movements. Several 
behavioral parameters were scored from the videos. Some of these concerned detailed 
scoring of biting and chewing behavior, and are further described in the Supplementary 
material. The primary readouts, however, concerned the rats’ forepaw use. For this, the 
total time spent actively handling the pasta piece was measured using a stopwatch during 
normal speed playback of the videos (MacLaren et al., 2014). This parameter specifically 
excluded occasions where the rats chewed, flipped over or dropped the pasta piece to 
obtain the time they actively manipulated it with their forepaws. Slow motion video 
playback (~50% of real-time) was then used to quantify the number of forepaw 
adjustments. The total number of adjustments of each paw was counted per trial. A 
normal adjustment was defined as any distinct removal and replacement of the paw, or of 
any number of digits, on the pasta piece after eating commences.  
Pellet reaching test
To assess skilled reaching, the rats were assessed in a pellet reaching test. Other protocols 
of such behaviors are sensitive to discreet neuropathologies (Farr and Whishaw, 2002; 
Klein and Dunnett, 2012). All sessions were conducted in a transparent Plexiglas box (35 
cm long x 35 cm wide x 35 cm tall) placed on a table surface. Each side presented two 1 
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cm wide, slit vertical openings that allowed the animals to reach for 45 mg grain-based 
precision pellets (Bio-Serv, Dustless Precision Pellets F0021, purchased through Bilaney 
Consultants, Duesseldorf, Germany) placed on a wooden frame attached to each side of 
the box, and allocated 3 cm above the floor. Before the first test occasion, the rats were 
habituated to the pellets by placing a spoonful into their home-cages for 5 consecutive 
days. Animals were then positioned in the apparatus individually and first acclimatized to 
the chamber with two shaping sessions in the dark phase, during which 20 pellets were 
placed, one at a time, on the wooden frame, at a distance of 1.5 cm from the openings. 
After shaping, limb preference of individual animals was determined by challenging each 
rat with a single session during which 100 reaching attempts were scored. During this, the 
pellets were placed centrally in front of one opening to allow the rat to use either paw. 
When 80% out of 100 reach attempts were made with one limb during this single session, 
that limb was identified as the preferred one. In the subsequent training sessions, food 
pellets were located contralateral to this limb at a distance of 1.5 cm from the slit openings. 
This enabled the animals to reach for pellets with their preferred limb. Animals that were 
not attempting to reach the pellets were further trained during the dark phase, placing 
the pellets at 1 cm distance from the slit openings to encourage reaching attempts. Some 
animals used their tongue instead of their paws and were further trained, during the dark 
phase, to reach the pellets at a distance of 2 cm from the openings. When all animals had 
made 20 reaching attempts within a single session, with the pellet placed 1.5 cm away 
from the slit, they progressed to the testing sessions. It took a total of five days for all rats 
to reach this criterion. During test sessions, rats were allowed to reach for a total of 30 
pellets (considered as 30 separate trials). The first ten pellets were considered as warm up 
trials, and the following 20 were considered testing trials. The pellets given on subsequent 
trials were placed so that the pellet position alternated between two sides of the box, but 
randomized between the two available slits on each wall. Through this, a predictable 
pattern of side alternation, but unpredictable pattern of specific pellet position was 
obtained. This was done to induce a partial searching behavior among the rats, which 
ensured goal-directed reaches. It should be noted that the exact use of the different slits 
was still balanced so that no opening was overrepresented during testing. Rats were given 
one test session per day until they reached a stable performance. This resulted in a total of 
8 test sessions per age point. The success rate of the rats’ reaching attempts was used as 
outcome measure. Reaches were considered successful if the rat had grabbed the pellet 
on the first reach attempt and managed to retrieve and eat it without dropping it into the 
cage bedding. All other behaviors were considered failure. Success rates were calculated 
as the number of successful reaches out of the final 20 pellets offered at each session. 
Recordings were made with a small action camera (Mini WiFi Camcorder 1, Rollei, Germany) 
connected to a computer using AVS videorecorder (http://www.avs4you.com/AVS-Vid-
eo-Editor.aspx). Slow motion video playback (~50% of real-time) was used to calculate the 
number of successful reaches.
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Experiment 2: Tests for Gross Motor Function and Locomotor Activity
Holding bar test
The holding bar test was used to assess forelimb hanging strength and balance over time 
(Li et al., 2004; Putten et al., 2012). The test apparatus consisted of a 37 cm-wide and 3 
mm-thick wooden bar tightly secured between two vertical stands placed around 75 cm 
above a pillow. The height was sufficient to encourage the animals to hold the bar, but 
also low enough to prevent them from injuries when falling down. Each animal was 
handled via the body and brought near the bar, allowing the grasping of the bar with the 
forepaws only. Each rat was videotaped with an iPhone® 6S (Apple, Cupertino, CA, United 
States) and given 3 consecutive trials (ITI = 1 min). The average of the three trials was used 
as main outcome measure. Moreover, the Holding Impulse (s*g) = hang time (s) x body 
mass (g) was used to correct for the negative effects of body mass on the hanging time, 
and it reflected the minimal amount of sustained tension (impulse) that the animal 
developed for supporting itself on the bar against gravity for the longest period of time 
(Putten et al., 2012). When improper behavior occurred (e.g. balancing on top of the bar or 
deliberately jumping off the bar) the trial was omitted and repeated. Suspension latencies 
were scored with slow motion video playback (~50% of real-time) using The Observer XT 
12 (Noldus Information Technology, Wageningen, The Netherlands).
Grip strength
This test is based on the tendency of a rat to instinctively grasp a bar or a grid when 
suspended by the body, and permits assessment of the strength of the forelimbs. The test 
apparatus (Grip Strength Meter, Ugo Basile, Italy) consisted of a grasping bar attached to a 
force transducer in order to measure the maximum force applied by the rat during the 
pull. The unit of force used was grams-of-force. Each animal was handled via the body and 
brought near the bar, allowing the grasping of the grid with both forepaws and then 
gently pulled back until they released it. Animals were trained and tested on two 
consecutive days, using the same protocol. Five such measurements were obtained for 
each animal, and the resting period between each pull was one minute (Aartsma-Rus and 
van Putten, 2014; Jeyasingham et al., 2001).
Locomotor activity in the PhenoTyper 
Locomotor activity was recorded by videotracking in the PhenoTyper (Noldus Information 
Technology, Wageningen, The Netherlands), an instrumented home-cage in which rodent 
behavior was automatically monitored through a video-based observation system, as 
described in detail by de Visser et al. (de Visser et al., 2006). The cages (45 cm x 45 cm x 45 cm) 
were made of transparent Perspex walls with an opaque Perspex floor covered with 
 cellulose-based bedding (Cellu-Dri, LBS Biotechnology, United Kingdom), and equipped 
with a water bottle, a feeding station and a shelter in one corner (14.3 cm x 14.3 cm x 11.5 cm). 
Food and water were provided ad libitum. Video tracking was performed by an infrared- 
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sensitive video camera installed in the top unit of each cage, infrared lighting sources 
and hardware and software needed for videotracking. EthoVision 9 was used for data 
acquisition and Ethovision XT 11.5 for analysis (Noldus Information Technology, Wageningen, 
The Netherlands). Rats were introduced into the PhenoTyper during the light phase 
(between 12:00 and 16:00 h) and monitored for six consecutive days. Spontaneous 
locomotor activity was assessed, scoring the following parameters: distance moved, 
velocity, number of jumps and time spent on top of the shelter. We additionally 
investigated potential sleep disruption and/or altered circadian rhythmicity, taking into 
account the time spent inside the shelter. All parameters were calculated using the means 
of day 4-6 (de Visser et al., 2006) and results were then split into dark and light phases, 
according to the day-night cycle of the animals. No human interference took place 
between the start and the end of the observations (hence, no intermediate cleaning of 
the cages).
Statistical Analyses
All statistical analyses were conducted using GraphPad Prism v.6.0 (GraphPad Software, 
San Diego California USA, http://www.graphpad.com). Two-way repeated measures 
ANOVAs were used to analyze all parameters. Age was used as within-subject factor, and 
genotype as between-subject factor. Bonferroni post-hoc test was used to follow up any 
significant effect of genotype found in the two-way ANOVAs. A p-value < 0.05 was 
considered statistically significant.
 During Experiment 1, two BACHD rats did not consume the pasta strands during every 
testing day, and were therefore excluded from the analysis. Between two testing periods 
of Experiment 2, two BACHD rats fell ill and had to be sacrificed and removed from the 
experiment at 9 and 11 months of age, respectively. In both cases, the illnesses concerned 
tumors. Due to technical problems, the locomotor activity/circadian rhythmicity data 
from two WT and four BACHD rats could not be analyzed. 
 Thus, the n of the analyses changed as follows: for the pasta handling test (WT: 12, 
BACHD: 10), for the pellet reaching task (WT: 12, BACHD: 12), for the holding bar test (WT:12, 
BACHD: 10), for the locomotor activity/circadian rhythmicity (WT: 8, BACHD: 8), for the grip 
strength (WT:12, BACHD: 10). Age development analyses excluded data from animals that 
were not assessed at all ages. No other exclusion criteria were used. 
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Results
Experiment 1: Fine Motor Control
Pasta Handling Test
Figure 1A shows a photo of a rat during the pasta-handling test, displaying its typical paw 
placement during consumption. The number of adjustments required to eat the pasta 
piece was calculated over different sessions at the three different test ages (Figure 1B). 
All groups were found to use less adjustments by the final age of testing (age effect: F(2, 40) 
= 17.51, p<0.0001) without any significant genotype or interaction effects. The handling 
time also changed with age (F(2, 42) = 16.08, p<0.0001), with both WT and BACHD rats 
showing a longer handling time during the first test age compared to the following 
two (Figure 1C). There was no difference between WT and BACHD rats’ handling time at 
any age (genotype effect: F(1, 21) = 0.3779, p=0.5454). The rate of adjustment, shown in 
Figure 1D, served as an indication of the number of adjustments over the total time 
of handling, which did not unravel significant age, genotype or interaction effects (age 
effect: F(2, 40) = 2.195, p=0.1246; genotype effect: (F(1, 20) = 0.02155, p=0.8848; interaction 
effect: F(2, 40) = 0.1206, p=0.8867 ). 
 We further performed a detailed analysis of parameters related to biting and chewing, 
which did not reveal any prominent phenotypes, and are described and discussed in the 
Supplementary material. 
Pellet Reaching Test 
Figure 2A,B show the pellet reaching setup with an animal engaging in the test. Figure 2C 
illustrates the mean reaching scores in the pellet reaching test. Performance did not differ 
between the two groups at any age, although success rate of both genotypes dropped 
over time (age effect: F(2, 22) = 10.26, p=0.0007; genotype effect: F(1, 11) = 0.2214, p=0.6472). 
The major reason for failure to retrieve a pellet in either group was that pellets were either 
dropped during the reaching attempt(s) or displaced from the frame. It should be noted 
that the protocol and setup for the pellet reaching resulted in rats frequently standing at 
an angle to the openings rather than straight in front of them. 
 However, more specific scoring suggested that differences in body position did not 
affect the rats’ success rate, and did not differ between genotypes (data not shown). 
Experiment 2: Gross Motor Function and Locomotor Activity
Holding Bar
Figure 3A presents the average holding time of three trials, which reduced in both 
genotypes between 2 and 7 months of age, showing significant age (F(2,40) = 10.06, 
p=0.0003) and age x genotype effect (F(2,40) = 6.226, p=0.004). BACHD rats exhibited 
significant impairment compared to WT rats at 2 months of age only, as shown by the 
reduced average hanging time (genotype difference in post-hoc analysis 2 months: 
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Figure 1  Basic parameters of the pasta handling test.
(A) A photo displaying a rat during consumption of a spaghetti piece. Rats grasp the pasta 
pieces with both front paws and guide them using a coordinated asymmetrical pattern. 
The “grasp” paw holds the pasta in a whole-paw grasp, typically positioned lower (away 
from the mouth) on the piece at the start of eating. The other paw is named the ‘’guiding” 
paw due to the fact that it is closer to the mouth than the grasping paw and is used to 
guide the pasta accurately between the teeth (Allred et al., 2008). (B) Age development of 
the number of adjustments needed for consuming a single spaghetti piece. (C) Age 
development of the total time spent handling a single spaghetti piece. (D) Age 
development of the rate of adjustment (number of adjustments over the total handling 
time). Data are expressed as means ± S.E.M. Two-way ANOVA results are displayed within 
each graph. Results from post-hoc analysis are indicated in case significant genotype 
differences were found. (***) p < 0.001, (****) p < 0.0001, ns (not significant)
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p<0.01). At 7 and 12 months of age, a genotype effect was not evident (F(1, 20) = 3.452, 
p=0.078). 
 The holding impulse decreased in WT rats with increasing age, while it non-signifi-
cantly increased in BACHD rats (age effect: F(2, 40) = 0.2972, p=0.1106; genotype effect: F(1 
20) = 2.788, p=0.1106; Figure 3B), resulting in a significant age x genotype effect (F(2,40) = 
7.318, p=0.002). Although ANOVA revealed no overall genotype effect, post-hoc analyses 
indicated the presence of deficits in the holding impulse in BACHD rats at 2 months of age 
(p<0.01).
Figure 2  Pellet Reaching test.
(A) Olfactory engagement with a food pellet and body posture of a rat before initiating a 
reach. (B) A rat reaching for a pellet through one of the slit openings. (C) Timeline of mean 
reaching success (per 20 reaches) in BACHD and WT control rats tested at 2, 7 and 12 
months of age. Data are expressed as mean success rate over eight different sessions ± 
S.E.M. Two-way ANOVA results are displayed within each graph. Results from post-hoc 
analysis are indicated in case significant genotype differences were found. (***) p < 0.001, 
ns (not significant)
C
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Grip Strength 
Figure 3C represents the average of the three highest values of grip strength, which did 
not show any significant genotype (F(1, 20) = 3.861, p=0.0635), age (F(2, 40) = 2.72, p=0.0781) or 
interaction effects (F(2, 40) = 0.07663, p=0.9264). Figure 3D shows the rats’ performance 
normalized to the animals’ individual body weight. The performance of BACHD and WT 
rats worsened between the age of 2 and 12 months, as reflected by a significant age 
effect (F(2, 40) = 123.1, p<0.0001). The ANOVA revealed a general genotype effect (F(1, 20) = 
6.186, p=0.0218), but no significant genotype x age interaction. Post-hoc analyses indicated 
that BACHD rats had significantly increased grip strength at 2 months of age (p<0.05). 
Figure 3  Holding Bar and Grip Strength tasks.
(A) Mean latency in the Holding Bar maneuver. (B) The Holding Impulse, outcome measure 
(s*g) reflecting the minimal amount of sustained tension (impulse) that is needed to oppose 
gravity. (C) Performance in the Forelimb Grip Strength test. (D) Performance in the Forelimb 
Grip Strength test normalized for body weight. Data are expressed as means ± S.E.M. 
Two-way ANOVA results are displayed within each graph. Results from post-hoc analysis are 
indicated in case significant genotype differences were found. (*) p < 0.05, (**) p < 0.01, (***) 
p < 0.001, (****) p < 0.0001, ns (not significant)
A
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Locomotor Activity in the PhenoTyper 
Dark phase
Distance travelled (age effect: F(2, 32) = 134.5, p<0.0001; Figure 4A) and velocity (age effect: 
F(2, 32) = 112.8, p<0.0001; Figure 4B)  during the dark phase was gradually reduced with age 
in animals of both genotypes. At each age, these parameters indicated similar behavior of WT 
and BACHD rats (distance travelled genotype effect: F(1, 16) = 0.35,  p=0.5624) (velocity genotype 
effect: F(1, 16) = 1.101, p=0.3095). However, BACHD rats showed a significant decrease of the 
number of jumps on top of the shelter compared to age-matched WT rats, exhibiting 
significant age (F(2, 32) = 3.886, p=0.0308) and genotype differences (Figure 4C; post-hoc 
analyses 2 months: p<0.05). On the other hand, animals of different genotypes did not 
present any significant differences in the time spent on the shelter (genotype effect: F(1, 16) = 
2.245, p=0.1535; Figure 4D). Moreover, BACHD and WT rats did not spend different 
amounts of time inside the shelter (genotype effect: F(1, 16) = 0.7144, p=0.4105); there was 
only a significant effect of age (F(2, 32) = 16,77, p<0.0001; Figure 4E).
Light phase
The overall locomotor activity changed with age in both WT and BACHD, showing a 
significant age effect in the distance moved (F(2, 32) = 45.45, p<0.0001; Figure 5A), in the 
velocity (F(2, 32) = 11.47, p=0.0002; Figure 5B) and in the time spent on the shelter (F(2, 32) = 
7.809, p=0.0017; Figure 5D). BACHD rats showed a significant reduction of the distance 
travelled and the velocity, exhibiting significant genotype differences in post-hoc 
analyses for distance moved (2 months: p <0.01, 7 months: p<0.001, 12 months: p<0.0001; 
Figure 5A), for velocity (2 months: p <0.001, 7 months: p<0.05, 12 months: p<0.01; 
Figure 5B) and for number of jumps on top of the shelter (2 months: p <0.01; Figure 5C). 
Moreover, BACHD rats showed decreased time spent on the shelter (Figure 5D), exhibiting 
a significant genotype effect in post-hoc analyses (12 months, p<0.0001) and significant 
interaction between genotype and age (F(2, 32) = 6.750, p=0.0036). On the contrary, BACHD 
rats spent significantly more time in the shelter, showing a genotype effect (F(1, 16) = 6.132, 
p=0.0248) in the time spent inside the shelter (Figure 5E), without showing any age 
(F(2, 32) = 1.408, p=0.2594) or interaction (F(2, 32) = 0.7329, p=0.4884) effect.
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Discussion 
In previous studies BACHD transgenic rats presented a strong motor coordination deficit 
in the Rotarod test (Abada et al., 2013b; Clemens et al., 2015; Yu-Taeger et al., 2012), mild gait 
impairments and altered open field activity (Abada et al., 2013b). The use of multiple 
motor paradigms in the present study allowed us to further investigate fine motor skills, 
muscle strength and endurance as well as several parameters of activity-related motor 
function in a home-cage-like environment. Taken together, these findings expand the 
existing knowledge of the behavioral phenotypes of the BACHD rat, showing the presence 
of selected behavioral deficits.
 Regarding fine motor control, BACHD rats did not present any significant impairment. 
Although HD patients are significantly impaired in fine motor skills such as skilled reaching 
or manual dexterity (Klein et al., 2011), both parameters appeared to be intact in BACHD 
rats when challenged with the pasta handling and the pellet reaching tests. The results 
are, however, in line with previous observations in another rat model of  HD (Fielding et al., 
2012). Overall, these results suggest that fine motor aspects most likely did not contribute 
to the gross motor deficits seen in Rotarod performance or in the gait pattern.
 Concerning muscle function, BACHD rats appeared significantly impaired in the 
holding bar task at 2 months of age, suggesting reduced muscle endurance. However, no 
differences were found at 7 and 12 months of age, as the WT rats’ performance dropped 
down to BACHD rat level at these ages. The difference at 2 months of age is possibly 
related to a reduced amount of muscle mass and increased amount of fat mass carried by 
BACHD rats, as found in a previous study (Jansson et al., 2014). A reduced performance in 
the holding bar test could therefore be expected, as the animals have to hold the same 
body weight with a significantly lower amount of muscle mass. On the other hand, the 
drop that WT animals exhibited might be either due to repeated testing or due to the 
large increase in body weight from 2 to 7 months of age, which might have made it 
impossible for the rats to hang longer than a certain minimum amount of time. Thus, the 
test might not allow us to draw final conclusions on muscle endurance in older rats.
 Conversely, the grip strength test did not show an indication that BACHD rats’ 
“passive” forelimb grip strength was reduced, even at the youngest age. A possible 
explanation could be that in the holding bar test the rats have to work against gravity and 
their own weight, while this is not the case in the grip strength test. Due to the abnormal 
body composition of BACHD rats with reduced muscle and increased fat mass, workload 
during the holding bar test is therefore higher than that of WT rats. In contrast, WT and 
BACHD rats are likely exposed to a more comparable workload during the grip strength 
test.
 Additionally, previous studies provided evidence of peripheral phenotypes such as 
weight loss and muscle wasting in HD patients (Cepeda et al., 2007; Imarisio et al., 2008; 
Miller and Bezprozvanny, 2010), progressive skeletal muscle atrophy in HD patients and in 
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the R6/2 mouse model for HD (She et al., 2011; Zielonka et al., 2014). The impairment seen 
in the holding bar test might be also related to deficits in the joints, ligaments and tendons, 
all structures which are compromised in HD patients and in the BACHD mouse model 
(De Aragão et al., 2016; Nguyen and Cenci, 2015). Further studies would be required to 
investigate if the deficit we have reported is due to the reduced muscle mass or to a 
peripheral pathology or a functional impairment.
 In addition to the assessment of motor phenotypes with classical tests, we implemented 
the observation in an automated home-cage system to investigate general aspects of 
motor function related to rats’ baseline behavior. In this setup, we found BACHD rats to 
show a generally reduced number of jumps on the shelter, while the time spent on the 
shelter was similar to WT rats. This suggests a specific motoric difficulty to reach the top of 
the shelter rather than a reduced motivation to use it. Interestingly, this phenotype was 
present at all investigated ages. 
 Furthermore, we found BACHD rats to have a generally reduced locomotor activity, 
specifically restricted to the light phase. These data suggest that, in our setting, the overall 
walking ability and activity of the rats was relatively preserved, as it was unaffected during 
the major activity phase. This is in line with previous observations in BACHD rats of the 
same age, which showed only mild gait abnormalities in both static and dynamic 
parameters during Catwalk testing (Abada et al., 2013b). Conversely, the results are in 
contrast with a lower rearing and ambulatory activity observed with the PhenoMaster 
system at 3 and 6 months of age (Yu-Taeger et al., 2012) and with an initial hyperactivity 
followed by hypoactivity starting at 4 months of age exhibited by BACHD rats in an open 
field test-like setup (Abada et al., 2013b). The different outcome could be due to the 
different test protocols and test setups used. Most prominently, we screened the animals 
for 6 consecutive days, while the other two studies screened for 22 hours and 1 hour, 
respectively. Thus, those results will probably rather reflect the rats’ response to novelty, 
while we have investigated their baseline behavior.
 The reduction in activity during the light phase might suggest the existence of an 
altered circadian rhythm, which would be in line with previous studies in HD patients and 
in the BACHD mouse model (Kuljis et al., 2012; Morton et al., 2005). However, further and 
more detailed studies are necessary to investigate the mechanism underlying this 
behavioral alteration.
 The robustness of our motor assessment study is that we performed a battery of 
behavior experiments, combining novel and classical test setups under well controlled 
environments (temperature, humidity, food restriction) making the monitoring of behavior 
across different ages possible. However, it has to be noted that we performed multiple 
behavioral tests with the same group of rats. Repeated testing might influence the outcome 
of the tests (carry-over effect), although such an approach offers a better possibility to 
investigate phenotype onset and development than in separate cohorts of rats. Another 
limitation is that we performed the classical tests during the light phase in order to enable 
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better visualization of the rats’ behavior. However, it is known that behavioral readouts 
differ when assessed during the light or dark phase, and the dark phase still represents the 
natural activity phase of rats.
 Taken together, our study revealed specific motoric impairments in the BACHD rats, 
which might be related to a reduced muscle mass and increased fat mass, as reported 
earlier (Jansson et al., 2014). We suspect that different factors might have influenced 
BACHD rats’ strong impairment in the Rotarod test reported in previous studies. Although 
there is definitely a motor component, the deficit may also be related to other, non-motor 
phenotypes such as motivation or anxiety, as such differences have been found early on 
(Clemensson et al., 2017b; Jansson et al., 2014; Yu-Taeger et al., 2012). Most importantly, the 
study revealed novel readouts that can be used for addressing the efficacy of novel 
therapies on different parameters of motor function in pre-clinical research.
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Supplementary material
Material and methods
In addition to the parameters discussed in the main article, parameters relating to orofacial 
aspects of food consumption and consumption speed were scored from subsets of the 
videos obtained from the pasta handling test.
 The full consumption time was measured from the point that a rat positioned the 
spaghetti piece into its mouths and started biting, to the point where the end of the pasta 
piece disappeared into its mouth. This parameter was scored at all ages. For videos 
gathered at two months of age, separate measurements of the time the rats spent actively 
biting on the pasta piece and the time they spent chewing and swallowing were also 
taken. The periods of active biting were clearly identifiable by the audible bite sounds that 
the rats produced. The periods of chewing were also clearly identifiable by the rat 
removing the spaghetti piece from its mouth and making characteristic chewing motions 
with their jaws. An additional and more discreet behavior was, however, included in these 
chewing periods. The rats would on occasion make breaks from biting on the spaghetti 
piece, and sit motionless with closed mouths, while still seemingly maintaining focus on 
the task at hand. The behavior was coupled with distinct sounds, and was deemed to be 
part of the feeding behavior, as we have not encountered it in other circumstances. 
Periods where the rats adjusted the position of the spaghetti piece, or stopped focusing 
on the spaghetti piece entirely, were not included in the measurement of consumption 
time, biting time or chewing time. Notably, these behaviors were all excluded despite the 
fact that rats would often couple them with some chewing motions. This was done to 
obtain a similar scoring protocol to what has been used in other studies of the BACHD rats’ 
food consumption behavior (Clemensson et al., 2017). The parameters above were scored 
using the open-source BORIS software for video annotation (Friard and Gamba, 2016). 
Videos gathered at 12 months of age were subjected to additional analyses to obtain the 
number of bites needed to consume a spaghetti piece and measure the temporal spacing 
of individual bites. This analysis was performed with The Observer XT 12.5 (Noldus 
Information Technology, Wageningen, The Netherlands), which allowed simultaneous 
viewing of a pasta handling video and its audio track. The timestamp of each audible bite 
sound was noted, and further processed to obtain the parameters of interest. 
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Statistical analysis
Videos where the full feeding was not recorded, where the rats broke the pasta piece, or 
handled it with only one paw were excluded from the analysis of all parameters. For the 
analysis of consumption time, biting time and chewing time, average values were 
obtained for each test age and rat, during periods of stable performance. Ultimately, the 
data was for a given rat was based on an average of 15 videos (i.e. individual pasta piece 
consumptions) during the first test age, 11 videos during the second test age, and 5 videos 
during the final test age. Sound analysis was based on four trials per rat. The videos were 
selected to obtain a sample of videos with optimal audio quality, during a period of stable 
performance. 
 Age progression of consumption time was subsequently analyzed with a two-way 
ANOVA, using age as within-subject factor, genotype as between-subject factor and 
Sidak’s post-hoc test. One WT and three BACHD rats were excluded from the analysis, as 
data was not available for all ages. Thus the final n for this analysis was 11 WT rats and 9 
BACHD rats. The analyses of consumption time, time spent biting and time spent chewing 
measured at the first test age used simple comparisons between WT and BACHD rats, and 
thus used individual t-tests. The n for these analyses were 12 for both genotypes. The total 
number of bites made during consumption of a spaghetti piece also used a simple 
comparison between WT and BACHD rats, but used a Mann-Whitney U test as the data 
from the BACHD rats did not appear to be normally distributed. Finally, data for frequency 
distribution of bite intervals were analyzed with two-way ANOVAs, using genotype as 
between-subject factor, bite interval as within-subject factor, and Sidak’s post-hoc test.
Results
The time needed for consuming the spaghetti piece changed with age (Age effect: 
p<0.001), with both WT and BACHD rats showing a seemingly longer consumption time 
during the first test age compared to the following two (Supplementary Figure 1A). 
There was no difference between WT and BACHD rats’ consumption time at any age. 
Interestingly, most of the consumption time was made up of time spent actively biting on 
the spaghetti piece, while very little time was spent on chewing and swallowing behaviors 
(Supplementary Figure 1B, 1C, 1D). 
 Supplementary Figure 2A shows an example of the audio readout that was used to 
score individual bites. There was no significant difference between WT and BACHD rats in 
terms of the total number of bites that were needed in order to consume a full spaghetti 
piece (Supplementary Figure 2B) or in terms of the absolute or relative frequency 
distribution of bite intervals (Supplementary Figure 2C, 2D). Most bites were evenly 
spaced, with intervals around 0.11-0.20 seconds, although some bites appeared in much 
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closer succession, showing intervals of 0.00-0.05 seconds. This is also evident from the 
audio printout shown in Supplementary Figure 2A. It should, however, be noted that 
this might not constitute individual biting motions, but rather a single bite causing the 
spaghetti piece to break in multiple places (e.g. inside the rats’ mouth). Although the 
analysis presented in Supplementary Figure 2 did not reveal any significant difference 
between WT and BACHD rats, it should be noted that one BACHD rat performed a 
remarkably high number of bites compared to the rest of the group. Excluding this rat 
from analysis did result in significant differences being detected between the genotypes 
(p<0.05 for Supplementary Figure 2B; genotype effect: p<0.05, interaction effect: 
Supplementary Figure 1  Spaghetti consumption behaviors.
(A) Age development of the time needed to consume a spaghetti piece. Group mean 
plus standard error is indicated. Results from two-way ANOVA are displayed in bottom left 
corner of graph. Results from post-hoc test are displayed for data points where 
performance of WT and BACHD rats differed significantly. Detailed analysis of spaghetti 
consumption at two months of age is displayed in separate graphs for the full consumption 
time (B), the total time spent actively biting on the spaghetti piece (C), and the total time 
spent on chewing and swallowing (D). Graphs indicate performance of individual rats and 
group mean. (***) p < 0.001, ns (not significant)
A
C
B
D
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p<0.01, post-hoc results for 0.00-0.05 bin: p<0.01, post-hoc results for 0.11-0.15 bin: p<0.05 
for Supplementary Figure 2C; unchanged results for Supplementary Figure 2D). 
This analysis approach was, however, not considered to be appropriate, as there was no 
reason to assume that the outlier was caused by sub-optimal experimental conditions, 
but was likely just a representative of biologically based variation between rats.
Supplementary Figure 2  Bite sound analysis of spaghetti consumption.
(A) An example of the audio printout that was analyzed to obtain the data of interest. Note 
that the second and seventh bite sounds appear in very close succession of the previous 
bite sounds. (B) Basic comparison of the total number of bites needed to consume a 
single spaghetti piece. Performance of individual rats and group mean is indicated. (C) 
Frequency distribution of bite intervals, presented in terms of the absolute number of 
bites. Group mean plus standard error is indicated. Results from two-way ANOVA are 
displayed in top left corner of graph. Results from post-hoc test are displayed for data 
points where performance of WT and BACHD rats differed significantly. (D) Frequency 
distribution of bite intervals, presented in terms of the relative numbers of bites. Group 
mean plus standard error is indicated. Results from two-way ANOVA are displayed in top 
left corner of graph. Results from post-hoc test are displayed for data points where 
performance of WT and BACHD rats differed significantly. (***) p < 0.001, ns (not significant)
A
B
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Supplementary Figure 2  Continued.
C
D
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Discussion
There was no difference between WT and BACHD rats in terms of how much time they 
needed to consume the spaghetti pieces. This is in line with results from measuring 
consumption rate of small (45mg) reward pellets (Jansson et al., 2014), but in contrast with 
results from measuring consumption rate of single pellets of standard rodent chow 
(Clemensson et al., 2017). In the latter case, BACHD rats have been found to reliably require 
longer time than WT rats when consuming chow pieces of comparable size and shape. 
As discussed in (Clemensson et al., 2017), the reason for this discrepancy might be due to 
the different involvement of chewing behaviors in the three food consumption tests. 
Consuming the small reward pellets appears to involve very little chewing (Jansson et al., 
2014), which is also true for the consumption of spaghetti pieces (Supplementary Figure 1D). 
In contrast, consumption of chow pieces, involves frequent, and extensive chewing 
(Supplementary Figure 8 in (Clemensson et al., 2017)). Thus, as a clear impairment in 
consumption rate has only been seen when assessing consumption of chow pieces, it is 
likely that BACHD rats show generally unimpaired biting and swallowing, while chewing 
motions are more strongly impaired. Still, discreet impairments have been noted also 
during biting behaviors (Clemensson et al., 2017). In line with this, the results from the 
current study show some indications that BACHD rats might suffer from discreet biting 
impairments, although the results are unclear (i.e. only significant if outliers are excluded). 
Essentially, although there does not appear to be any overt impairment present, BACHD 
rats might suffer from discreet deficits, resulting in them taking slightly fewer bites 
compared to WT rats. Unfortunately, the audio quality of the videos recorded in the 
current study was of generally poor quality, resulting in a quite limited data set (i.e. four 
spaghetti pieces per rat). A more extensive study is thus needed in order to determine if 
the slight trends noted in the current results are indicative of an actual phenotype, or due 
to chance.
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Abstract
Background: Huntington disease (HD) is a devastating inherited neurodegenerative 
disorder characterized by progressive motor, cognitive, and psychiatric symptoms without 
any cure to slow down or stop the progress of the disease. The BACHD rat model for HD 
carrying the human full-length mutant huntingtin protein (mHTT) with 97 polyQ repeats 
has been recently established as a promising model which reproduces several HD-like 
features. While motor and cognitive functions have been characterized in BACHD rats, 
little is known about their social phenotype.
Objective: This study focuses especially on social behavior since evidence for social 
disturbances exists in human patients. Our objective was to compare social behavior in 
BACHD and wild-type (WT) rats at different ages, using two different measures of sociability.
Methods: Animals were tested longitudinally at the age of 2, 4 and 8 months in the social 
interaction test to examine different parameters of sociability. A separate cohort of 
7 months old rats was tested in the three chamber social test to measure both sociability 
and social novelty. Gene expression analyses in 8 months old animals were performed 
by real time qRT-PCR to evaluate a potential involvement of D1 and D2 dopaminergic 
receptors and the contribution of Brain-derived neurotrophic factor (BDNF) to the observed 
behavioral alterations.
Results: In the social interaction test, BACHD rats showed age-dependent changes in 
behaviour when they were-re introduced to their cagemate after a 24 hours-period of 
individual housing. The time spent on nape attacks increased with aging. Furthermore, a 
significant higher level of pinning at 2 months of age was shown in the BACHD rats 
compared to wild-types, followed by a reduction at 4 and 8 months. On the other hand, 
BACHD rats exhibited a decreased active social behaviour compared to wild-types, 
reflected by genotype-effects on approaching, following and social nose contact. In the 
three chamber social test, BACHD rats seemed to show a mild deficit in preference for 
social novelty, but no changes in social interest. Molecular analyses revealed that BACHD 
animals exposed to the social interaction test displayed decreased mRNA levels of the 
total form of BDNF in ventral striatum and unaltered striatal expression of D1 and D2 
dopamine receptors. 
Conclusions: Taken together, these results indicate deficits in several parameters 
representative of sociability. Altered BDNF expression in the ventral striatum may contribute 
to the deficits in sociability in 8 months old BACHD rats. These data support the validity of 
the BACHD rat model in mimicking features of certain social deficits that could be relevant 
to symptoms in patients.
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Introduction
Huntington disease (HD) is a dominantly inherited neurodegenerative disorder that is 
caused by an unstable expansion of a CAG repeat within the coding region of the 
huntingtin (HTT) gene (Huntington’s Disease Collaborative Research Group, 1993). It is 
characterized by motor impairment, abnormal choreic involuntary movements and by 
psychiatric, psychological and intellectual disorders (Kumar et al., 2015). Although more 
emphasis has been placed on detecting the early cognitive and motor impairments 
(Aylward et al., 2004; Kirkwood et al., 1999; Lawrence et al., 1998; Paulsen et al., 2006), 
emotional dysfunction might also precede the clinical HD diagnosis (Duff et al., 2007; 
Johnson et al., 2007). Thus, the identification of early psychiatric symptoms may be 
particularly important in HD because of their deleterious effects on everyday functioning 
and quality of life (Duff et al., 2007; Marder et al., 2000). Characterizing early neuro-
psychiatric phenotypes in animal models of HD is therefore especially important. 
 The BACHD rat model of Huntington disease was generated using a human bacterial 
artificial chromosome (BAC) which contains the full-length HTT genomic sequence with 
97 CAG/CAA repeats and all regulatory elements (Yu-Taeger et al., 2012). BACHD rats 
present motor, cognitive and emotional alterations. Previous characterization studies in 
these rats showed clasping behavior starting at the age of 3 weeks, robust deficits in 
the Rotarod task already at 1 month (Yu-Taeger et al., 2012), decreased activity in the 
Phenomaster from 3 till 6 months (Yu-Taeger et al., 2012) and mild gait alterations in 
the Catwalk test by 12 months of age (Abada et al., 2013b). In a fear conditioning 
set-up, BACHD rats exhibited associative memory deficits by 4 months of age while an 
impairment of their reversal learning performance emerged at 6 months when rats were 
tested in a cross maze task (Abada et al., 2013a). At this age, also signs of fronto-striatal 
impairment were observed in different Skinner box tasks for short term memory 
(Clemensson et al., 2017). Starting at 4 months of age, BACHD rats display also changes in 
emotionality as suggested by the decreased anxious-like behavior in the elevated plus 
maze (Yu-Taeger et al., 2012). At a comparable age (between 3 and 5 months), an 
impulsive-like phenotype was demonstrated in a delayed discounting paradigm and in 
the Differential Reinforcement of Low Rate of Responding task (Manfré et al., 2016) while 
later, at 9 months of age, deficits in prepulse inhibition became evident as well (Abada 
et al., 2013b). In spite of the extensive use of the BACHD rat line in the last years, its 
psychiatric phenotype has been only partly investigated indicating that the BACHD rat 
line requires further phenotyping. 
 In this study, we focused on social behavior of BACHD rats as its changes are an 
important component of neuropsychiatric symptoms. Some aspects of social behavior 
have been partly examined in different rodent models of HD, showing altered social 
interaction (Pietropaolo et al., 2011; Nguyen et al., 2006; Wood et al.,2015) and social 
preference (Pietropaolo et al., 2011), reduced social memory and recognition (Ciamei and 
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Morton, 2008; Rudenko et al., 2010) and even increased levels of aggression (Shelbourne 
et al., 1999), supporting the view of impaired social behavior in HD.  
 We therefore investigated different parameters of the social behavior repertoire and 
associated molecular alterations in the BACHD rat model of HD. We performed detailed 
analyses of social behavior parameters to monitor development of potential deficits over 
time. To achieve this aim we performed: 1) a social interaction test to investigate different 
parameters of sociability at different ages; 2) a so-called three chamber social test to assess 
both sociability and social novelty. To link behavior to molecular correlates of social 
behavior, we quantified mRNA levels of D1 and D2 dopamine receptors and the total 
form of BDNF. Subtle impairments in specific aspects of social behavior were found which 
could be relevant readouts in pre-clinical HD-treatment studies. Additionally, changes 
in molecular markers were detected and they could underlie the social behavior deficits 
in HD. 
Material and methods
Ethical statement
The experiments were carried out at 2 different locations. The experiments reported here 
were either approved by the Animal Ethics Committee (Dier Experimenten Commissie, 
RU-DEC, Nijmegen, The Netherlands) or by the local ethics committee (Regierungspraesidium 
Tuebingen, Germany), in full compliance with the European Union legislation on the use 
of animals for scientific purposes (Directive 2010/63/EU). All experimental procedures at 
Radboudumc (Nijmegen, The Netherlands) were performed under a project license from 
the Central Committee on Animal Experiments (Centrale Commissie Dierproeven, CCD, 
The Hague, The Netherlands), in full compliance with the legal requirements of Dutch 
legislation on the use and protection of laboratory animals (Animal Testing Act, WOD). 
All experimental procedures at the University of Tuebingen (Tuebingen, Germany) were 
performed in accordance with the German Animal Welfare Act and the guidelines of the 
Federation of European Laboratory Animal Science Associations.
Animals
For the social interaction test, fifteen transgenic males were supplied from a BACHD 
colony (TG5 line, Yu-Taeger et al., 2012) at Charles River (Wilmington, MA, USA) and an 
in-house breeding colony was preserved and maintained at Radboudumc (Nijmegen, 
The Netherlands) by cross-breeding these males with wild-type female rats (Charles River, 
Germany). WT and BACHD animals (N=24/group) were maintained on a Sprague-Dawley 
(SD) background. Genotyping and determination of BAC transgene integrity were 
performed via PCR analysis using genomic DNA extracted from ear biopsy tissue at 
postnatal day (PND) 21. Rats were weaned at PND 21 and test pairs were then group-housed 
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two per cage with littermates of the same genotype and sex in a constant temperature 
(19.5 ± 1°C) and humidity room (55 ± 10%) with a reversed 12 h light/dark cycle with lights 
on/off at 8:00 P.M. /8:00 A.M.). Housing by test pairs (N=2 siblings per cage) was chosen 
because two familiar animals were tested for social interaction, on the base of previously 
published protocols (Peters et al., 2016). 
 All experimental animals used in the three chamber social test (University of 
Tuebingen, Germany) were bred on an SD background by pairing heterozygous BACHD 
males with wild-type females (Charles River, Germany). Rats were genotyped following 
previously used protocols (Yu-Taeger et al., 2012) at PND 20. At weaning (PND 21), rats were 
housed in groups of 4 with same sex-littermates of mixed genotype like in previous 
behavioral characterization experiments in the BACHD rat model to keep conditions as 
much comparable as possible between experiments in the same facility. All experimental 
animals were maintained in a room with constant temperature (22 ± 1°C) and humidity 
(55 ± 10 %) with a regular 12 h light/dark cycle (lights on/off at 6:00 A.M. /6:00 P.M.). 
 All experimental animals in both facilities were provided food and water ad libitum, 
and behavioural tests were conducted during the active (dark) phase of the cycle. 
 The BACHD rat colony in Nijmegen, including the animals used for this study, was the 
F1 generation of animals ordered from the original breeder that were bred in-house with 
regular SD wild-type females, also specifically ordered from the regular supplier. Since the 
same procedure of generating animals for sectional and longitudinal studies has been 
used in Tuebingen and the two colonies have not been bred on different sites for a long 
period of time, the chance of genetic drift or other breeding/colony-effects is relatively 
low. Notably, other studies confirmed that the timeline of onset of deficits, such as the 
impaired Rotarod performance, is comparable between different labs applying different 
housing conditions (Abada et al., 2013a, 2013b; Yu-Taeger et al., 2012).
Behavioral Procedures
Experiment 1: Social Interaction Test
Apparatus and procedures. A total of 48 male rats (24 WT and 24 BACHD) was used for 
the study. All animals were longitudinally tested during the dark phase at 2, 4 and 8 months to 
monitor the progression of deficits and underwent the same schedule. The protocol of 
the social interaction test (adapted from (Peters et al., 2016)) is based on social interest and 
interaction with a familiar animal. Table 1 provides a survey of the timeline of experiments, 
performed as follows: on day 1, the body weight was measured and a first 20 minute 
habituation session in the test-arena was given to each animal individually. On day 2 
cagemates were habituated (i.e. under social conditions) for a second time to the test 
arena for another 20 minute session. Any initial novelty-induced behavior declines after 
repeated exposure to the test environment (Rossetti et al., 2016; Schmittgen and Livak, 2008) 
therefore the effect of repeated testing was considered to be minimized by these 2 days of 
habituation that were repeated for each test at each age-point. On day 3 animals were 
70
Chapter 3
given 1 day-rest and on day 4 cagemates were separated and individually housed for 24 h. 
During this period of time cagemates were unable to see each other, but could smell and hear 
all the animals present in the room. Thus, only real active social interaction was prevented. 
The day of rest was given for practical reasons since the testing required the full day 
without any chance of separating the animals in between. On day 5 cagemates were 
brought together and tested for 20 min in the social interaction test. 
The arena used in this experiment consisted of an enlarged, customized version of 
the PhenoTyper® (PhenoTyper 9000, Noldus Information Technology, Wageningen, 
The Netherlands). The animals were tested in these large chambers since it is argued 
that the expression of social behavior requires space (Peters et al., 2016; Spruijt et al., 2014). 
The arenas themselves consisted of a black floor plate (floor dimensions: 90 × 90 cm) 
and transparent Perspex walls (height: 100 cm) (Figure 1). The large PhenoTypers (PT-900) 
were equipped with a camera and infrared lighting. PhenoTypers were wiped clean with 
70% ethanol between test subjects.
 Variables measured. Video recordings were used to score behavior from captured 
video files using ½ playback speed of the video by using Observer XT 12.5 (Noldus 
Information Technology, Wageningen, The Netherlands). The time spent in social 
interactions (see Table 2 for the used ethogram, adapted from (Peters et al., 2016)) was 
manually scored by one observer blind to the test subjects’ genotype. Since the behavioral 
elements were scored from the view of one of the animals (focal animal) of a pair, 
behavioral elements from the category ‘social’ are scored either as receiver or as actor 
(Peters et al., 2016) and data are thus representative of N=12 per genotype. 
Table 1  Timeline of experiment 1.
Age Days
1 2 3 4 5
2 Months Body 
Weight
Single 
Habituation
Habituation 
in Pairs
Rest 
day
Individual 
Housing
Social  
Interaction Test
4 Months Body 
Weight
Single 
Habituation
Habituation 
in Pairs
Rest 
day
Individual 
Housing
Social  
Interaction Test
8 Months Body 
Weight
Single 
Habituation
Habituation 
in Pairs
Rest 
day
Individual 
Housing
Social 
Interaction 
Test
Animals 
sacrificed
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Experiment 2: three chamber social test 
Apparatus and procedure. A three chamber social test was applied in a cohort of 7 
month old rats (17 WT and 15 BACHD) to assess sociability and social novelty using 
procedures adapted from previously published protocols (Crews et al., 2012; Toth and 
Neumann, 2013). Behavior was assessed in a black Plexiglas box (40 x 120 x 45 cm) divided 
in three sub-chambers (or arenas) consisting of a central arena (named neutral arena) and 
two lateral ones, interconnected by two transparent walls. While the central arena was 
empty for the whole length of the test, each lateral arena contained a wire mesh box that 
was either empty or hosted a stranger rat, depending on the testing phase. These stimu-
lus-animals were naïve age- and weight-matched wild-type male rats from the same 
strain. Restraining the stranger rats in these boxes has the advantage of limiting the 
mobility of the stranger rat while still allowing visual, olfactory and tactile interaction 
between the experimental rat and the strangers. By limiting the mobility of the stranger 
rats, one can examine the social interest of a test animal reducing the influence of the 
Figure 1  PhenoTyper® 9000 (PT9000) cage setup for testing.  
A photo displaying two rats during the social interaction test. Cagemates were brought 
together after being individually housed for 24h. Animals were marked red or black using 
a permanent marker in order to distinguish each rat of the couple. In contrast to black 
marking, the red marking was not visible because of the infrared lighting conditions, and 
it was used to prevent that the marking could become a confounding factor.
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social interaction levels of the strangers in the test performance. In this way, a test animal 
can choose whether to explore a stranger and whether to explore the familiar or the novel 
animal that instead serve as social stimuli. Moreover, placing stranger animals in wire 
mesh boxes prevents the development of possible aggressive responses that may develop 
between test and stranger animals. 
 Testing was performed in the dark phase. Animals were allowed to habituate to the testing 
room for an hour before starting the test that consisted of three consecutive sessions: 
habituation (5 min), social interaction (10 min, 1 stranger rat present) and social novelty 
(10 min, 2 stranger rats present). Animals were given a 7 min intertrial interval between 
test sessions. During the first session (habituation), an experimental rat was placed in the 
central arena and was allowed to explore the box while each lateral arena contained an 
empty wire mesh box. In the second session (social interaction), a stranger conspecific rat 
was placed in the cage of one of the two lateral arenas while the test rat was re-introduced 
in the neutral arena and let explore the whole box. In this phase the preference of the test 
rat for exploring the stranger (social stimulus) or an empty box (non-social stimulus) on 
Table 2  Ethogram. Definitions of all scored behaviors in the social interaction test.
Behavioral 
category
Behavioral 
element
Description
Social contact Nape attacking The focal animal attacks the neck area of another with  
its front part of the body
Pinning An animal turns on its back and the focal animal pins  
the other animal to the ground with its forepaws or its 
whole body
Social nose 
contact
The focal animal establishes contact or near-contact  
with its nose to the another animals’ body part
Allogrooming The focal grooming animal has one or both front paws 
on top of the other and pulls/licks at its fur
Social interest Approaching The focal animal gets in proximity of another animal,  
by a directed movement whereby the space between 
the 2 animals readily decreases
Following The focal animal moves/follow the other to maintain  
a close distance while the other animal is moving 
around/away
Social 
avoidance
Moving away The focal animal moves away from another animal after 
being in close proximity
Non-social Solitary The animal performs individual actions such as self-
grooming, rearing, exploration (at least 1 body-length 
away from the other animal)
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the opposite side is measured. In the third session (social novelty), a second stranger rat 
was placed in the cage of the opposite lateral arena. In this phase, the experimental rat can 
choose whether to explore the rat that was already present in the box in the social 
interaction phase (familiar rat) or the newly introduced one (novel rat). Social and novelty 
arenas and strangers were randomized between left and right sides in the box to avoid 
that a side preference in the box may influence the time spent exploring social/familiar 
or novelty arenas and relative strangers. The strangers were additionally randomized 
between WT and BACHD testing animals and between test phases. To prevent that 
removing animals from a cage could affect the performance of the remaining animals in 
the same cage, testing of cage mates on the same day was avoided. The stranger animals 
were not habituated to the wire mesh cages before the test. However, since the order of 
testing was randomized, as mentioned above, any effect of confinement of the strangers in 
the boxes is expected to be equally distributed over the groups/genotypes, preventing 
a strong effect on any genotype-results. The chamber and the wire mesh cages were wiped 
clean with 70% ethanol between test subjects.
 Variables measured. The time spent in each arena and the time spent exploring the 
wire mesh boxes in each phase were manually scored with The Observer XT 12.5 (Noldus 
Information Technology, Wageningen, The Netherlands). Wire mesh box exploration was 
defined as sniffing the box (apparent snout contact), climbing the box, resting on the box 
with the front limbs, sitting and moving on the box. A rat was considered accessing a 
chamber when entering inside with half of the body length. 
 Reliability analysis. Since behavioral variables were scored manually in both social 
tests, a second observer re-scored part of the social interaction test and the three chamber 
social test videos in order to assess the reliability of our results. The second scoring was 
performed using ½ playback speed of the video with Observer XT 12.5 on six videos (three for 
each genotype) for each test, randomly chosen. By using a built-in reliability analysis feature in 
The Observer XT, the percentages of agreement between the two observers were calculated 
and the resulting statistics is presented in the Supporting Information (S1 and S2 tables). 
 Tissue collection. After the last social interaction test 8 months-old animals were 
euthanized by intraperitoneal injection of 90 mg/kg pentobarbital. Immediately after 
death, the animals were decapitated and their brains removed, isolated and frozen in 
aluminium foil on dry ice and stored at −80ºC. In a cryostat (−12ºC), the brains were 
prepared in 300 μm-thick coronal slices in order to obtain punches from dorsal and ventral 
parts of the striatum (Bregma +3.72 and +3.30 mm). The brain areas were bilaterally 
punched out with a Miltex 1.0 mm biopsy puncher (Miltex Inc., York, PA, USA), collected in 
sterile vials, immediately placed on dry ice and stored at −80ºC.
 RNA extraction. Total RNA was isolated by single step guanidinium isothiocyanate/
phenol extraction using PureZol RNA isolation reagent (Bio-Rad, Hercules, USA), according 
to manufacturer’s instructions. RNA concentrations were measured and RNA purity 
checked (A260/280 ratio between 1.8 and 2.0) with a NanoDrop 1000 spectrophotometer 
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(Thermo Scientific, Waltham, USA). Subsequently, an aliquot of each sample was treated 
with DNAse to avoid DNA contamination to perform gene expression analyses as 
previously reported (Rossetti et al., 2016). 
 Real time qRT-PCR. The mRNA levels of total BDNF, D1 and D2 dopamine receptors 
were analyzed by TaqMan qRT-PCR instrument (CFX384 real-time system, Bio-Rad 
Laboratories S.r.l) using the iScriptTM one-step RT-PCR kit for probes (Bio-Rad Laboratories 
S.r.l.). Samples were run in 384-well format in triplicate as multiplexed reactions with a 
normalizing internal control (β-actin). The following primer and probe sequences were 
used; Bdnf-Fw: 5’ AAGTCTGCATTACATTCCTCGA-3’, Bdnf-Rev: 5’ GTTTTCTGAAAGAGGGA-
CAGTTTAT -3’, Bdnf-Probe: 5’ TGTGGTTTGTTGCCGTTGCCAAG -3’, D1-Fw: 5’ GTCTGTCCTTA-
TATCCTTCATCCC -3’, D1-Rev: 5’ ATACGTCCTGCTCAACCTTG -3’, D1-Probe: 5’ ACAGTTGTCA-
TCCTCGGTGTCCTC -3’, D2-Fw: 5’ ACCACTCAAGGGCAACTG -3’, D2-Rev: 5’ TGACAGCATCTC-
CATTTCCAG -3’, D2-Probe: 5’ AGCATCCATTCTCCGCCTGTTCA -3’, β-actin -Fw: 5’ CACTTTCT-
ACAATGAGCTGCG -3’, β-actin  -Rev: 5’ CTGGATGGCTACGTACATGG -3’, β-actin -Probe: 5’ 
TCTGGGTCATCTTTTCACGGTTGGC -3’. Thermal cycling was initiated with a 10-min incubation 
at 50°C during which the reverse transcription of RNA to cDNA took place (RNA retro-
transcription), followed by 5 min at 95°C (TaqMan polymerase activation) and 39 amplification 
cycles with 10s at 95°C and 30s at 60°C. A comparative cycle threshold (Ct) method was 
used to calculate the relative target gene expression versus the control group. Specifically, 
relative target gene expression was calculated according to the 2 -ΔCT method (Schmittgen 
and Livak, 2008).
Statistical analyses
Two-way repeated measures ANOVAs were used to analyze all behavioral parameters of 
the social interaction test. The pairs were the statistical unit, with N=24 per genotype 
resulting in 12 pairs of animals per genotype that were analyzed using age as within-subject 
factor and genotype as between-subject factor. Bonferroni post-hoc test was used to 
follow up any significant effects of genotype found in the two-way ANOVAs. The three 
chamber social test was analyzed with two-way ANOVA, followed by Tukey or Sidak 
post-hoc test when appropriate. One WT individual was identified as outlier based on the 
standard deviation of the mean and the residuals of the statistical model and therefore 
excluded from the statistical analyses. The real time RT-PCR 2 -ΔCT data have been normalized 
to the average of the wild-type group and have been analyzed using an unpaired 
t student’s test. 
 Statistical analyses for the social interaction test and the RT-PCR were conducted 
using GraphPad Prism v.6.0 (GraphPad Software Inc., San Diego, USA) while analyses of 
three chamber social test parameters were performed using GraphPad Prism v.7.0. 
Statistical significance was set at p< 0.05 in all tests.
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Results
Behavioral experiments 
Experiment 1: social interaction test
Animals of both genotypes showed a significant increase of time spent on ‘’nape 
attacking’’ between 2 and 8 months of age (age effect: F(2, 22) = 7.310, p=0.0037). When 
compared to their WT littermates, BACHD animals spent an increased time spent on ‘’nape 
attacking’’ showing significant genotype (8 months: p<0.0001) and age x genotype (F(2, 22) 
= 3.922, p=0.0349) effects (Figure 2A). Conversely, transgenic animals exhibited a 
decreased time performing ‘’pinning’’ between 2 and 8 months of age, showing a 
significant genotype (2 months p<0.01), age (F(2, 22) = 10.07, p=0.0008) and age x genotype 
effects (F(2, 22) = 4.733, p=0.0195) (Figure 2B). 
‘’Social nose contact’’ (sniffing) is the most frequently used parameter to define the 
interest of an animal in another animal (Himmler et al., 2013). The duration of ‘’social nose 
contact’’ increased in both WT and BACHD between 2 and 4 months of age while it 
remained stable between 4 and 8 months of age, showing a significant age (F(2, 22) = 65.78, 
p<0.0001) effect  (Figure 2C). At the three different ages BACHD rats spent significantly 
less time on ‘’social nose contact’’ compared to WT rats (genotype effect (F(1,11) = 6.281, 
p=0.0292). 
 After an initial increase of “allogrooming” in BACHD rats at 2 months of age (post-hoc 
analyses p<0.001) (Figure 2D), with increasing age they exhibited a trend to groom each 
other less compared to the control rats, showing significant genotype x age effect (F(2, 22) 
= 11.79, p=0.0003). Post-hoc analyses of ‘’approaching’’ revealed a significant genotype 
effect in BACHD rats aged 4 and 8 months (Figure 2E), indicating that transgenic rats 
showed less “approaching” behavior (post-hoc analyses at 4 and 8 months: p<0.05). 
Interestingly, both the “approaching” and “allogrooming” decreased in both BACHD and 
WT rats between 4 and 8 months of age (significant age effect for approaching (F(2, 22) = 
14.02, p=0.0001) and for allogrooming (F(2, 22) =53.28, p<0.0001). Conversely, the “following” 
significantly decreased in both groups of animals between 2 and 8 months of age (F(2, 22) 
= 55.02, p<0.0001) and post-hoc analyses showed significant reduction in the time spent 
on ‘’following’’ of 2 months old BACHD rats compared to WT (2 months: p<0.05) (Figure 2F). 
BACHD rats seemed to spend less time on following the partner compared to the control 
group. The ‘’moving away’’ parameter did not show any significant differences whatsoever 
(Figure 2G). Concerning non-social behavior, BACHD rats exhibited augmented “solitary” 
behavior. A significant interaction between age and genotype was found (F(2, 22) = 8.571, 
p=0.0018) (Figure 2H), although a significant genotype effect was only present at 4 months 
of age (post-hoc analyses p<0.05). We further performed a reliability analysis of the present 
results, and the outcome reported in the Supporting Information (S1 table). 
76
Chapter 3
Fi
gu
re
 2
  S
oc
ia
l i
nt
er
ac
tio
n 
te
st
.
(A
) N
ap
e 
A
tt
ac
ki
ng
. (
B)
 P
in
ni
ng
. (
C)
 S
oc
ia
l N
os
e 
Co
nt
ac
t. 
(D
) F
ol
lo
w
in
g.
 (E
) A
pp
ro
ac
hi
ng
. (
F)
 A
llo
gr
oo
m
in
g.
 (G
) M
ov
in
g 
Aw
ay
. (
H
) S
ol
ita
ry
. 
D
at
a 
ar
e 
ex
pr
es
se
d 
as
 m
ea
ns
 +
 S
.E
.M
. T
w
o-
w
ay
 A
N
O
VA
 re
su
lts
 a
re
 d
isp
la
ye
d 
ab
ov
e 
ea
ch
 g
ra
ph
. R
es
ul
ts
 fr
om
 p
os
t-
ho
c 
an
al
ys
is
 a
re
 in
di
ca
te
d 
on
 th
e 
gr
ap
h 
in
 c
as
e 
si
gn
ifi
ca
nt
 g
en
ot
yp
e 
di
ffe
re
nc
es
 w
er
e 
fo
un
d.
 N
=1
2 
pa
irs
 o
f W
T 
an
d 
12
 p
ai
rs
 o
f B
AC
H
D
 ra
ts
.
A E
B F
C G
D H
77
Social behavior differences in BACHD rats
3
Experiment 2: three chamber social test
In the habituation phase WT and transgenic animals spent a comparable length of time in 
the left and right arenas and exploring the empty boxes (Figures 3A, 3B). Within each 
genotype, no significant preference was detected for left or right arena and the respective 
empty boxes. Two-way ANOVA showed an arena effect (F(2,87) = 51.92, p<0.0001) and no 
genotype or arena x genotype interaction. Tuckey test revealed only a difference in time 
spent exploring the neutral arena compared to the lateral compartments (both p<0.0001), 
but no differences between left and right side (p=0.2281). 
 In the social interaction phase, when a conspecific rat was introduced in one of the 
boxes, both genotypes showed a comparable preference for the social arena and box 
with conspecific relative to non-social arena and empty box, respectively (Figures 3C, 
3D). Two-way ANOVA in this phase showed an arena effect (F(2,87) = 405.8, p<0.0001) and 
an arena x genotype interaction (F(2,87) = 3.175, p=0.0467), but no genotype differences 
(F(2,87) = 3.719e-007, p=0.9995). Post-hoc test indicated a preference for the social arena 
versus both neutral and empty arenas in both genotypes (all p<0.0001). ANOVA analyses 
showed also a box effect (F(1,58) = 268.6, p<0.0001), but no genotype (F(1,58) = 0.2843, 
p=0.5959) or box x genotype interaction (F(1,58) = 2.216, p=0.1420). 
 In the social novelty phase, when a novel conspecific was introduced in the previously 
empty arena, transgenic rats spent a comparable amount of time in the familiar and novel 
arenas and exploring the boxes with familiar and novel conspecifics, while WT rats stayed 
longer in the novel than in the familiar arena and showed higher interest in the novel 
conspecific relative to the familiar one (Figures 3E and 3F). Two-way ANOVA analyses 
showed an arena effect (F(2,87) = 36.83, p<0.0001) and an arena x genotype interaction 
(F(2,87) = 4.109, p<0.05), but no genotype differences (F(2,87) = 2.549e-007, p=0.9996). 
Similarly, ANOVA analyses showed a box effect (F(1,58) = 4.4665, p=0.0349) and a box x 
genotype interaction (F(1,58) = 4.484, p=0.0385), but no genotype effects (F(1,58) = 0.1332, 
p=0.7164). Post-hoc analyses revealed a significant difference in time spent between novel 
arena and neutral arena in both genotypes (both p<0.0001) and a difference in time spent 
between novel arena and familiar arena in WT (p=0.0028), but not in transgenic animals 
(p=0.9390). In line with the arena effects, Sidak test also indicated a significant difference 
in time spent exploring the novel and familiar conspecific in WT (p=0.0064) and not in 
transgenic animals (p=0.9995). We further performed a reliability analysis of the present 
results, and the outcome reported in the Supporting Information (S2 table).
Molecular analysis
Gene expression analysis of dopamine D1 and D2 receptors in the striatum
mRNA levels of D1 and D2 dopamine receptors have been measured in the ventral and 
dorsal striatum of BACHD rats to evaluate their potential involvement in the previously 
observed behavioral alterations. However, as shown in Figure 4, we did not find any 
significant difference in the gene expression of both receptors in the mutant animals in 
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Figure 3  Three chamber social test.
The figure shows the time spent in the arenas (A, C, E) and exploring the conspecifics 
(boxes) (B, D, F) in the three test phases. Data are expressed as means + S.E.M. The p 
values obtained from the two-way ANOVA analyses, are displayed above each graph. The 
p values resulting from post-hoc analyses are indicated on the graph for significant 
differences between genotypes as well as for significant differences among arenas and 
between boxes within genotype. N=16 WT and 15 BACHD. Abbreviation: Ar. = Arena.
A
C
E
B
D
F
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comparison with wild-type rats, neither in the ventral (D1: WT 1 ± 0.11, N=11; BACHD 0.97 
± 0.11, N=9; t(18)= 0.1947, p=0.8478. D2: WT 1 ± 0.09, N=11; BACHD 1.01 ± 0.16, N=9; t(18)= 
0.045, p=0.9649) nor in the dorsal striatum (D1: WT 1 ± 0.081, N=9; BACHD 0.87 ± 0.06, 
N=10; t(18)= 1.304, p=0.2096. D2: WT 1 ± 0.1, N=11; BACHD 1.15 ± 0.09, N=12; t(21)= 1.175, 
p=0.2531). 
Gene expression analysis of BDNF in the striatum
Alterations of the neurotrophin Brain-derived neurotrophic factor (BDNF) are thought to 
be relevant for the neurodegeneration observed in Huntington’s disease (Zuccato and 
Cattaneo, 2007). Therefore, we evaluated the mRNA levels of the total form of BDNF in 
both ventral and dorsal striatum of BACHD rats with respect to wild-type animals. As 
shown in Figure 5, we observed a significant and marked decrease of the mRNA levels of 
the total form of BDNF in the ventral striatum of BACHD rats compared to WT littermates 
(WT 1 ± 0.21, N=9; BACHD 0.31 ± 0.1050, N=8; t(15)= 2.846, p<0.01). Conversely, the 
expression of the neurotrophin was not modulated by the genotype in the dorsal striatum 
(WT 1 ± 0.14, N=10; BACHD 1.33 ± 0.15 N=10; t(18)= 1.601, p=0.1269).
Figure 4   mRNA levels of D1 (A) and D2 (B) receptors in the ventral striatum and mRNA 
levels of D1 (C) and D2 (D) receptors in the dorsal striatum of WT and BACHD rats. 
Data were normalized to the average of the fold changes in the WT group (set at 1.0) and 
analyzed using unpaired t student’s tests. Abbreviations: vST = ventral striatum; dST = 
dorsal striatum.
A
C
B
D
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Discussion
The use of multiple social paradigms permitted us to detect potential HD-related deficits 
in different specific aspects of social behavior. The social interaction test revealed abnormal 
social play and aggressive behavior in BACHD animals as well as a trend towards a 
decreased interaction with conspecifics. It is worth mentioning the fact that we decided 
to use familiar pairs (cagemates) to have a better translational value of the results since HD 
causes major disruption in family life (Vamos et al., 2017). The three chamber social test 
showed mild deficits in social recognition in transgenic animals, providing an estimation 
of the social interest towards an unknown conspecific as well as of the recognition abilities 
between familiar and novel conspecifics, with limited physical interaction. Additionally, 
striatal expression of D1, D2 receptors and BDNF was assessed and related to social contact 
and social interest in 8 month old animals, reporting a decrease in the expression of BDNF 
in the ventral striatum and intact dopamine receptor expression.
 In rats, one of the most notable social behaviors is play fighting, which involves attack 
and defense of the nape of the neck, which if contacted, is gently nuzzled with the snout 
(Himmler et al., 2013). When initiating social play, one animal directs to the neck region of 
the partner and this can be accompanied with biting and pulling fur in that region. BACHD 
rats performed more play-fighting compared to their WT littermates, as showed by the 
increased nape attacking. 8 month old BACHD rats showed a twofold increase in the time 
spent on nape attacks, and a decreased duration of pinning compared with control rats. 
Pinning is a commonly used measure for play, which essentially involves the subject 
positioned supine with its partner standing on top (Himmler et al., 2013; Panksepp, 1981).
Figure 5   mRNA levels of total BDNF in the ventral (A) and dorsal (B) striatum of WT and 
BACHD rats.
Data were normalized to the average of the fold changes in the WT group (set at 1.0). 
Data were analyzed using unpaired t student’s tests. Abbreviations: vST = ventral striatum; 
dST = dorsal striatum.
A B
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These rougher and more aggressive play behaviors likely reflect abnormal social play 
behaviors and might facilitate the development of social and aggressive behaviors 
(Veenema and Neumann, 2009). Conversely, “following” significantly decreased in both 
groups of animals between 2 and 8 months of age, suggesting a reduced inclination to 
search for an interaction over time. The lack of these social behaviors in BACHD rats may 
suggest a “social deficit” that could be related to coping styles (Van Den Berg et al., 1999; 
Varlinskaya and Spear, 2008), and considered as a form of apathy (Wood and Morton, 2015) 
as showed by the R6/2 mouse model of HD. 
 Although we cannot directly confirm apathy with the parameters we measured, 
apathy has been previously reported in the BACHD and in z_Q175 mouse models 
(Oakeshott et al., 2012) and is commonly reported in patients with HD (Naarding et al., 
2009). Future studies on other specific aspects of social behavior, e.g., social reward, will be 
important to define whether or not a social apathy-like phenotype is present in BACHD 
rats. Alternatively, the deficits in social behaviors described in BACHD rats may represent 
behavioral changes that depend more specifically on alterations in brain social networks 
which mechanisms in HD are still mostly unclear. 
 Interestingly, at 2 months of age the BACHD rats “nape attacking” was significantly 
increased as well as “pinning”, where we can assume that the rats established the 
dominance hierarchy, leading to a dominant and a subordinate rat. This disappeared at 4 
and 8 months of age, probably because the dominance was already determined. 
 The lower approaching and following behaviors observed in this study are not likely 
to be affected by anxiety levels in BACHD rats, as previous studies in this model showed 
decreased exploratory anxious behavior in the elevated plus maze starting at 4 months of 
age (Yu-Taeger et al., 2012). If we consider the time spent on nape attacks related to social 
dominance and dominance to be dependent on anxiety levels (Hollis et al., 2015) with 
dominant individuals being less anxious than subdominant ones, than the increase in 
nape attacking in BACHD rats could be facilitated by the lower anxiety levels in these 
animals. However, one should keep in mind that the decreased anxious-like behavior in 
BACHD rats was shown only with the elevated plus maze (Yu-Taeger et al., 2012). It is 
therefore difficult to conclude anything about the anxious phenotype in BACHD rats and 
to relate it to social behavior parameters. 
 It is worth noting that these social behavior alterations were not confounded by an 
overall reduced motor activity, such as levels of general exploration or activity, as BACHD 
animals reported similar levels of locomotion compared to their wild-type littermates in 
our previous study (Manfré et al., 2017) . Furthermore, during all other social tests, 
transgenic animals did not differ from wild-types in the expression of non-social activities. 
 Besides the changes in social interaction parameters, we also detected a mild deficit 
in social novelty in transgenic animals at 7 months of age, as suggested by a lack of 
preference for a novel conspecific relative to a familiar one in the three chamber social 
test. Cognitive deficits have already been described in BACHD rats for different aspects 
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not related to social behavior (Abada et al., 2013a; Clemensson et al., 2017; Manfré et al., 
2016). The novelty effect in our study is in line with earlier research in HD mouse models 
showing alterations in social recognition and memory (Ciamei and Morton, 2008; Rudenko 
et al., 2010) as well as with evidence of disrupted social cognition in HD patients (Larsen et 
al., 2016; Snowden et al., 2003). The brain changes underlying these symptoms in HD are 
not well known and it is not clear to which extent deficits in social cognition, mostly 
described as impaired emotion recognition, may depend on other cognitive and 
emotional changes and whether they could be the cause of social behavior alterations in 
HD patients.
 While decreased or increased social interaction (Nguyen et al., 2006; Pietropaolo et al., 
2011; Wood and Morton, 2015) have been described in other animal models of HD using 
different behavioral paradigms, we did not observe altered sociability levels in BACHD rats 
exposed to the three chamber social test. In line with these findings, one recent study 
showed no changes in the preference for an unknown conspecific relative to an unknown 
object in BACHD rats (Lamirault et al., 2017). Although unchanged levels of social 
interaction in the three chamber social test are present, they are not necessarily in contrast 
with parameters measured in the social interaction test within this study. For example, 
increased approaching in the social interaction test is present along with an increased 
nape attacking which may relate to a play fighting-like behavior that is prevented in the 
other test where limited physical contact is allowed. 
Gene expression analyses were carried out in 8 month old animals tested for social 
interaction, highlighting an altered expression of BDNF in ventral striatum and an intact 
striatal D1 and D2 receptors expression. The striatum is one of the most affected brain 
areas in HD where alterations in dopaminergic and BDNF brain systems have been well 
described previously (Cepeda et al., 2014; Zuccato and Cattaneo, 2007). mRNA levels of 
striatal BDNF and dopaminergic receptors were therefore examined as potential 
mechanisms at the base of behavioral abnormalities. Furthermore, we linked social 
behavior to striatal functionality via D1 and D2 dopamine receptors in 8 month old animals 
which, along with BDNF, have been proposed as possible underlying regulatory factors 
(Báez-Mendoza and Schultz, 2013). The lack of changes in mRNA levels of D1 and D2 
dopamine receptors in BACHD rats subjected to the social interaction test would not 
suggest a direct link between the dopaminergic system and the behavioral changes. 
Measuring protein levels in future social interaction studies may help to understand better 
whether the dopaminergic system plays a role in the behavioral changes. BDNF mRNA 
levels were also quantified. We detected a decreased expression in the ventral striatum of 
BACHD animals and no changes in the dorsal region. Therefore, it is possible that altered 
BDNF expression in this region may have contributed to the deficits in sociability in 8 
months old BACHD rats.  Nonetheless, we are aware that the limit of molecular 
investigations is the restriction of the analyses to the transcript levels. Striatal BDNF 
transcripts are very low at basal level and usually BDNF protein is not directly transcribed 
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in the striatum, but it is produced in the cerebral cortex and anterogradely transported to 
the striatum (Zuccato et al., 2010). Therefore, we cannot draw any conclusion on the 
mechanisms underlying the BDNF decrease and its link to social deficits in BACHD rats and 
it will be assessed in future experiments. Alternative mechanisms that could have 
contributed to the social deficits and are worthwhile to assess in future studies are the 
oxytocinergic and vasopressinergic systems, which are interesting in the context of their 
involvement in social recognition and social behavior (Báez-Mendoza and Schultz, 2013). 
 The strength of our study is that we performed two different behavior experiments 
to investigate different aspects of BACHD rats’ social behavior: the social interaction test 
was performed longitudinally to make the monitoring of behavior across different ages 
possible; the three chamber social test provided an estimation of the social interest 
towards an unknown conspecific as well as of the recognition abilities between familiar 
and novel conspecifics. Additionally, two different observer coded the behaviors in both 
social tests, strengthening the reliability of our results. Accordingly, the correspondence is 
in line with inter-observer agreement, i.e., generally acceptable to a level of 70–85% 
(Martin and Bateson, 2007). On the other hand, we are aware that animals of both 
experiments had different housing conditions and applying the same housing conditions 
in the two experiments would have improved the study design since they can affect 
animals’ behavior. However, this was not the main goal of this chosen setup, and we do 
not consider our results incompatible, since we should bear in mind that: 1) this study 
assesses different aspects of social behavior in the same animal model and does not 
present a direct comparison of the same parameters obtained with two different tests; 2) 
we do not make any statistical correlation of the changes in parameters obtained in one 
test with those shown in the other test; 3) we do not think that the results shown in the 
social interaction test are in contrast to those in the three chamber social test. We do not 
know to what extent the housing conditions may have affected the results in each 
experiment of our study because these tests were performed for the first time in the 
BACHD rat model. Performing both experiments with each of the housing settings would 
be certainly informative about that although this was not the aim of the present study. In 
conclusion, this study characterizes social behavior in the BACHD rat model. We report 
changes in different parameters of social interaction and recognition and potential 
molecular correlates by using paradigms that are well established in rodents (Silverman et 
al., 2010; Veenema and Neumann, 2009) and that can be used to study disturbances in this 
spectrum (Silverman et al., 2010). Being easily measurable, such parameters provide the 
basis for further social behavior studies and may represent valid readouts for treatment 
studies. 
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Supporting information
S1 Table  Percentage of scoring agreement – Social Interaction Test.
Genotype Percentage of agreement ± SEM
WT 77.396 ± 1.902
BACHD 82.188 ± 1.042
Data are expressed as means ± S.E.M
S2 Table  Percentage of scoring agreement – Three Chamber Social Test.
Genotype Test Phase Percentage of agreement ± SEM
WT Habituation 89.620 ± 0.828
Social Interaction 90.800 ± 3.933
Social Novelty 89.234 ± 1.096
BACHD Habituation 95.041 ± 0.463
Social Interaction 91.283 ± 3.072
Social Novelty 92.189 ± 1.722
Data are expressed as means ± S.E.M
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Highlights
• Different forms of impulsivity were assessed in early symptomatic BACHD rats (line TG5), 
a transgenic rat model of Huntington’s disease (HD).
• BACHD rats showed high levels of choice impulsivity favoring “smaller, sooner” over 
“larger/later” rewards (delay discounting task).
• BACHD rats also exhibited a lack of behavioral inhibition indicated by bursts and 
premature responses in a DRL task assessing action impulsivity.
• Our study is the first to provide evidence of deficits in impulse control in a rodent model 
of HD.
• These results are relevant to psychiatric alterations in early symptomatic HD patients. 
They increase the face-validity of the BACHD rat model.
Abstract
Impulsivity trait was characterized in 3-5 months old BACHD rats, a transgenic model of 
Huntington Disease, using (1) the delay discounting (DD) task to assess cognitive/choice 
impulsivity, and (2) the Differential Reinforcement of Low Rates of Responding (DRL) task 
to evaluate motor/action impulsivity. Transgenic animals showed a high level of choice 
impulsivity and, to a lesser extent, action impulsivity. Our results provide the first evidence 
that the transgenic BACHD rat line displays changes in impulsivity as early as 3 months old, 
as described in early symptomatic HD patients, thus adding to the face validity of the rat 
model.
Keywords: Huntington disease, Impulsivity, Executive functions, Decision making, Transgenic 
rats
93
Impulsivity trait in BACHD rats
4
Impulsiveness is a behavioral trait that refers to the tendency to engage in inappropriate 
or maladaptive behaviors. Impulsivity is not a unitary trait, but embraces two categories of 
behaviour: motor or action impulsivity, defined as the inability to withhold a prepotent 
motor response (Neill 1976; Sokolowski and Salamone 1994; Uslaner and Robinson 2006), 
and cognitive or choice impulsivity, which is the inability to weigh and/or to use all 
consequences of events (Evenden 1999; Arce & Santisteban, 2006). Impulsivity, poor risk 
assessment and altered behavioral inhibition are frequently encountered personality traits 
in many neuropsychiatric disorders (Hamilton et al., 2003; Duff et al., 2007) and in neurode-
generative diseases such as Parkinson’s (Antonini et al, 2011; Bugalho & Oliveira-Maia, 2012; 
Weintraub et al, 2015) and Huntington’s diseases (HD; Beglinger et al, 2008; Kalkhoven et 
al, 2014).
 HD is an autosomal dominantly inherited, progressive neurodegenerative disorder 
caused by an expansion of the polyglutamine repeat of variable length (>38 CAG repeats) 
in exon 1 of the gene encoding the protein huntingtin (HTT) (Huntington et al., 1993). 
HD results first in neurodegeneration of medium spiny neurons of the striatum (Vonsattel 
et al. 1985), and in atrophy of cortical and limbic structures as the disease progresses 
(Rosas et al. 2005, 2008). Cognitive/psychiatric disorders, including perseveration, lack of 
insight, distractibility, and impulsivity, affect HD patients before motor symptoms, (Novak 
& Tabrizi 2010; Rosenblatt, 2007) and have thus an early deleterious impact on the quality 
of HD patient’s life (Guttman et al., 2003; Rosenblatt, 2007). 
 Modeling the complexity of the psychiatric symptoms of pre-clinical HD in a rodent 
model is therefore important for increasing our understanding of the neurobiological 
mechanisms underlying the HD neuropathology. However, certain behavioral processes 
(e.g. impulsivity trait) are typically more challenging to evaluate in mice (Tecott & Nestler 
2004; Wistantley et al, 2011). Therefore, we aimed at investigating impulse control disorders 
in a recently generated transgenic rat model of HD, using a human bacterial artificial 
chromosome (BAC) which contains the full-length HTT genomic sequence with 97 CAG/
CAA repeats and all regulatory elements (Yu-Taeger et al. 2012). Primary characterization of 
BACHD rats demonstrated an early progressive HD-like phenotype with motor dyscontrol 
and emotional impairment (Yu-Taeger et al., 2012; Abada et al, 2013). To determine 
impulsivity traits in these rats, we used two different paradigms, the delay discounting 
task (DD), and the Differential Reinforcement of Low Rates of Responding task (DRL), to 
assess respectively choice and action impulsivity. Animals were food deprived at 85% of 
their normal weight and all experiments were performed in accordance with the recom-
mendations of the EEC and the French Ethics Committee for compliance and use of 
laboratory animals.
 Impulsivity in the DD task is characterized by a preference for small, immediate 
rewards (SS: smaller, sooner) over larger, delayed rewards (LL: larger, later). The task design 
was modified from Simon et al. (2013) and run in operant chambers with 2 levers each side 
of a food magazine (Coulbourn Instruments, USA). Three months old naive male WT 
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(n=16) and BACHD (n=7) rats were trained to lever-press for food on a daily schedule. A 30 
min-session of magazine training with 30 pellets (45 mg food pellets, Bioserv) delivered 
using a VI60 (range from 30 to 90s) was followed by lever-press sessions under a continuous 
reinforcement schedule (CRF) until 50 reinforcements were earned in 30 minutes, one 
session for each lever (Coulbourn Instruments, USA). The animals were then trained for 
8 sessions to discriminate between a small (1 pellet) and a large (3 pellets) reward 
associated with the left or the right lever (counterbalanced between rats). Five blocks of 
12 trials (2 forced choices and 10 free choices) were run during each session. Each 60-s trial 
began with a 10-s illumination of the food magazine during which a nose poke into the 
magazine extinguished the light and triggered extension of either a single lever 
(forced-choice trials) or both levers simultaneously (free-choice trials) for a maximum of 
10 s. Once a lever was pressed and food delivered, both levers were retracted for the 
remainder of the trial. At the end of training, WT and BACHD animals chose the large 
reward in more than 90% of free trials, with no genotype difference or genotype x training 
session interaction (Fs<2.33, ns). Animals were then trained for 12 sessions in the delay 
discounting task. Each session and trial organization was kept the same except that delays 
were introduced between lever pressing and the large reward delivery. Each block started 
with two forced-choice trials to expose the rats with the delays in effect for that block, 
followed by 10 free-choice trials. The delay duration increased between each block of 
trials (0, 4, 8, 16, 32 seconds), but remained constant within each block. The averaged 
choice for the large reward (LL choice) was calculated for each delay across all blocks of 
the 12 sessions. Contrast analyses of variance (ANOVAs) using VAR3 statistical software 
(Rouanet et al., 1990) as well as the Fisher Exact Test, with an alpha level of 0.05, were used 
for statistical assessments. As the delays increased, BACHD and WT rats shifted progressively 
their choices to the immediate small reward (Figure 1A; F(4,84) = 65.03, P<.001). BACHD rats 
shifted more rapidly to the immediate small reward than WT rats (genotype: F(1,21)= 6.20, 
P<.05; genotype x delay interaction: F(4,84)= 5.01, P<.01). The higher proportion of impulsive 
rats (less than 50% choices for the large delayed reward) in BACHD compared to WT 
animals was confirmed for delays longer than 8s (Figure 1B).  
 Impulsivity in the DRL task is characterized by the inability to withhold responses for 
a required amount of time. If the time between two responses (inter-response time, IRT) is 
less than t seconds, no reward is delivered and the timing contingency reset. WT (n=12) 
and BACHD (n=11), 5 months old, male naive rats were trained on magazine training (30 
min, 30 pellets), and on a CRF session until a criterion of 50 reinforced lever presses earned 
in 30 minutes. Then, rats started a DRL-5s schedule for five sessions, during which a lever 
press resulted in a food pellet delivery only if at least 5 seconds had elapsed from the 
previous lever press. If the rat performed a premature lever press, the 5 s time period was 
reset. Animals were then trained for ten sessions on a DRL-10s schedule, during which the 
response had to be withheld for 10 seconds to obtain the reward. Each DRL session ended 
either after 60 minutes or 200 reinforcements were earned, whichever came first. Several 
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indexes of performance were calculated and the results are presented in Figure 2, for 5 
sessions of DRL-5s (left panel) and 10 sessions of DRL-10s (right panel). First, the efficiency/
impulsivity measured the ratio of correct/rewarded responses (>5s or >10s) to total 
responses. Then, inter-response times (IRTs) were classified according to a ratio of the DRL 
value as burst responses (responses during 0-1s for DRL-5s and 0-2s for DRL-10s), premature 
responses (1-4s and 2-8s for DRL-5s and -10s, respectively) and timing error (4-5s and 8-10s 
for DRL-5s and -10s). 
 During the DRL-5s, WT rats learnt the task and showed improvement of their efficiency 
accross sessions (Figure 2A; F(4,44)= 13.02, P<.001) whereas BACHD rats did not (F(4,40)= 
Figure 1   Delay-discounting task showing higher choice impulsivity in BACHD rats 
compared to WT.
(A) Mean + S.E.M percentage of choice of delayed reward across different delays. Genotype 
significant difference is indicated by (*) P = 0.05. Significant interaction is indicated by (#) 
P<0.01. (B) Percentage of high impulsive (<50% choice of large reward choices) animals 
for the different delays (Fisher exact-tests: delay 8s, P = 0.022; delay 16s, P = 0.026; delay 
32s, P = 0.02).
A
B
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2.23, ns); there was a significant genotype x session interaction (F(4,84)= 4.46, P<.005) and 
no genotype difference (F<1). The number of bursts responses decreased for both groups 
with session repetition (Figure 2C; F(4,84)= 12.99, P<.001) with no group x session interaction 
(F(4,84)=2.16, ns) and no genotype difference (F<1). Both groups decreased their number of 
premature responses across sessions (Figure 2E; (F(4,44)= 19.78, P<.001 and F(4,40)=2.94, 
p<.05 respectively) with no genotype difference (F<1). However, a significant genotype x 
session interaction (F4,84)= 8.79, p<.001) indicated that WT rats decreased their premature 
responses more rapidly than BACHD rats. Finally, BACHD rats increased more their timing 
errors than WT rats (Figure 2G; F(1,21)= 4.23, P=.05) with a significant genotype x session 
interaction (F(4,84)= 3.54, P<.05). 
 When switching to the DRL-10s, both groups initially dropped their efficiency to then 
improve over the 10 training sessions (Figure 2B; WT: F(9,99)= 21.32, p<.001; BACHD: 
F(9,90)= 8.02, p<.001), with no significant interaction between genotype and session 
(F(9,189) = 1.49, ns) and no genotype effect (F(1,21)= 1.35, ns). The number of bursts responses 
decreased with session repetition (Figure 2H; F(9,189)= 9.44, P<.001). However, BACHD 
transgenic rats exhibited a higher rate of burst responding compared to WT (F(1,21)= 4.53, 
P<.05), with no genotype x session interaction (F(9,189)= 1.43, ns). The number of premature 
responses decreased also significantly (Figure 2F; F(9,189)= 66.12, P<.001), but with no 
group difference and no genotype x session interaction (Fs<1). There was a slight evolution 
of timing errors for both groups (Figure 2D; F(9,99)= 2.24, p<.05 and F(9,90)= 3.66, p<.01 
respectively), with no genotype difference (F<1) and no genotype x session interaction 
(F(9,189)= 1.76, ns). Taken together, these results indicate that BACHD rats were nearly as 
efficient as WT in completing the DRL-5s and -10s tasks, with a less precise temporal 
discrimination and a higher rate of burst responses during the very first seconds following 
a reward. 
 These results demonstrate that HD pathology in 3 to 5 months old BACHD rats induce 
a high level of choice impulsivity and, to a lesser extent, action impulsivity. The DD 
paradigm describes primarily the devaluation of an event as the delay to that event 
increases: the maintained bias toward larger delayed gratification has been taken to index 
increased self-control (Isles et al. 2004). Indeed, most decision-making procedures confront 
the individuals with several alternatives differing in cost and benefit. The increment of 
costs for the usually more-preferred larger reward leads to a discounting in the value of 
this option. The DRL paradigm describes the capacity to withhold actions during a fixed 
amount of time and mostly involves two cognitive/behavioral abilities: (1) behavioral 
inhibition or self-control (Barkley, 1997) indicated by bursts and premature responses. 
Burst responses, which follow immediately a rewarded lever-press, indicate perseverative 
responses induced by the failure to re-obtain an immediate feedback to their responses; 
(2) the temporal discrimination ability, which allows to know when the time t has elapsed 
(Kramer and Rilling, 1970), indicated by timing errors. BACHD rats exhibited a steep delay 
discounting curve in the DD showing a high level of cognitive/choice impulsivity. On the 
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Figure 2   Temporal characteristics of responding at DRL-5s (left panels) and -10s  
(right panels) schedules. 
(A,B) Percent efficiency (reinforced lever presses/total lever presses x 100) across DRL 
schedules; (C,D) Burst responses are those occurring <1s (DRL-5s) and <2s (DRL-10s) since 
the previous response; (E,F) Premature responses are those occurring 1-4s (DRL-5s) and 
2-8s (DRL-10s) since the previous response; (G,H) Timing-error responses occurring at 4-5s 
(DRL-5s) and 8-10s (DRL-10s) since the previous response. Data are expressed as means + 
S.E.M. Genotype significant differences are indicated by (*) P < 0.05. Significant interactions 
are indicated by (#) P<0.05.
A
C
E
G
B
D
F
H
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other hand, they show a nearly normal efficiency in the DRL, but timing errors and the 
high rate of burst responses when the delay increased indicate signs of motor impulsivity. 
These results could reflect an impairment in timing and/or working memory. In fact, both 
procedures (DD and DRL) are dependent upon limits on memory and sustained attention 
abilities. Deficits of these functions alter the ability to analyze all information about the 
possible alternatives and thus difficulties to evaluate future options, breaking the 
possibility to anticipate the consequences of actions and leading to incapacity to plan the 
most efficient behavior. Working memory deficits have previously been demonstrated in 
different tasks in early symptomatic HD patients (Harrington et al, 2014; You et al, 2014; 
Georgiou-Karistianis et al, 2013; Stout et al, 2011). However, the inability of BACHD rats to 
resist immediate rewards and/or to wait for larger rewards in DD rather suggests an 
impaired decision process, possibly due to the failure of the autonomous nervous system 
to mark negative outcomes (Campbell et al, 2004) or to process correctly the cue/outcome 
contingencies through trial-to-trial feedback processing (Holl et al, 2012).
 At the neurobiological level, lack of inhibitory control has been observed in several 
neuropathological disorders associated with abnormal dopaminergic transmission 
(deficit/hyperactivity disorder, Parkinson’s Disease, Alzheimer’s Disease and HD  (Barkley, 
1997; Rosenblatt, 2007; Rochat et al., 2008; Novak & Tabrizi 2010; Nombela et al., 2014)). 
Furthermore, there is a strong correlation between dopamine receptors availability and 
the two different types of impulsivity: variation in striatal D2/D3 receptor levels is negatively 
correlated with impulsive action in rodents (Dalley et al., 2007; Laughlin et al. 2011) and 
with impulsive choice and action in humans (Lee et al., 2009; Ghahremani et al., 2012), 
whereas D1-like receptors appear to be most selectively involved in mediating impulsive 
choice in rats which may be explained by their differing locations within the prefrontal 
cortex (PFC), an area known to be involved in impulsive choice (Loos et al., 2010; Koffarnus 
et al, 2011). In BACHD rats, a decreased D2 receptor binding potential has been observed 
in the striatum, as well as an imbalance between the striatal striosome and matrix 
compartments (Yu-Taeger et al. 2012). Since these two compartments contain dispropor-
tionate amounts of D1 and D2 neurons, the striosome/matrix imbalance may influence 
the equilibrium of the inhibitory and excitatory output from the striatum to downstream 
neurons and thus have a behavioral impact that could account for BACHD rats’ impulsivity. 
Furthermore, impulsivity, as well as compulsivity and flexibility, are closely interrelated 
executive processes in the context of inhibitory control mediated by the PFC (Bari & 
Robbins, 2013; Wise, 2008). However, according to the model proposed by Bechara in 
2005, willpower emerges from the dynamic interaction of two separate, but interacting, 
neural systems: an impulsive system, in which the amygdala is a critical neural structure 
involved in triggering the affective and emotional signals of immediate outcomes, and a 
reflective system, in which the ventral PFC is crucial in triggering the affective and 
emotional signals of long-term outcomes. Using a delay discounting paradigm, rats with 
inactivation and disconnection of the medial PFC and basolateral amygdala become 
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more impulsive, showing preference for smaller immediate over larger delayed rewards 
(Churchwell et al, 2009). Similarly, rats with amygdala lesions (basolateral nuclei) are more 
impulsive when rewards are delayed, preferring the immediate reward more quickly than 
controls (Winstanley et al., 2004; Cardinal, 2006; Churchwell et al., 2009; Ghods-Sharifi et al., 
2009). In HD patients, both the prefronto-striatal circuit and the amygdala system seem to 
be dysfunctional (Thieben et al., 2002; Rosas et al., 2003; Douaud et al., 2006). In BACHD 
rats from 3 months of age, a high expression of mutant huntingtin (mhtt) aggregates was 
found in the neocortex and in limbic areas including the amygdala (Yu-Taeger et al, 2012). 
A dysfunctional prefronto-striatal/amygdala imbalance could thus account for the high 
level of choice impulsivity observed in BACHD rats, giving rise to behavioral inadaptability.
 In sum, given the differences observed between WT and BACHD rats, it can be 
assumed that this transgenic rat model recapitulates some of the cognitive/psychiatric 
impairments already seen in HD patients. To our knowledge, our study is the first to 
provide evidence of deficits in impulse control in a rodent model of HD. This gap is 
surprising, due to the relevance of psychiatric alterations in the initial phases of HD and 
their deleterious impact on the quality of HD patient’s life (Guttman et al. 2003; Rosenblatt, 
2007), but may be due to a lack of models until now that would permit testing of 
self-control. Taken together, our results indicate that early symptomatic BACHD rats 
express a high level of impulsivity, impairments described in early symptomatic HD 
patients, which makes this rat model highly suitable for drug discovery purposes. 
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Abstract
Background: Huntington disease (HD) is a progressive neurodegenerative disorder 
characterized by motor, cognitive and neuropsychiatric symptoms. Although anxiety has 
been under-researched in HD, it is recognized as a common feature of this disorder and 
has an early deleterious impact on the quality of HD patient’s life. The BACHD transgenic 
rat is the newest rat model for HD and its psychiatric phenotype has not been fully 
determined yet.
Objective: The present study aims to characterize risk assessment and anxiety-like traits 
in BACHD rats, combining classical paradigms with an automated tool for the automatic 
assessment of anxiety within the home cage, the light spot test (LS).
Methods: Risk assessment and anxiety-like traits were characterized in 2–4–8–12 
month-old wild-type and transgenic BACHD rats. To measure anxiety and risk assessment 
in a novel environment, rats were challenged with classical tests: the elevated plus maze 
and the light-dark box. Home-cage anxiety-like responses were assessed in an automated 
home-cage environment, the PhenoTyper®, applying an adverse stimulus (‘light spot’) 
directed at the food-hopper during a part of the dark-(active) phase.
Results: BACHD rats did not show any changes in anxiety-like behavior or risk assessment 
in the elevated plus maze and the light-dark box. However, the light spot test indicated a 
decreased anxiety-like response in BACHD rats at 2, 8 and 12 months of age, as shown by 
an increased time spent in the feeder zone while the light spot was on.
Conclusions: Our results did not confirm anxiety-like traits over different ages in the 
BACHD rat model. Overall, our results do not mimic the generalized anxiety observed in 
HD patients.
Keywords: Huntington disease, polyglutamine disease, model characterization, anxiety, 
anxiety-like response, transgenic rat, neurodegenerative disorders, elevated plus maze, 
light-dark box, automated home-cage monitoring.
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Introduction
Huntington disease (HD) is a severe autosomal dominant neurological disorder and the 
onset of symptoms is during middle age, consisting of a triad of motor, cognitive and 
psychiatric symptoms (Walker, 2007). HD motor symptoms are varied and include 
involuntary movements such as chorea as well as impaired voluntary movements, which 
cause limb incoordination and impaired hand function (Novak and Tabrizi, 2010). These 
symptoms are worsened by loss of postural reflexes and their pattern tends to change 
over time, with chorea declining and dystonia, rigidity, and bradykinesia becoming more 
marked (Nguyen and Cenci, 2015; Novak and Tabrizi, 2010). Typical latency from diagnosis 
to death is 20 years (Walker, 2007; Watt, 1990). This so-called polyglutamine (polyQ) disease 
is caused by an expanded CAG mutation in the huntingtin (HTT) gene (Huntington’s 
Disease Collaborative Research Group, 1993), leading to initial atrophy and cell loss in the 
neostriatum (caudate nucleus and putamen in humans), then spreading to cortical areas 
and ultimately affecting the whole brain (Vonsattel et al., 1985). Although disease 
progression is currently untreatable, efforts are aimed at identifying novel symptomatic, 
neuroprotective and reparative treatments (Frank, 2014). Thus far, the clinical diagnosis of 
HD is dependent on the motor signs of the disease, involving problems with voluntary 
and involuntary movements. However, cognitive and psychiatric symptoms may be present 
many years before the onset of motor problems (Dale and van Duijn, 2015; Videnovic, 
2013). The psychiatric component of the disease can involve a number of different 
complaints including depression, irritability, anxiety, apathy, obsessive-compulsive behaviors 
(OCBs), and psychosis (Craufurd et al., 2001; van Duijn et al., 2007). Although motor and 
cognitive symptoms worsen with time, psychiatric symptoms appear to have a more 
variable course (Paulsen et al., 2005) with the exception of apathy, which is more prevalent 
in advanced disease stages. A systematic review of psychopathology in HD identified that 
the prevalence of anxiety among manifest HD participants was between 34% and 61%, 
depending on the disease stage and the measure used (van Duijn et al., 2007). 
 Because of the deleterious effects on patients’ lives, studying the psychiatric disorders 
along with the motor symptoms at both clinical and preclinical level is very valuable. 
Therefore, including psychiatric symptoms in the modeling of the disease with animals is 
crucial for the validity of preclinical studies. However, studying the complexity of such 
symptoms in a fully translational way in animal models may be challenging. The BACHD 
rat is the latest transgenic rat model of HD expressing full-length human mutant huntingtin 
(mHTT) and is currently being characterized in order to understand its advantages and 
limitations concerning modeling of HD.
 In this study we focused on anxiety as one of the non-motoric symptoms seen in HD 
patients, combining the standard behavioral tests elevated plus maze and light-dark box 
with an anxiety test implemented in the automated home cage PhenoTyper 4500 (Noldus 
IT, Wageningen, NL) hereafter mentioned as light spot test (LS). Anxiety in the elevated 
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plus maze is mostly characterized by less time spent in the open arms. In the same set-up, 
risk assessment, defined as movements of the snout or head out of the closed area with 
the rest of the body and all four paws remaining in the closed arms (Fernandes et al., 1999; 
File and Wardill, 1975; Kyriakou et al., 2017a; Wall and Messier, 2001), also contributes 
significantly to assessing a more complete anxiety-like phenotype. The light-dark box is a 
broad animal paradigm used in pharmacology to assess anxious behavior in rodents in 
response to their aversion to light (Bourin and Hascoët, 2003; Kulesskaya and Voikar, 2014; 
Miller et al., 2011). Variables that are measured are, typically, the percentage of time spent 
inside the brightly illuminated area and the number of transitions between the two 
compartments. The light spot test is a relatively recent tool for studying anxiety in rodents 
by measuring their responses when a white light spot is directed at the feeding area of a 
home cage environment for a certain amount of time during the animals’ dark (i.e. active) 
phase (Aarts et al., 2015, Kyriakou, 2017). When a light spot is directed towards the feeding 
area, where the rats need to go in order to eat, this negative stimulus evokes an 
 approach-avoidance conflict: the first is an exploratory response geared at investigating 
stimulus change, and the second is to avoid the bright light (Godsil and Fanselow, 2004). 
The light spot takes advantage of the natural tendency of rodents to become active at 
the beginning of the dark phase including a clear peak in feeding behavior, thus creating 
this approach-avoidance conflict in rats.
 In order to investigate disease development over time in relation to anxiety-like 
behavior, in the present study we focused on tasks that may reveal (subtle) disturbances 
in this behavioral trait related to human HD. To achieve that, we combined classical 
behavioral paradigms with automated home-cage observations which allow high- 
throughput testing. The tests were performed at four different ages (2, 4, 8 and 12 months) 
to assess the onset and progression of anxiety-like behavioral traits.
Material and methods
Ethical statement
All experiments reported here were approved by the Animal Ethics Committee (Dier 
Experimenten Commissie, RU-DEC, Nijmegen, The Netherlands) in full compliance with 
the European Union legislation on the use of animals for scientific purposes (Directive 
2010/63/EU). All experimental procedures were carried out at Radboudumc (Nijmegen, 
The Netherlands) and performed under a project license from the Central Committee on 
Animal Experiments (Centrale Commissie Dierproeven, CCD, The Hague, The Netherlands), 
in full compliance with the legal requirements of Dutch legislation on the use and 
protection of laboratory animals (Animal Testing Act, WOD).
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Animals
Fifteen transgenic males were supplied from a BACHD colony (TG5 line, Yu-Taeger et al., 
2012) at Charles River (Wilmington, MA, USA) and an in-house breeding colony was 
preserved and maintained at Radboudumc (Nijmegen, The Netherlands) by cross-breeding 
these males with wild-type female rats (Charles River, Germany). WT and BACHD animals 
were maintained on a Sprague-Dawley (SD) background. The BACHD rat colony was the 
F1 generation of animals ordered from the original breeder that were bred in-house with 
regular SD wild-type females, also specifically ordered from the regular supplier. 
Genotyping and determination of BAC transgene integrity were performed via PCR 
analysis using genomic DNA extracted from ear biopsy tissue at postnatal day (PND) 21. 
Rats were weaned at PND 21 and test pairs were then group-housed two per cage with 
littermates of the same genotype and sex in a constant temperature (19.5 ± 1°C) and 
humidity room (55 ± 10%) with a reversed 12 h light/dark cycle with lights on/off at 8:00 
P.M. /8:00 A.M.). 
 All experimental animals were provided food and water ad libitum, and behavioural 
tests were conducted during the active (dark) phase of the cycle. 
Study design
24 animals (N=12/group) were divided in two groups of 6 WT and 6 BACHD for each group, 
and longitudinally tested at 2, 4, 8 and 12 months of age according to the following 
scheme. On day 1, rats were challenged with the light dark box test. On day 2 animals were 
housed in the PhenoTyper® 4500 cages for seven consecutive days (day 2-9) to assess 
anxiety with the light spot test after a 5-day habituation period. On day 9 animals were 
then taken out of the PhenoTyper® and tested in the elevated plus maze. All behavioral 
tests were performed during the dark phase and carried out by a single experimenter 
blind to the rats’ genotype. 
Behavioral procedures
Light-dark box test
The light/dark box test was used to determine the unconditioned anxiety-like rodent 
behavior that is based on the innate aversion of rodents to brightly illuminated areas and 
the conflict between the drive to explore novel areas and the tendency to avoid the 
unfamiliar (neophobia) (Bourin and Hascoët, 2003). The set-up consisted of two 
compartments, a dark and an illuminated compartment separated by a connecting gate. 
Dark and light compartments were of the same size (32,5 x 32,5 x 32 cm) with different 
brightness conditions: 5.50 lux inside the dark compartment and circa 400 lux inside the 
light compartment. The rats were initially placed inside the illuminated arena, and the 
amount of time spent in each chamber and the number of transitions was measured over 
a 5 minute-session (Bourin and Hascoët, 2003). During each trial two animals were tested 
and videotaped in two different light/dark boxes. In order to facilitate the scoring, animals’ 
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fur was black painted with a marker. Between trials the chambers were cleaned with 70% 
ethanol. The following day the rats were placed into the PhenoTypers®.
Light spot (LS) test in the PhenoTyper
Rats were individually housed in PhenoTyper 4500 cages (Noldus Information Technology, 
Wageningen, The Netherlands) with dimensions 45 × 45 × 55 cm for a total duration of 
7 days. Each cage has an opaque floor covered with cellulose-based bedding, a water 
bottle, a shelter at the right corner and a food dispenser. The tracking of the animals was 
performed by an infrared sensitive video camera installed on the top unit of each cage 
together with a number of infrared LEDs. The first 5 days were considered habituation 
days in which the rats were allowed to acclimatize to the new home-cage environment 
(Kyriakou et al., 2017b).
 The rats were placed into the PhenoTyper the day after the light dark box test, during 
the dark phase. Rats were then housed into the Phenotypers for a total of seven days. 
After 5 days of habituation in the PhenoTyper 4500, the measurements of the 5th day were 
taken as a baseline for the normal activity pattern of each animal. On day 6, fifteen minutes 
after the start of the sixth dark phase, a bright light (the ‘light spot’, 500 lux) was 
automatically turned on, resulting in the illumination of the feeding dispenser. The 
15-minutes delay after the start of the dark phase assured that the shift from light to dark 
phase and the activation of the light spot do not overlap. Thus, the time of the light beam 
coincides with the period during which rats are usually active in search of food (Aarts et 
al., 2015). After three hours the light spot switched off. Moreover, in order to minimize 
stress and to diminish the influence of humans on the outcome a radio was provided as 
background noise for the whole duration of the experiment. After the light beam, rats had 
one day-rest and the next day they were tested in an elevated plus maze.
Elevated plus maze
The elevated plus maze (EPM) is an anxiety test based on the animal’s aversion to open 
spaces and on the tendency to remain near to vertical surfaces. The test setting consisted 
of a plus-shaped apparatus with two open arms located perpendicular to two closed 
arms surrounded by 40 cm-high walls. The four arms (50 cm-long) were connected by a 
central area (10 x 10 cm) and elevated 50 cm above the floor. At the beginning of the test 
each animal was placed in the central area, facing one of the open arms. Activity was 
recorded for five minutes. Room was illuminated by white light of approximately 10 lux in 
the open arm and 2,5 lux in the closed arm. After each trial the plus maze was cleaned 
with 70% alcohol solution to prevent transmission of olfactory cues. Animals were 
videotaped using a camera placed above the maze and the number of entries into the 
closed and open arms as well as the entries into the central area was tracked with 
Ethovision 11.5 (Noldus Information Technology, Wageningen, The Netherlands). All 
animals were tracked with three-point detection (center of gravity, nose and tail base) in 
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order to have a clear location of the animal in the maze. The analysis includes the traditional 
anxiety-related behavior parameters measured in the EPM (time spent and number of 
entries in the open arms) as well as measure of risk assessment behavior (head dips in the 
open arms). After each testing phase the animals were returned to their home-cages. 
Statistical Analyses
All statistical analyses were conducted using GraphPad Prism v.6.0 (GraphPad Software, 
San Diego California USA, http://www.graphpad.com). Two-way repeated measures 
ANOVAs were used to analyze all parameters. Age was used as within-subject factor, and 
genotype as between-subject factor. Bonferroni post-hoc test was used to follow up any 
significant effect of genotype found in the two-way ANOVAs. A p-value < 0.05 was 
considered statistically significant.
 Between two testing periods, two WT rats had to be sacrificed and removed from the 
experiment at 11 months of age due to the reaching of the HEP (Humane Endpoint). In 
both cases, the reason for the HEP concerned tumors. Due to technical problems, the light 
spot data from two WT and two BACHD rats could not be analyzed. 
 Thus, the N of the analyses changed as follows: for the light-dark box (WT: 10, BACHD: 12), 
for the light spot (WT: 10, BACHD: 10), for the elevated plus maze (WT: 10, BACHD: 12). Age 
development analyses excluded data from animals that were not assessed at all ages. No 
other exclusion criteria were used. 
Results
Light-dark Box
Figures 1A and 1B highlight that the percentage of time spent in the light and the 
number of transitions increased slightly in both BACHD and WT rats between 2 and 8 
months of age and decreased slightly at 12 months of age. These data show a significant 
age effect in both parameters (% time spent in the light: F(3, 60) = 11.03, p<0.0001; number 
of transitions: F(3, 60) = 20.98, p<0.0001). However, there was no significant effect of the 
genotype (% time spent in the light: F(1, 20) = 0.3203, p=0.5777; number of transitions: F(1, 20) 
= 0.2075, p=0.6537) or interaction (% time spent in the light: F(3, 60) = 0.5937, p=0.6216; 
number of transitions: F(3, 60) = 0.7043, p=0.5532) in both parameters. Taken together, these 
results show that BACHD rats exhibit similar anxiety-like responses compared to WT 
littermates after exposure to the light-dark box.
Light Spot in the Phenotyper
Figure 2 illustrates the frequency of entrances in / visits to the feeder zone during the 
light spot (A), the time spent in the feeder zone during the light spot normalized for the 
total time outside the shelter (B), and the time spent outside the shelter during the light 
spot normalized for the total time (C). 
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The frequency in the feeder zone and the time spent outside the shelter decreased 
between 2 and 12 months of age in WT animals, showing significant age effects for the 
number of entrances / visits (F(3,27) = 22.49, p<0.0001), the time spent in the feeder (F(3,27) 
= 3.78, p=0.0219), and for the time spent outside the shelter (F(3,27) = 7.371, p=0.0009). 
Interestingly, while WT animal presented a strong decrease of the time spent in the light 
spot /feeder zone with increasing age, BACHD animals spent more time in the light spot / 
feeder zone at 2, 8 and 12 months of age compared to their WT littermates (genotype 
effect; F(1,9) = 5.237, p=0.0479). Conversely, BACHD entered the light spot / feeder zone 
with the same frequency as WT littermates (genotype effect; F(1,9) = 0.2463, p=0.6316). 
During the light spot, a decrease over time was shown in the time spent outside the 
shelter, which was comparable in transgenic and control animals (genotype effect; F(1,9) = 
2.156, p=0.1761). At all separately analyzed ages, no interactions concerning age and 
genotype were observed (p >0.05). In summary, the light spot test reveals a decreased 
anxiety-like response in BACHD rats at 2, 8 and 12 months of age, as shown by an increased 
time spent in the feeder zone while the light spot was on.
Figure 1   Light Dark Box. 
(A) Percentage of time spent in the light compartment. (B) Number of transitions between 
the light and the dark compartment. Data are expressed as means ± S.E.M. Two-way 
ANOVA results are displayed within each graph. Results from post-hoc analysis are indicated 
in case significant genotype differences were found. N= 10 WT and 12 BACHD rats.
(***) p < 0.001, (****) p < 0.0001, ns (not significant).
A B
113
Measuring anxiety-like behavior in BACHD rats
5
Elevated Plus Maze
As shown in Figure 3A, the percentage of time spent in the open arms decreased in both 
BACHD and WT over time, showing a significant age effect (F(3, 60) = 6.86, p=0.0005) and 
non-significant effects of genotype (F(1, 20) = 0.1785, p=0.6771) as well as no interaction 
between age and genotype (F(3, 60) = 0.1592, p=0.9233). BACHD rats did not seem to have 
a different frequency of entries in the open arms compared to WT littermates at each age 
tested (p >0.05) (Figure 3B). This trend may suggest a less anxiety-like behavior phenotype 
of the BACHD rats, although it did not reach statistical significance. 
Figure 2   Light Spot in the Phenotyper. 
(A) Frequency of entrances/visits to in the light spot / feeder zone when the light spot was 
on. (B) Mean proportion of time spent in the feeder zone during the light spot. (C) Mean 
proportion of time spent outside the shelter during the light spot. Data are expressed as 
means ± S.E.M. Two-way ANOVA results are displayed within each graph. Results from 
post-hoc analysis are indicated in case significant genotype differences were found. N= 10 
WT and 10 BACHD rats. (*) p < 0.05, (***) p < 0.001, (****) p < 0.0001, ns (not significant).
A
C
B
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In addition, risk assessment parameters were measured, with both BACHD and WT animals 
having a significant effect of age on the time spent head dipping (F(3,60) = 7.266, p=0.0003). 
Neither a genotype effect was detected (F(1,20) = 0.1013, p=0.7535) nor a genotype x age 
interaction (F(3,60) = 0.6936, p=0.5596) (Figure 3C). Conversely, both BACHD and WT rats 
showed fluctuations in the frequency of head dips in the open arms over different ages 
(age effect: F(3, 60) = 12.34, p<0.0001) without presenting any genotype effect (F(1, 20) = 
0.2684, p=0.6101) (Figure 3D). 
Figure 3   Elevated Plus Maze.
(A) Percentage of time spent in the open arms. (B) Frequency in the open arms. (C) Time 
spent head dipping inside the open arms. (D) Head dip frequency in the open arms. Data 
are expressed as means ± S.E.M. Two-way ANOVA results are displayed within each graph. 
Results from post-hoc analysis are indicated in case significant genotype differences were 
found. N= 10 WT and 12 BACHD rats. (***) p < 0.001, (****) p < 0.0001, ns (not significant).
A
C
B
D
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In contrast to the light spot test, the outcome of EPM exposure did not disclose BACHD 
rats’ significant anxiety-related changes by measuring the EPM classical parameters and 
the risk assessment parameters.
Discussion
In this study we focused on the development of the anxiety-like responses of the BACHD 
rat model over four different ages (at 2, 4, 8 and 12 months), attempting to have a 
comprehensive picture of BACHD rats’ repertoire of anxiety-like behavior. Although HD is 
a neurodegenerative disorder best known for its effect on motor control, mood 
disturbances such as depression, anxiety, and irritability have a high prevalence in patients 
with HD, and often start before the onset of motor symptoms (Pla et al., 2014). The BACHD 
transgenic rat is the newest rat model for HD and its psychiatric phenotype has not been 
fully determined yet, with previous studies reporting decreased anxiety-like behavior in 
the elevated plus maze (Clemens et al., 2015; Yu-Taeger et al., 2012) and increased 
impulsivity (Manfré et al., 2016) in the delay discounting and in the Differential 
Reinforcement of Low rate of responding (DRL) tasks. Modeling the complexity of the 
psychiatric symptoms of pre-clinical HD in a rodent model is therefore important for 
increasing our understanding of the neurobiological mechanisms underlying the HD 
neuropathology. To our knowledge our study is the first one to explore the anxiety-like 
phenotype of BACHD rats by challenging them with a battery of tests, not only classical 
ones in a novel environment, but also including an automated test in the home-cage. 
Our data demonstrated a very subtle decrease of anxiety-like behavior in BACHD 
transgenic rats across 4 different developmental stages of the disease. Although not 
striking, there were still some behavioral differences in the three tests.
 In the light–dark box BACHD rats showed similar anxiety-like responses when 
compared to control animals. The results of the light-dark box test are in line with BACHD 
rats’ spending, in comparison with control animals, the same amount of time and having 
the same frequency of visits in the open arms of the EPM. In a previous study it has been 
reported that BACHD rats spent significantly more time in the open arms of the EPM 
compared to WT animals (Clemens et al., 2015; Yu-Taeger et al., 2012) starting at 4 months 
of age. Our BACHD animals did not replicate the same EPM phenotype, likely because of 
repeated testing. A subtle change in risk assessment behavior, as reflected by a slight 
increase in time spent head dipping in the open arms, was detected in BACHD rats at the 
age of 4 months, although it did not reach statistical significance. The employment of the 
ethological measurement of risk assessment in this study confirms a unaltered coping 
strategy of BACHD animals. Overall, the outcome of both traditional test might not allow 
us to draw final conclusions on anxiety in BACHD rats. 
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Quantification of anxiety levels for the purpose of behavioral characterization of an animal 
model often contains the application of a battery of tests in order to capture the whole 
phenotype (Steimer, 2011). We implemented the light spot test since it is based on the 
rodents’ natural aversion for brightly lit areas and the assurance that a covered shelter is 
offered. Therefore, using a mild aversive stimulus in a home-cage environment circumvents 
the stress of handling, transportation and novelty, and also offers the opportunity for 
continuous automated quantification of behavior (Aarts et al., 2015). No prior manipulations 
such as food restriction or deprivation or any kind of training is needed to stimulate the 
animal’s participation to the light spot test. The lack of a need for prior training and food 
or water deprivation suggest to use the LS in the same way as described for the light-dark 
box test (Bourin and Hascoët, 2003): the time spent in the feeder zone is indicative of the 
approach response to the stimulus and it could be directly compared to the time spent in 
the light compartment during the light-dark box. In the case of the light-dark box, the 
animal can choose in which of the two sides it will stay without being forced to get 
exposed into the bright light (Ennaceur, 2014). Instead, in the case of the LS, the animal has 
to face its natural instinct of feeding whereas in the light-dark box there is the instinct of 
exploration of the novel box (Bourin and Hascoët, 2003). In addition, in the light-dark box 
the animal is directly placed in the light compartment whereas the animal is placed in the 
home-cage environment during the dark phase. As well as in traditional tests, in the LS 
test there is the element of curiosity for exploring the new situation presented in the 
home cage and assessing the potential threat. Another advantage of the LS test is that it 
is conducted in a home-cage environment after a full 5 days of habituation. The continuous 
monitoring and high sampling-rate provides great opportunities with respect to the 
within-group comparison to baseline to optimally use the data acquired. BACHD rats 
spent significantly more time in the feeder zone at 2, 8 and 12 months of age, suggesting 
reduced anxiety-like behavior. However, no differences were found at 4 months of age. 
Interestingly, BACHD rats’ time spent in the feeder zone during the light spot remains fairly 
constant from 4 to 12 months of age, demonstrating the same coping strategy with an 
adverse or unexpected situation (the ‘approach-avoidance’ conflict). In addition, future 
research should aim at investigating even older animals to establish if the phenotype 
remains stable over time.
 One might argue that altered anxiety-like responses might be related to changes in 
locomotion (Pla et al., 2014). However, in our study it is unlikely that BACHD rats’ increased 
time spent in the feeder zone is influenced by locomotor alterations, given that our 
previous study showed an intact locomotor activity of BACHD animals during their active 
phase (Manfré et al., 2017). 
 The reliability and robustness of our study is the fact that the battery of behavioral 
experiments, combining novel and classical test setups, was conducted under well 
controlled environments (temperature, humidity, food), allowing the monitoring of 
behavior across different ages. Rodents, and especially rats, are highly suitable animals for 
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preclinical studies and in the last decade there has been a concerted effort towards 
automating methods for continuous automated home-cage assessment (Bains et al., 2017; 
Chort et al., 2013; Vandeputte et al., 2010), embracing rodent models of polyglutamine 
diseases (Kyriakou et al., 2015, 2017a; Manfré et al., 2017; Portal et al., 2013). Different 
technologies and paradigms have been developed to capture a wide range of behaviors 
through the possibility to house rodents in automated home-cage environments for 
extended periods of time and to measure voluntary activity without interference from the 
investigator (Schaefer and Claridge-Chang, 2012). Moreover, automated home cage 
observation allows data collection 24 h a day, 7 days a week, and it eliminates the handling 
and transportation of animals from home cage to test apparatus (de Visser et al., 2006; Kas 
and Van Ree, 2004). Several options for home cage monitoring are commercially available 
for rodents. PhenoTyper home cages but also many other automated home cages are 
used for the measurement of a broad variety of parameters, including cognition, 
locomotor activity, velocity, food and water consumption (Spruijt and DeVisser, 2006). 
Therefore, we decided to employ an automated test in the home-cage besides the 
traditional tests. Our results support the notion that going beyond the classical behaviors 
provides a more comprehensive analysis, thus adding value to the EPM and light-dark box 
behavioral patterns. This was shown by the fact that 2-, 8- and 12-month old BACHD 
animals seem to exhibit a decrease in their anxiety-like response in the light spot task, 
indicated by a statistically significant decrease compared to WT. By definition, anxiety is a 
complex biological phenomenon as a response to an unknown danger or threat stimulus 
or even an internal conflict that in turn triggers the appropriate response. The responses 
can vary depending on several factors (such as the type of the signal, environmental 
factors or contextual clues and even individual differences). Therefore, at this point we 
cannot exclude that the increased time spent in the feeder zone during the light spot may 
be related to a decreased eye-sight, or to a slower feeding speed. In previous studies, WT 
and BACHD rats deprived to 85% of their free-feeding body weight did not seem to differ 
in their interest in consuming 100 reward pellets, although BACHD rats needed more time 
to eat all pellets (Jansson et al., 2014). It may be that BACHD rats need more time to 
consume the same amount of food of WT animals, thus spending more time in the feeder 
zone.
 On the other hand, it has to be noted that we performed multiple behavioral tests 
with the same group of rats. Repeated testing might have influenced the outcome of the 
tests (carry-over effect), although such an approach offers a better possibility to investigate 
phenotype onset and development than in separate cohorts of rats. It should be also 
noted that the LS test is a rather recent test which to our knowledge has only been 
reported once in mice and once for rats thus far (Aarts et al., 2015; Kyriakou, et al., 2017). As 
the light-dark box test has been repetitively described in literature being sensitive to 
strain, weight and age differences (Hascoët et al., 2001), the LS test may also be influenced 
by those variables. Therefore, further research may be needed (possibly using different 
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mouse and rat strains) to validate this test and verify its robustness under different 
circumstances, although the option to use a within-group baseline offers a solid basis for 
the interpretation of the data.
Conclusion
Taken together, our results indicate that the BACHD rat model does not display clear-cut 
anxiety-like responses in the classical paradigms over different ages. Interestingly, BACHD 
rats seemed to show reduced anxiety-like behavior when tested in an automated 
home-cage setting when an aversive stimulus (light spot) was offered. In translation to a 
patients’ situation, our results are not in line with findings of mood changes including 
anxiety in early- and late-symptomatic patients. Overall, our results do not mimic the 
generalized anxiety as seen in case reports, making the BACHD rat, as tested thus far, a less 
suitable model for therapeutic studies in the domain of anxiety. 
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Thesis objective
Understanding strengths and weaknesses of the various animal models of Huntington 
Disease (HD), as well as knowledge of their phenotypes and end points, should guide 
researchers in the selection of the right animal model for a particular purpose and research 
question.
 The aim of this thesis was to investigate aspects of the different psychiatric and motor 
phenotypes of the BACHD rat model of Huntington disease and parallel them to patients’ 
symptoms. To this purpose, the studies described in this thesis aimed at detecting 
phenotypes that resemble HD-like symptoms, as well as at monitoring their development 
by investigating the animals at different ages. We therefore selected different behavioral 
domains and designed different behavioral experiments, employing a specific battery of 
tests, to acquire more knowledge about certain aspects of the disease-phenotype that 
can be utilized for the identification of candidate compounds with therapeutic promise.
In chapter 2, we set out to investigate how different aspects of motor activity could 
influence the poor rotarod performance BACHD rats exhibited in previous studies. In 
accordance with these previous findings, our transgenic animals exhibited the same 
performance, confirming that BACHD animals present behavioral anomalies in motor 
performance in comparison with their WT littermates. We further investigated other 
aspects of this motor phenotype, testing rats for fine motor control by using the pasta 
handling and the pellet reaching tests. These tests did not reveal fine motor control 
deficits in BACHD animals at 2, 7 and 12 months of age. However, when WT and BACHD 
rats were assessed for gross motor function in the holding bar test, transgenic animals 
exhibited impairments indicative of decreased muscle endurance. Conversely, transgenic 
animals showed no impairments in performance in the grip strength test when compared 
to control animals, indicative of normal muscle strength. Interestingly, when tested in an 
automated home-cage environment, BACHD rats showed a decreased locomotion during 
the light (inactive) phase only, indicated by a reduced distance moved, velocity and time 
spent on the shelter.
Other than motor symptoms, psychiatric disturbances are quite common in manifest HD, 
although less is known about these symptoms in the earliest phase of the illness. Therefore, 
in chapter 3 we decided to perform a longitudinal study to establish the onset of social 
behavior disturbances in HD animals. BACHD rats showed age-dependent changes in 
behavior when they were re-introduced to their cagemate after a 24 hours-period of 
individual housing. In the social interaction test, BACHD rats showed abnormal social play 
and decreased active social behavior compared to their WT littermates. In the three 
chamber social test, BACHD rats seemed to show a mild deficit in preference for social 
novelty without any changes in social interest. We also carried out molecular analyses, 
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revealing that BACHD animals exposed to the social interaction test displayed decreased 
mRNA levels of the total form of BDNF in the ventral striatum and unaltered striatal 
expression of D1 and D2 dopamine receptors. 
In chapter 4 we subjected control and BACHD rats to two Skinner box tests to assess their 
impulsivity trait. Impulsivity, poor risk assessment and altered behavioral inhibition are 
frequently encountered personality traits in HD so we explored two different aspects of 
impulsive behavior, namely choice and action impulsivity. When tested on the delay 
discounting (DD) task, BACHD rats showed high levels of choice impulsivity favoring 
“smaller, sooner” over “larger, later” rewards. Additionally, BACHD rats exhibited a lack of 
behavioral inhibition as indicated by bursts and premature responses in a DRL-5 and -10 
(Differential Reinforcement of Low Rate of Responding task).
In spite of being under-researched, the prevalence of anxiety in manifest HD ranges from 
13% to 71%, thus being an important clinical feature of HD. As HD patients may suffer from 
anxiety, in chapter 5 we conducted a longitudinal study to assess anxiety-like behavior in 
BACHD and WT rats at 2, 4, 8 and 12 months of age. In this chapter, classical and novel 
behavioral tests were used to assess different traits of anxious-like and risk assessment 
behavior, using the elevated plus maze, the light-dark box and the light spot (LS) test in 
the Phenotyper. In all tests, BACHD rats showed a trend towards decreased anxiety, 
making this model less suitable for finding potential treatments of anxiety-related 
disorders in HD-patients.
BACHD rats present muscle endurance but not fine motor control 
deficits on a test battery of motor function
Previous experiments have shown a strong motor coordination deficit in the Rotarod test 
(Abada et al., 2013b; Clemens et al., 2015; Yu-Taeger et al., 2012), mild gait impairments and 
altered open field activity (Abada et al., 2013b) in BACHD rats. In order to further dissect 
the motor phenotype of transgenic animals, fine motor skills, muscle strength and 
endurance have been assessed, as well as several parameters of activity-related motor 
function in a home-cage-like environment. 
 With respect to fine motor control, BACHD rats did not present any significant 
impairment. Although HD patients are significantly impaired in fine motor skills (Klein et 
al., 2011), skilled reaching and manual dexterity appeared to be intact in BACHD rats when 
tested in the pasta handling and the pellet reaching tests. However, our results are in line 
with previous observations in the transgenic Huntington disease (tgHD) rat strain (Fielding 
et al., 2012), which expresses a truncated N-terminal fragment of mHTT. We could conclude 
that fine motor skills did not play a role in the poor rotarod performance previously 
reported in these rats.
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Concerning muscle strength, transgenic rats exhibited a significant impairment in the 
holding bar task at 2 months of age, suggesting reduced muscle endurance. Nevertheless, 
no differences were found at 7 and 12 months of age, as WT rats’ performance dropped 
down to BACHD rats level at these ages. The difference at 2 months of age is perhaps 
related to a reduced amount of muscle mass and increased amount of fat mass carried by 
BACHD rats, as reported in a previous study (Jansson et al., 2014). Accordingly, a reduced 
performance in the holding bar test could be expected, as transgenic animals have to 
sustain the same body weight with a significantly lower amount of muscle mass, when 
compared to their WT littermates. On the other hand, the drop that WT animals exhibited 
at 7 and 12 months of age might be either due to repeated testing or due to the large 
increase in body weight from 2 to 7 months of age, which might have made it impossible 
for the rats to hang longer than a certain minimum amount of time. Thus, the test might 
not allow us to draw final conclusions on muscle endurance in older rats.
 Conversely, the grip strength test did not show an indication that BACHD rats’ 
“passive” forelimb grip strength was reduced, even at the youngest age. A possible 
explanation could be that in the holding bar test the rats have to work against gravity and 
their own weight, while this does not take place in the grip strength. Due to the abnormal 
body composition (reduced muscle and increased fat mass), BACHD rats’ workload during 
the holding bar test is higher than that of WT rats. In contrast, WT and BACHD rats are likely 
exposed to a more comparable workload during the grip strength test.
 Our study revealed specific motoric impairments in the BACHD rats although it is 
hard to draw a final conclusion on what caused the strong rotarod impairment. Even 
though there is a motor component, the deficit may also be related to non-motor aspects, 
like motivation or increased fat mass, as such differences have been reported in previous 
studies (Clemensson et al., 2017; Jansson et al., 2014). Future research will be therefore 
needed to understand the underlying mechanisms contributing to this motor deficit.
Automated home-cage monitoring revealed subtle differences in 
locomotor and activity patterns in BACHD animals
Automated methods for continuous automated home-cage assessment and for 
measuring motor function have been extensively used in the last years (Bains et al., 2017; 
Chort et al., 2013; Vandeputte et al., 2010). A comprehensive range of behaviors, free from 
experimenter bias, can be captured through the possibility to house rodents in automated 
home-cage environments for extended periods of time and to measure voluntary activity 
(Schaefer and Claridge-Chang, 2012).
 To expand the repertoire of meaningful motor function tests in our rat model, 
we investigated general aspects of motor function related to rats’ baseline behavior 
through a video-based observation system in a home-cage like setting, namely the 
Phenotyper®. In this setup, BACHD rats exhibited a generally reduced number of jumps 
on the shelter, while the time spent on the shelter was similar to WT rats. This suggests a 
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specific motoric difficulty to reach the top of the shelter rather than a reduced motivation 
to use it. Interestingly, this phenotype was present at all investigated ages. Furthermore, 
we found BACHD rats to have a generally reduced locomotor activity, as became apparent 
by a lower distance moved, velocity and time spent and number of jumps onto the shelter, 
specifically restricted to the light phase. These data suggest that, in our setting, the overall 
walking ability and activity of the rats was relatively preserved, as it was unaffected during 
their active phase. This is in line with previous findings in BACHD rats of the same age, 
which showed only mild gait abnormalities in both static and dynamic parameters in the 
Catwalk system (Abada et al., 2013b). Conversely, the results are in contrast with a lower 
rearing and ambulatory activity observed with the PhenoMaster set-up at 3 and 6 months 
of age (Yu-Taeger et al., 2012) and with an initial hyperactivity followed by hypoactivity 
starting at 4 months of age showed by BACHD rats in an open field test-like setup (Abada 
et al., 2013b). The different outcome could be due to the different test protocols and test 
setups used. Most prominently, we screened the animals for 6 consecutive days, while the 
other two studies screened for 22 hours and 1 hour, respectively. Thus, those results will 
probably reflect the rats’ response to novelty, while we have investigated their baseline 
behavior.
 In conclusion, the reduction in activity during the light phase might suggest the 
existence of an altered activity pattern, which would be in line with the disrupted circadian 
rhythmicity HD patients as well as the BACHD and the R6/2 mouse models exhibited in 
previous studies (Kuljis et al., 2012; Morton et al., 2005). As circadian sleep disturbances are 
an important pathological feature of HD, further investigations may reveal insights in the 
underpinnings of an abnormal circadian activity.
Abnormal social play and diminished active social behavior in  
BACHD animals 
The complex disease symptoms result in loss of independence, eliciting devastating 
personal and social consequences in HD patients. Since HD causes major disruption in 
family life (Vamos et al., 2017) there is an urgent need to use a family perspective when 
assessing the necessity for psychosocial intervention in HD. Thus, we decided to use 
familiar pairs (cagemates) in the social interaction test in order to have a better translational 
value of our results. By using two different social paradigms we aimed to detect potential 
HD-related deficits in social behavior. 
 The social interaction test revealed abnormal social play in BACHD animals as well as 
a trend towards a decreased interaction with conspecifics. Play fighting is one of the most 
notable social behaviors in rats, involving attack and defense of the nape of the neck, 
which if contacted, is gently nuzzled with the snout (Himmler et al., 2013). When initiating 
social play, one animal directs to the neck region of the partner and this can be 
accompanied with biting and pulling fur in that region. BACHD rats performed more 
play-fighting compared to their WT littermates, as showed by the increased nape 
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attacking. 8 month-old BACHD rats showed a twofold increase in the time spent on nape 
attacks, and a decreased duration of pinning compared with control rats. Pinning is a 
commonly used measure for play, which essentially involves the subject positioned supine 
with its partner standing on top (Himmler et al., 2013; Panksepp, 1981). 
 Social play has been suggested to represent a separate category of behavior (Baenninger, 
1967; Hole, 1991b; Panksepp et al., 1984) and considerable differences between social play 
and aggressive behavior have been found (Hole, 1991a). Nevertheless, such behaviors are 
likely to represent more than just precursors of adult sexual or aggressive behaviors 
(Vanderschuren et al., 1997). We can therefore presume that these rougher and more 
aggressive play behaviors might facilitate the development of aggressive behaviors 
(Veenema and Neumann, 2009), which has been listed as psychiatric manifestation in 
patients who carry the HD mutation (Epping et al., 2016; Rosenblatt, 2007). More specific 
tests are anyway needed to verify the occurrence of aggressive behavior in adult 
BACHD animals. 
 Furthermore, the following and approaching parameters significantly decreased in 
BACHD animals at different age points, suggesting a reduced inclination to search for an 
interaction. The lack of these social behaviors in BACHD rats may suggest a “social deficit” 
that could be related to coping styles (Van Den Berg et al., 1999; Varlinskaya and Spear, 
2008), and considered as a form of apathy, as showed by the R6/2 mouse model of HD 
(Wood and Morton, 2015). Among HD’s psychiatric manifestations, apathy has an 
extremely high prevalence and, as a psychiatric symptom distinct from depression, has 
been described as a combination of diminished motivation, reduced goal-directed 
behavior, lack of interest in new experiences, and diminished emotional responsivity 
(Starkstein and Leentjens, 2008). Although we cannot directly confirm its occurrence with 
the parameters we measured, apathy has been previously reported in the BACHD, in the 
z_Q175, and in the HttQ111/+ mouse models (Minnig et al., 2017; Oakeshott et al., 2012) and 
is commonly reported in patients with HD (Naarding et al., 2009). Changes in instrumental 
motivation may serve as a translatable readout of basal ganglia dysfunction in rodent 
models of HD. Future studies on other specific aspects of social behavior, e.g., social 
reward, will be important to define whether or not a social apathy-like phenotype is 
present in BACHD rats. Alternatively, the deficits in social behaviors described in BACHD 
rats may represent behavioral changes that depend more specifically on alterations in 
brain social networks which mechanisms in HD are still mostly unclear. 
 The lower approaching and following behaviors observed in this study are not likely 
to be affected by anxiety levels in BACHD rats, as in chapter 5 we reported unchanged 
anxiety-like responses in the elevated plus maze, in the light-dark box and a slightly 
decreased anxiety-like response in the light spot test. Furthermore, it is worth noting that 
these social behavior alterations were likely not confounded by an overall reduced motor 
activity, such as levels of general locomotion or activity: BACHD animals display similar 
levels of locomotion compared to their wild-type littermates as shown in chapter 2. 
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In summary, these results indicate deficits in several parameters representative of social 
play and active social behavior, thus replicating the disrupted social behaviors seen in HD.
BACHD rats exhibit mild deficits in preference for social novelty,  
but no changes in social interest
Cognitive deficits have already been described in BACHD rats for different aspects not 
related to social behavior (Abada et al., 2013a; Clemensson et al., 2017). 
 While decreased or increased social interaction (Nguyen et al., 2006; Pietropaolo et al., 
2011; Wood and Morton, 2015) have been described in other animal models of HD using 
different behavioral paradigms, we did not observe altered sociability levels in BACHD rats 
exposed to the three chamber social test. In line with these findings, one recent study 
showed no changes in the preference for an unknown conspecific relative to an unknown 
object in BACHD rats (Lamirault et al., 2017). Although unchanged levels of social 
interaction in the three chamber social test are present, they are not necessarily in contrast 
with parameters measured in the social interaction test within this study. For example, 
increased approaching in the social interaction test is present along with an increased 
nape attacking which may relate to a play fighting-like behavior that is prevented in the 
other test where limited physical contact is allowed. 
 The novelty effect in our study is in line with earlier research in HD mouse models 
showing alterations in social recognition and memory (Ciamei and Morton, 2008; Rudenko 
et al., 2010) as well as with evidence of disrupted social cognition in HD patients (Larsen et 
al., 2016; Snowden et al., 2003). The brain changes underlying these symptoms in HD are 
not well known and it is not clear to which extent deficits in social cognition, mostly 
described as impaired emotion recognition, may depend on other cognitive and 
emotional changes and whether they could be the cause of social behavior alterations in 
HD patients. In conclusion, we were also able to detect a mild deficit in social novelty in 
BACHD animals at 7 months of age, as suggested by a lack of preference for a novel 
conspecific relative to a familiar one in the three chamber social test. These data, along 
with the changes in social interaction parameters, support the validity of the BACHD rat 
model in mimicking features of certain social deficits that could be relevant to symptoms 
in patients.
Possible involvement of BDNF in transgenic animals’ decreased sociability
Gene expression analyses were carried out in 8 month-old animals tested for social 
interaction, highlighting an altered expression of BDNF in ventral striatum and an intact 
striatal D1 and D2 receptors expression. The striatum is one of the most affected brain 
areas in HD where alterations in dopaminergic and BDNF brain systems have been well 
described previously (Cepeda et al., 2014; Zuccato and Cattaneo, 2007). We therefore 
investigated mRNA levels of striatal BDNF and dopaminergic receptors as potential 
mechanisms at the base of behavioral abnormalities. Furthermore, we linked social 
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behavior to striatal functionality via D1 and D2 dopamine receptors in 8 month-old animals 
which, along with BDNF, have been proposed as possible underlying regulatory factors 
(Báez-Mendoza and Schultz, 2013). The lack of changes in mRNA levels of D1 and D2 
dopamine receptors in BACHD rats subjected to the social interaction test would not 
suggest a direct link between the dopaminergic system and the behavioral changes. 
However, this result is in line with unpublished studies of our collaborators that showed 
unaltered density of D2 receptors in the striatum of 3 and 9 months old BACHD rats. 
Nonetheless, measuring protein levels in future studies may help to understand better 
whether the dopaminergic system plays a role in the behavioral changes. BDNF mRNA 
levels were also quantified and we detected a decreased expression in the ventral striatum 
of BACHD animals and no changes in the dorsal region. Therefore, it is possible that altered 
BDNF expression in this region may have contributed to the deficits in sociability in 8 
months old BACHD rats. One should keep in mind that striatal BDNF transcript levels are 
very low at basal level and that usually BDNF protein is not directly transcribed in the 
striatum, but it is produced in the cerebral cortex and anterogradely transported to the 
striatum (Zuccato et al., 2010). In light of this, we cannot draw any conclusion on the 
mechanisms underlying the BDNF decrease and its link to social deficits and it should be 
the aim of future experiments, possibly using different age cohorts of BACHD rats.
BACHD animals exhibit high levels of choice and action impulsivity 
Impulsivity, poor risk assessment and altered behavioral inhibition are frequently 
encountered personality traits in Huntington disease (Duff et al., 2007; Weintraub et al., 
2015). Cognitive and psychiatric disorders affect HD patients before motor symptoms 
(Novak & Tabrizi 2010; Rosenblatt, 2007) and have a detrimental impact on the quality of 
HD patients’ life (Guttman et al., 2003; Rosenblatt, 2007). 
 To determine impulsivity traits in these rats, we used two different paradigms to 
assess choice and action impulsivity. During the delay discounting task (DD), BACHD and 
WT rats shifted progressively their choices to the immediate small reward as the delays 
increased. BACHD rats shifted more quickly to the immediate small reward than WT rats, 
thus showing high levels of choice impulsivity. In the DRL-5s and -10s (Differential 
Reinforcement of Low Rate of Responding task) BACHD rats were almost as efficient as WT 
animals, with a less precise temporal discrimination and a higher rate of burst responses 
during the very first seconds following a reward. In addition, BACHD rats exhibited a lack 
of behavioral inhibition as indicated by bursts and premature responses in the DRL task.
 These results demonstrate the occurrence of a high level of choice impulsivity and, 
to a minor extent, action impulsivity in BACHD rats. The DD paradigm describes primarily 
the devaluation of an event as the delay to that event increases: the maintained bias 
towards larger delayed gratification has been taken to index increased self-control (Isles 
et al., 2004). The DRL paradigm depicts the capacity to withhold actions during a fixed 
amount of time. Burst responses, which follow immediately after a rewarded lever-press, 
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indicate perseverative responses induced by the failure to re-obtain an immediate 
feedback to their responses. Timing errors define the temporal discrimination ability, 
which allows assessment of when the time t has elapsed (Kramer and Rilling, 1970). BACHD 
rats exhibited a steep delay discounting curve in the DD showing a high level of cognitive/
choice impulsivity. On the other hand, they show a nearly normal efficiency in the DRL, 
but the timing errors and the high rate of burst responses when the delay increased 
indicate signs of motor impulsivity. 
 At the neurobiological level, lack of inhibitory control has been observed in several 
neuropathological disorders associated with abnormal dopaminergic transmission such 
as deficit/hyperactivity disorder (ADHD), Parkinson disease, Alzheimer disease and 
Huntington disease (Barkley, 1997; Rosenblatt, 2007; Rochat et al., 2008; Novak & Tabrizi 
2010; Nombela et al., 2014). Furthermore, there is a strong correlation between dopamine 
receptors availability and the two different types of impulsivity: variation in striatal D2/D3 
receptor levels is negatively correlated with impulsive action in rodents (Dalley et al., 2007; 
Laughlin et al. 2011) and with impulsive choice and action in humans (Lee et al., 2009; 
Ghahremani et al., 2012). On the other hand, D1-like receptors appear to be most selectively 
involved in mediating impulsive choice in rats which may be explained by their different 
locations within the prefrontal cortex (PFC), an area known to be involved in impulsive 
choice (Loos et al., 2010; Koffarnus et al, 2011). Furthermore, impulsivity, as well as 
compulsivity and flexibility, are closely interrelated executive processes in the context of 
inhibitory control mediated by the PFC (Bari & Robbins, 2013; Wise, 2008). However, 
according to the model proposed by Bechara (Bechara, 2005), willpower emerges from 
the dynamic interaction of two separate, but interacting, neural systems: an impulsive 
system, in which the amygdala is a critical neural structure involved in triggering the 
affective and emotional signals of immediate outcomes, and a reflective system, in which 
the ventral PFC is crucial in triggering the affective and emotional signals of long-term 
outcomes. Using a delay discounting paradigm, rats with inactivation and disconnection 
of the medial PFC and basolateral amygdala become more impulsive, showing preference 
for smaller immediate over larger delayed rewards (Churchwell et al., 2009). In HD patients, 
both the prefronto-striatal circuit and the amygdala system seem to be dysfunctional 
(Rosas et al., 2003). Starting from 3 months of age, BACHD rats present a high expression 
of mutant huntingtin (mhtt) aggregates in the neocortex and in limbic areas including the 
amygdala (Yu-Taeger et al., 2012). Although further studies are needed, we assume that a 
dysfunctional prefronto-striatal/amygdala imbalance might contribute to the high level of 
choice impulsivity observed in BACHD rats. Similar to the impulsive and perseverative 
behaviors described in early symptomatic HD patients, BACHD rats resembles the same 
features, making this rat model highly suitable for drug discovery purposes.
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BACHD animals show unchanged anxiety-like responses in classical  
but not automated tests 
Although chorea is a prerequisite for formal clinical diagnosis (Loy and McCusker, 2013; 
Reilmann et al., 2014) and the most recognized HD-related deficit (Papoutsi et al., 2014), 
psychiatric (and cognitive) symptoms often appear during the prodromal phase of the 
disease, as many as 10 years prior to the onset of motor dysfunctions (Epping et al., 2016; 
Tabrizi et al., 2013). Anxiety may be an early feature of HD and it may coexist with depression 
(Craufurd et al., 2001) and these aspects are often described as being the most burdensome 
symptoms to both HD patients and their families (Paulsen, 2011).
 Our study attempted to explore the anxiety-like phenotype of BACHD rats by 
challenging them with a battery of tests, not only classical ones in a novel environment, 
but also including an automated test in the home-cage. Our data did not demonstrate 
marked differences in anxiety-like behavior in BACHD transgenic rats across 4 different 
developmental stages of the disease. 
 The time spent and the number of entries in the light compartment of the light-dark 
box did not reveal any significant differences in any age group. Similarly, in the elevated 
plus maze test, the time spent and the number of entries into the open arms did not differ 
between the two groups at any age, which indicates a similar level of anxiety in the two 
groups. The outcome of both test is in contrast with previous findings in patients and in 
different rodent models of HD. Increases in anxiety-like behavior have been shown in 
BACHD mice using the open-field test, the elevated zero maze, the elevated plus maze, 
the light-dark box test and a fear conditioning test (Carter et al., 1999; Menalled et al., 2010). 
Conversely, some studies have shown that R6/2 mice exhibit a decrease in anxiety-like 
behavior in the EPM (File et al., 1998). Similarly, a decrease in anxiety-like behavior has been 
shown in the R6/1 mouse (Naver et al., 2003) and in our BACHD rat model in the EPM 
(Yu-Taeger et al., 2012), where a reduced level of anxiety was observed. Additionally, we 
employed the ethological measurement of risk assessment. A subtle change in risk 
assessment behavior, as reflected by a slight increase in time spent head dipping in the 
open arms, was detected in BACHD rats at the age of 2 months, although it did not reach 
statistical significance. 
 In the last decade, the continuous monitoring and high sampling-rate made possible 
by automated systems provides great opportunities with respect to the within-group 
comparison to baseline to optimally use the data acquired. We decided to combine the 
light-spot and the light-dark box tests as the lack of a need for prior training and food or 
water deprivation suggest to use the LS in the same way as described for the light-dark box 
test (Bourin and Hascoët, 2003): the time spent in the feeder zone is indicative of the 
approach response to the stimulus and it could be directly compared to the time spent in 
the light compartment during the light-dark box. BACHD rats spent significantly more 
time in the feeder zone at 2, 8 and 12 months of age, suggesting reduced anxiety-like 
behavior. However, no differences were found at 4 months of age. Interestingly, BACHD 
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rats’ time spent in the feeder zone during the light spot remains fairly constant from 4 to 
12 months of age, demonstrating the same coping with an adverse or unexpected 
situation (the ‘approach-avoidance’ conflict). In addition, future research should aim at 
investigating even older animals to establish if the phenotype remains stable over time. 
Furthermore, one has to keep in mind that an altered anxiety-like behavior might be 
related to changes in locomotion (Pla et al., 2014). It is unlikely that BACHD rats’ increased 
time spent in the feeder zone is influenced by locomotor alterations, given that in chapter 2 
we show an intact locomotor activity of BACHD animals during their active phase. Overall, 
the outcome of traditional and automated tests investigated within the thesis would 
suggest that the BACHD rat is not a reliable model of the anxious behavior exhibited by 
HD patients, thus making BACHD rats a less suitable model for therapeutic studies in the 
domain of anxiety.
Concluding remarks
Based on the findings presented in this thesis we proposed several interesting directions 
for future research, as summarized above. These future perspectives stress the importance 
of modeling the complexity of motor and psychiatric symptoms of Huntington Disease in 
a pre-clinical setting to increase our understanding of the neurobiological mechanisms 
underlying the HD neuropathology, and develop and validate robust disease models for 
therapeutic efficacy studies. 
In our motor control study we dissected the motor phenotype of BACHD rats looking at 
different aspects of motor control, namely fine and gross motor control. We provided 
evidence of BACHD rats’ impairment in muscle endurance that can be possibly linked to a 
reduced amount of muscle mass and/or to an increased amount of fat mass as showed in 
previous experiments (Jansson et al., 2014). Furthermore, previous studies provided 
evidence of peripheral pathology such as weight loss and muscle wasting in HD patients 
(Cepeda et al., 2007; Imarisio et al., 2008; Miller and Bezprozvanny, 2010), progressive 
skeletal muscle atrophy in HD patients and in the R6/2 mouse model for HD (She et al., 
2011; Zielonka et al., 2014). Another possibility is that this impairment might be related to 
deficits in the joints, ligaments and tendons, which are structures that are compromised 
in HD patients and in the BACHD mouse model (De Aragão et al., 2016; Nguyen and Cenci, 
2015). In an automated home-cage setting the global walking ability and activity of 
BACHD rats appeared to be preserved, as it was unaltered during the dark phase, the 
major activity phase. Interestingly, BACHD rats exhibited a generally reduced locomotor 
activity during the light phase only. These findings are interesting in the context of 
previous studies in HD patients and in the BACHD mouse model that reported alterations 
in the circadian rhythm (Kuljis et al., 2012; Morton et al., 2005). Since our findings indicate 
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that BACHD animals exhibited a reduced activity during the light phase, that could be 
indeed indicative of an altered night-day activity pattern. Therefore, a direction for 
follow-up research should be towards a detailed assessment of circadian behavior in order 
to investigate the mechanism underlying this behavioral alteration, as it can very well be 
related to the reduction in muscle endurance that we found, resulting in exhaustion and 
a higher need to rest or sleep during the inactive phase. 
 Overall, the results from the motor phenotyping study are not robust enough to 
justify, at this stage, using this line for therapeutic studies to test efficacy of pharmacolog-
ical compounds, although the literature suggests that the histopathology of this model is 
quite robust.
By using two different social paradigms we detected the occurrence of HD-related deficits 
in specific aspects of social behavior. The social interaction test highlighted abnormal 
social play and social dominance behaviors in BACHD animals as well as a trend towards a 
decreased interaction with conspecifics. Furthermore, the three chamber social test 
disclosed mild deficits in social recognition in transgenic animals. Due to the dramatic 
impact HD has on family life on a daily basis, we decided to use familiar pairs (cagemates) 
in the social interaction test in order to have a better translational value of our results. 
Additionally, it would be interesting to implement the resident-intruder test in order to 
assess the occurrence of aggressive behavior in BACHD animals after exposure to a naive 
animal.
 In our study we have also investigated potential molecular correlates of social 
behavior. We did not detect any changes in the mRNA levels of D1 and D2 dopamine 
receptors in BACHD rats subjected to the social interaction test, thus excluding a direct 
link between the dopaminergic system and the behavioral changes. We disclosed a 
decreased expression of BDNF mRNA in the ventral striatum of BACHD animals and no 
differences in the dorsal region. Therefore, it is possible that altered BDNF expression in 
this region may have contributed to the deficits in sociability in 8 months old BACHD rats. 
Alternative measurement techniques should be employed to assess the oxytocinergic 
and vasopressinergic systems in future studies, which are interesting in the context of 
their involvement in social recognition and social behavior (Báez-Mendoza and Schultz, 
2013). A battery of classical and novel paradigms has been employed to characterize 
anxiety-like behaviors in BACHD animals. The light-dark box and the elevated plus maze 
did not highlight any changes in anxiety-like responses, in contrast with HD patients who 
appear to have a more anxious behavior. Interestingly, the light spot test in an automated 
home-cage system showed a decrease of anxious behavior in presence of a mild stimulus 
such as the light into the food hopper. The outcome of our battery of tests evidences that 
the BACHD rats are not suitable for the investigation of molecular markers of the 
generalized anxiety seen in HD patients in case reports.
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To summarize the observations within the psychiatric domain, the BACHD animals 
resemble selected neuropsychiatric symptoms of HD, namely alterations of social 
behaviors and impulsivity. Although being a complex trait, we shed light on the psychiatric 
manifestations shared with the human patients. The BACHD rat appeared to be not 
appropriate for the anxiety-like profiling and highly suitable for investigations of the social 
and impulsive behavior domains, making them valuable markers of the pre-motor phase 
of HD pathology, 
 Future studies should then unravel the mechanisms underpinning impulsive and 
social behavior, guiding us in advancing promising therapeutic agents to deliver effective 
treatments for HD patients. 
In conclusion, the question of which species and which particular model to choose for 
studying HD is dependent on the purpose of the research and the question of interest. 
Different species of animals suit better for modelling certain aspects of HD and for 
different applications. Rodent models of HD are versatile, especially due to the presence 
of test batteries available for the assessment of cognitive, psychiatric and motor-like 
features of the disease. 
 With this thesis we bring new information about the appearance and the progression 
of different motor and psychiatric phenotypes of the BACHD rat model. The outcome of 
our studies should be used to address specific questions about possible phenotype 
manifestations and their course in order to design novel and targeted interventional 
studies. Hopefully, the collective efforts of the field will lead to the achievement of the 
ultimate goal: effective disease-modifying treatments for HD. 
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English Summary
Neuropsychiatric and neurological disorders constitute a major health problem in Europe, 
and their impact on public health and society is increasing with the aging of the 
population. In 2006, the World Health Organization estimated that neurological disorders, 
ranging from epilepsy to Alzheimer disease, from stroke to headache disorders, affect up 
to one billion people worldwide. 
 One particularly relevant neurological disorder in the framework of the foregoing 
concerns is Huntington disease (HD). HD is an autosomal-dominantly inherited, fatal, neu-
rodegenerative disorder. It is caused by an unstable, expanded CAG base triplets in the 
coding region of the Huntingtin gene (HTT), resulting in an abnormal polyglutamine 
sequence in the huntingtin protein (htt). HD patients typically suffer from a triad of 
movement, psychiatric and cognitive symptoms. The onset of the symptoms, that can 
vary between individuals and affected members of the same family, usually occurs in 
mid-adulthood (30-40 years old), but the onset of disease may be earlier or later in life. The 
diagnosis of adult-onset HD typically involves involuntary motor abnormalities and chorea 
that often decrease in a late stage, when parkinsonism, dystonia and rigidity dominate. In 
the early stages patients have deficits in executive system functioning, short-term 
memory and visuospatial functioning. The later stages are characterized by bradykinesia, 
spasticity, dysarthria, dysphagia and incontinence. In addition to motor abnormalities, 
cognitive decline and personality changes are part of HD, and, like motor impairments, 
they deteriorate gradually. Additionally, cognitive deficits progress to more widespread 
global subcortical dementia with apathy, impulsiveness and depression, resulting in a 
negative impact in social life and interpersonal relations. Less common are delusional 
depression or schizophrenia-like-psychosis, which might require psychiatric treatment. 
 Since the discovery of the HTT mutation 25 years ago, more than 13,000 papers have 
been published on HD, approximately half of which relate to attempts to model various 
aspects of the disease. Thus, despite the considerable progress in our understanding of 
the disease, an effective treatment that either prevents or slows the pace of HD remains 
out of reach. The slow rate of progression of HD often necessitates lengthy and therefore 
costly clinical trials. In addition, the number of patients with HD who are available to 
participate in such trials is limited, which means that a relatively small number of 
compounds can be tested every time. 
 Therefore, one of the most important challenges for finding more effective drugs for 
brain disorders is the development of model systems that translate to human pathology 
and are predictive of clinical efficacy. Accordingly, part of that research effort involves 
identifying suitable animal models that provide a valid representation of the pathological 
and behavioral profile of the human disease and that can serve for the identification of 
therapeutic candidates and novel approaches to therapy. 
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Several animal models of Huntington disease have been established following the 
discovery of the Huntingtin gene and the disease-causing mutation. Each model has 
strengths and weaknesses, and their combined use is of importance for preclinical research 
concerning disease mechanisms and potential therapeutics. Thorough  characterization 
of a given animal model is important in order to understand to what extent it models the 
actual disease and how to work with it in an appropriate way. In particular, rodent models 
of HD are versatile, especially when considering the high number of established batteries 
of tests available that allow assessment of motor, cognitive and psychiatric-like features of 
the disease. Studies in rodents that emphasize careful behavioral analysis are being 
developed as effective and inexpensive models that complement clinical studies. The 
BACHD rat is the latest rat model of HD, and expresses the full length human huntingtin 
(fl-mhtt) with 97 CAG-CAA repeats under the control of the human HD promoter gene 
and all its regulatory elements to determine its similarity to the human condition (construct 
validity). The BACHD rat model is particularly relevant since it presents motor, emotional 
and cognitive impairments resembling symptoms seen among HD patients (face validity). 
Furthermore, neuroanatomically and histologically, the models would display selective, 
age-dependent striatal and cortical neuronal loss and atrophy, nuclear inclusions and 
neuropil aggregates. Its predictive validity is currently impossible to establish, as for 
diseases such as HD there is no effective treatment available yet. Despite the extensive use 
of the BACHD rat line in the last years, the studies performed so far did not cover fine and 
gross motor function as well as psychiatric endophenotypes such as social behavior, 
impulsivity and anxiety. In this thesis the focus is on the investigation of these domains, 
which is necessary for the early detection of the first core symptoms of the disease and for 
the monitoring of its development so that possible therapies can be more effective in 
preventing further development of neurodegeneration. 
 Patients and several HD rodent models have been found to present cognitive 
symptoms already before the start of any motor symptoms. Conversely, BACHD transgenic 
rats have repeatedly been found to show early impairments in the Rotarod test which 
progressively worsen over time. Altered activity in the PhenoMaster and in an open field 
test-like setup as well as abnormalities in unhindered walking gait have also been reported. 
These findings suggested that a more in-depth investigation of various aspects of motor 
function in BACHD rats was needed. In chapter 2, we set out to investigate how different 
aspects of motor activity could influence the poor Rotarod performance BACHD rats 
exhibited in previous studies. In accordance with these previous findings, our transgenic 
animals exhibited the same performance, confirming that BACHD animals present 
behavioral anomalies in motor performance in comparison with their wild-type (WT) 
littermates. We further investigated other aspects of this motor phenotype, testing rats for 
fine motor control by using the pasta handling and the pellet reaching tests. These tests 
did not reveal fine motor control deficits in BACHD animals at 2, 7 and 12 months of age. 
However, when WT and BACHD rats were assessed for gross motor function in the holding 
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bar test, transgenic animals exhibited impairments indicative of decreased muscle 
endurance. Conversely, transgenic animals showed no impairments in performance in the 
grip strength test when compared to control animals, indicative of normal muscle 
strength. Interestingly, when tested in an automated home-cage environment, BACHD 
rats showed a decreased locomotion during the light (inactive) phase only, indicated by a 
reduced distance moved, velocity and time spent on the shelter.
 Cognitive and psychiatric symptoms, including perseveration, lack of insight, distract-
ibility, impaired social life, anxiety and impulsivity, affect HD patients before motor 
symptoms and have thus an early deleterious impact on the quality of HD patients’ life. 
The psychiatric phenotype of BACHD rats has been only partly investigated indicating 
that the BACHD rat line requires further phenotyping to test the parallels of their 
phenotypes to patients’ symptoms. Therefore, in chapter 3 we decided to perform a 
longitudinal study to establish the onset of social behavior disturbances in HD animals. 
BACHD rats showed age-dependent changes in behavior when they were re-introduced 
to their cagemate after a 24 hours-period of individual housing. In the social interaction 
test, BACHD rats showed abnormal social play and decreased active social behavior 
compared to their WT littermates. In the three chamber social test, BACHD rats seemed to 
show a mild deficit in preference for social novelty without any changes in social interest. 
We also carried out molecular analyses, revealing that BACHD animals exposed to the 
social interaction test displayed decreased mRNA levels of the total form of BDNF 
(brain-derived neurotrophic factor) in the ventral striatum and unaltered striatal expression 
of D1 and D2 dopamine receptors. 
 In chapter 4 we subjected control and BACHD rats to two Skinner box tests to assess 
their impulsivity trait. Impulsivity, poor risk assessment and altered behavioral inhibition 
are frequently encountered personality traits in HD so we explored two different aspects 
of impulsive behavior, namely choice and action impulsivity. When tested on the delay 
discounting (DD) task, BACHD rats showed high levels of choice impulsivity favoring 
“smaller, sooner” over “larger, later” rewards. Additionally, BACHD rats exhibited a lack of 
behavioral inhibition as indicated by bursts and premature responses in a DRL-5 and -10 
(Differential Reinforcement of Low Rate of Responding task).
 In spite of being under-researched, the prevalence of anxiety in manifest HD ranges 
from 13% to 71%, thus being an important clinical feature of HD. As HD patients may suffer 
from anxiety, in chapter 5 we conducted a longitudinal study to assess anxiety-like 
behavior in BACHD and WT rats at 2, 4, 8 and 12 months of age. In this chapter, classical and 
novel behavioral tests were used to assess different traits of anxious-like and risk 
assessment behavior, using the elevated plus maze, the light-dark box and the light spot 
(LS) test in the Phenotyper. In all tests, BACHD rats showed a trend towards decreased 
anxiety, making this model less suitable for finding potential treatments of anxiety-related 
disorders in HD-patients.
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In chapter 6, we provided an extensive discussion of the research findings summarized 
above and we proposed directions for future research. 
 In conclusion, this thesis includes a series of studies focusing on the characterization 
of different psychiatric and motor phenotypes of the BACHD rat model of Huntington 
disease in order to parallel them to patients’ symptoms. To this purpose, the studies 
described in this thesis aimed at detecting phenotypes that resemble HD-like symptoms, 
as well as at monitoring their development by investigating the animals at different ages. 
The outcome of our studies should therefore be used to address specific questions about 
possible phenotype manifestations and their course in order to design novel and targeted 
interventional studies. 
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Nederlandse samenvatting
Neuropsychiatrische en neurologische aandoeningen vormen een groot gezondheids-
probleem in Europa, en hun invloed op de volksgezondheid en de samenleving neemt 
toe met de vergrijzing van de bevolking. De World Health Organization schatte in 2006 
neurologische aandoeningen, variërend van epilepsie tot de ziekte van Alzheimer, van 
beroerte tot hoofdpijn stoornissen, wereldwijd circa 1 miljard mensen treffen.
 Een bijzonder relevante neurologische aandoening in het kader van de voorgaande 
overwegingen is de ziekte van Huntington (ZvH). ZvH is een autosomaal-dominant 
overgeërfde, fatale, neurodegeneratieve aandoening. Het wordt veroorzaakt door een 
onstabiele, uitgezette CAG-base-tripletten in het coderende gebied van het Huntington- 
gen (HTT), resulterend in een abnormale polyglutamine-sequentie in huntingtine-eiwitten 
(htt). ZvH-patiënten lijden doorgaans aan een drietal bewegingen, psychiatrische en 
cognitieve symptomen. Het begin van de symptomen, die kunnen variëren tussen individuen 
en aangedane leden van dezelfde familie, komt meestal voor in het midden van de 
volwassenheid (30-40 jaar), maar het begin van de ziekte kan eerder of later in het leven 
zijn. De diagnose van volwassen ZvH gaat meestal gepaard met onvrijwillige motorische 
afwijkingen en chorea die vaak in een laat stadium afnemen, wanneer parkinsonisme, 
dystonie en stijfheid domineren. In de vroege stadia hebben patiënten tekorten in de 
uitvoerende werking van het systeem, korte-termijn geheugen en visueel-ruimtelijke 
werking. De latere stadia worden gekenmerkt door bradykinesie, spasticiteit, dysartrie, 
dysfagie en incontinentie. Naast motor abnormaliteiten zijn cognitieve achteruitgang en 
persoonlijkheidsveranderingen onderdeel van de ZvH, en gaan ze, net als motorische 
beperkingen, geleidelijk achteruit. Bovendien ontwikkelen cognitieve achterstanden zich 
tot meer wijdverbreide uitgebreid subcorticale dementia met apathie, impulsiviteit en 
depressie, resulterend in een negatieve impact in het sociale leven en interpersoonlijke 
relaties. Minder vaak komen waanideeëndepressie of schizofrenie-achtige psychose voor, 
waarvoor psychiatrische behandeling nodig kan zijn.
 Sinds de ontdekking van de HTT- mutatie 25 jaar geleden, zijn meer dan 13.000 artikelen 
op de ZvH gepubliceerd, waarvan ongeveer de helft betrekking heeft op pogingen om 
verschillende aspecten van de ziekte te modelleren. Dus, ondanks de aanzienlijke 
vooruitgang in ons begrip van de ziekte, blijft een effectieve behandeling die het tempo 
van de ZvH voorkomt of vertraagt buiten bereik. De trage progressie van ZvH maakt vaak 
lange en daarom dure klinische onderzoeken noodzakelijk. Bovendien is het aantal 
patiënten met ZvH dat beschikbaar is om deel te nemen aan dergelijke onderzoeken 
beperkt, wat betekent dat een relatief klein aantal verbindingen elke keer kan worden 
getest.
 Daarom is de ontwikkeling van modelsystemen die zich vertalen in menselijke pathologie 
en de klinische werkzaamheid voorspellen een van de belangrijkste uitdagingen voor het 
vinden van effectievere geneesmiddelen voor hersenstoornissen. Dienovereenkomstig 
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omvat een deel van die onderzoeksinspanning het identificeren van geschikte dier- 
modellen die een geldige weergave geven van het pathologische en gedragsprofiel van 
de menselijke ziekte en die kunnen dienen voor de identificatie van therapeutische 
kandidaten en nieuwe behandelingsbenaderingen.
 Verschillende diermodellen voor de ziekte van Huntington zijn vastgesteld na de 
ontdekking van het Huntington-gen en de ziekte-veroorzakende mutatie. Elk model 
heeft sterke en zwakke punten, en hun gecombineerde gebruik is van belang voor 
preklinisch onderzoek met betrekking tot ziektemechanismen en potentiële therapieën. 
Grondige karakterisering van een bepaald diermodel is belangrijk om te begrijpen in 
welke mate het de werkelijke ziekte modelleert en hoe ermee op een geschikte manier te 
werken. Met name zijn de ZvH-modellen van ZvH veelzijdig, vooral als wordt gekeken 
naar het grote aantal gevestigde batterijen van beschikbare tests die de beoordeling van 
motorische, cognitieve en psychiatrische eigenschappen van de ziekte mogelijk maken. 
Studies bij knaagdieren die de nadruk leggen op zorgvuldige gedragsanalyse, worden 
ontwikkeld als effectieve en goedkope modellen die een aanvulling vormen op klinische 
studies. De BACHD-rat is het nieuwste ratmodel van de ZvH en drukt het menselijke 
huntingtine van de volledige lengte (fl-mhtt) uit met 97 CAG-CAA-repeats onder de 
controle van het menselijke ZvH-promotorgen en alle regulerende elementen om de 
gelijkenis met de mens te bepalen voorwaarde (constructvaliditeit). Het BACHD-ratten-
model is bijzonder relevant omdat het motorische, emotionele en cognitieve stoornissen 
vertoont die lijken op symptomen waargenomen bij ZvH-patiënten (gezichtsvaliditeit). 
Bovendien zouden de modellen neuroanatomisch en histologisch selectief, leeftijds-
afhankelijke striataal en cortex neuronaal verlies en atrofie, nucleaire insluitsels en neuro-
pilaggregaten vertonen. Het is momenteel onmogelijk om het voorspellend vermogen is 
vast te stellen, wanneer voor ziekten zoals ZvH er geen effectieve behandelingen 
beschikbaar zijn. Ondanks het uitgebreide gebruik van de BACHD-ratlijn in de afgelopen 
jaren hebben de tot nu toe uitgevoerde onderzoeken geen betrekking op fijne en grove 
motorische functies en op psychiatrische endofenotypen zoals sociaal gedrag, impulsiviteit en 
angst. In dit proefschrift ligt de focus op het onderzoek van deze domeinen, wat nodig is 
voor de vroege detectie van de eerste kernsymptomen van de ziekte en voor het 
monitoren van de ontwikkeling ervan, zodat mogelijke therapieën die effectiever kunnen 
zijn in het voorkomen van verdere ontwikkeling van neurodegeneratie.
 Het is gebleken dat patiënten en verschillende ZvH-knaagdieren reeds vóór het begin 
van motorische symptomen cognitieve symptomen vertonen. Omgekeerd is herhaaldelijk 
gevonden dat BACHD transgene ratten  vroege stoornissen in de Rotarod-test vertonen 
die na verloop van tijd geleidelijk verslechteren. Veranderde activiteit in de PhenoMaster 
en in een open veld testachtige opstelling, evenals afwijkingen in een ongehinderd lopen 
gang zijn gemeld. Deze bevindingen suggereren dat een meer diepgaand onderzoek 
van de verschillende aspecten van de motorische functies in BACHD ratten nodig was. 
In hoofdstuk 2 hebben we onderzocht hoe verschillende aspecten van motorwerking de 
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slechte Rotarod-prestaties konden beïnvloeden die BACHD-ratten vertoonden in eerdere 
studies. In overeenstemming met deze eerdere bevindingen vertoonden onze transgene 
dieren dezelfde prestatie, hetgeen bevestigt dat BACHD-dieren gedragsafwijkingen 
vertonen in motorprestaties in vergelijking met hun wild-type (WT)-nestgenoten. 
We onderzochten verder andere aspecten van dit motorfenotype door ratten te testen op 
fijne motorische controle door het gebruik van de pasta handling and the pellet reaching 
testen. Deze testen toonden geen fijne motorische controle-tekortkomingen bij BACHD- 
dieren op de leeftijd van 2, 7 en 12 maanden. Echter, wanneer WT en BACHD ratten 
werden beoordeeld op de grove motorische functie in de holding bar test, vertoonden 
transgene dieren stoornissen die indicatief zijn voor verminderd spieruithoudings-
vermogen. Omgekeerd vertoonden transgene dieren geen stoornissen in de prestaties 
bij de grip strength test vergeleken met controledieren, hetgeen indicatief is voor 
normale spiersterkte. Interessant genoeg toonden BACHD-ratten bij een test in een 
 geautomatiseerde thuiskooiomgeving een verminderde motoriek tijdens de lichte 
(inactieve) fase alleen, wat wordt aangegeven door een verminderde afstand, snelheid en 
tijd besteed aan de shelter.
 Cognitieve en psychiatrische symptomen, waaronder doorzettingsvermogen, 
gebrek aan inzicht, afleidbaarheid, verminderd sociaal leven, angst en impulsiviteit, 
beïnvloeden ZvH-patiënten vóór motorische symptomen en hebben dus een vroeg 
schadelijk effect op de kwaliteit van het leven van de ZvH-patiënt. Het psychiatrische 
fenotype van BACHD-ratten is slechts gedeeltelijk onderzocht, wat aangeeft dat de 
BACHD-ratlijn verdere fenotypering vereist om de parallellen van hun fenotypen te testen 
met die van patiënten. Daarom, hebben we in hoofdstuk 3  een longitudinale studie uit 
tegevoerd om het ontstaan van sociaal gedragsstoornissen bij ZvH-dieren vast te stellen. 
BACHD-ratten vertoonden leeftijdsafhankelijke gedragsveranderingen toen ze opnieuw 
werden geïntroduceerd in hun cagemate na een periode van 24 uur van individuele 
huisvesting. In de sociale interactietest toonden BACHD-ratten een normaal sociaal spel 
en verminderde actief sociaal gedrag in vergelijking met hun WT-nestgenoten. In de 
sociale test met drie kamers leken BACHD-ratten een mild tekort te vertonen in de 
voorkeur voor sociale nieuwigheid zonder enige verandering in maatschappelijk belang. 
We voerden ook moleculaire analyses uit, waaruit bleek dat BACHD-dieren die werden 
blootgesteld aan de sociale interactietest, verminderde mRNA-niveaus vertoonden van 
de totale vorm van BDNF in het ventrale striatum en onveranderde striatale expressie van 
D1- en D2-dopaminereceptoren.
 In hoofdstuk 4 onderwierpen we controle en BACHD-ratten op twee Skinner-box 
testen om hun impulsiviteitskenmerken te beoordelen. Impulsiviteit, slechte risicobeoor-
deling en veranderde gedragsinhibitie zijn vaak aangetroffen persoonlijkheidskenmerken 
in de ZvH. Daarom hebben we twee verschillende aspecten van impulsief gedrag 
onderzocht, namelijk keuze en actie-impulsiviteit. Bij het testen op de delay discounting 
(DD) toonden, BACHD-ratten een hoge mate van keuze-impulsiviteit, waarbij “kleinere, 
152
Chapter 7
eerder” dan “grotere, latere” voordelen werden bevoordeeld. Bovendien vertoonde de 
BACHD-rat een gebrek aan gedragsinhibitie zoals aangegeven door bursts en premature 
responsen in een DRL-5 en -10 (Differential Reinforcement of Low Rate of Responding 
task).
 Ondanks het feit dat het te weinig onderzocht is, varieert de prevalentie van angst in 
manifeste ZvH van 13% tot 71%, wat dus een belangrijk klinisch kenmerk van ZvH is. 
Omdat ZvH-patiënten last van angst kunnen hebben, hebben we in hoofdstuk 5 een 
longitudinale studie uitgevoerd om angstachtig gedrag bij BACHD- en WT-ratten op 2, 4, 
8 en 12 maanden oud te beoordelen. In dit hoofdstuk werden klassieke en nieuwe 
gedragstests gebruikt om verschillende kenmerken van angstachtig en risicobeoorde-
lingsgedrag te beoordelen, met behulp van het elevated plus maze, de light-dark box en 
de light spot (LS) -test in de Phenotyper. In alle testen vertoonden BACHD-ratten een 
trend naar verminderde angst, waardoor dit model minder geschikt was om potentiële 
behandelingen van angstgerelateerde stoornissen bij ZvH-patiënten te vinden.
 In hoofdstuk 6 hebben we een uitgebreide bespreking gegeven van de onderzoeks-
resultaten die hierboven zijn samengevat en hebben we richtingen voor toekomstig 
onderzoek voorgesteld.
 
Concluderend, deze proefschrift omvat een reeks studies gericht op het karakteriseren 
van verschillende psychiatrische en motorische fenotypen van de BACHD-ratmodel, 
parallel aan symptomen van patiënten met de ziekte van Huntington. Voor dit doel zijn 
de studies beschreven in dit proefschrift gericht op het opsporen van fenotypen die 
lijken op HD-achtige symptomen, evenals op het toezicht op hun ontwikkeling door 
het onderzoeken van de dieren op verschillende leeftijden. De resultaten van onze studies 
moeten daarom worden gebruikt om specifieke vragen over mogelijke fenotype- 
manifestaties en hun cursus aan te pakken om nieuwe en gerichte interventionele studies 
te ontwerpen.
153
Sommario | Italian summary
7
Sommario 
I disturbi neuropsichiatrici e neurologici costituiscono un grave problema di salute in 
Europa e il loro impatto sulla salute pubblica e sulla società è in continuo aumento con 
l’invecchiamento della popolazione. L’Organizzazione Mondiale della Sanità ha stimato 
nel 2006 che i disturbi neurologici, che vanno dall’epilessia alla malattia di Alzheimer, 
dall’ictus alle cefalee, colpiscono fino a un miliardo di persone in tutto il mondo.
 Una malattia neurodegenerativa di rilevante importanza è la malattia di Huntington, 
o còrea di Huntington. La malattia di Huntington è una malattia genetica neurodegenerativa 
causata da una mutazione autosomica dominante in una delle due copie (alleli) di un 
gene codificante una proteina chiamata huntingtina. La malattia di Huntington è una 
delle malattie ereditarie da espansione di triplette: esse sono causate dall’allungamento, in 
misura superiore al normale, di una sezione ripetuta di un gene. Il gene, chiamato HTT, 
contiene una sequenza di tre basi di DNA - citosina-adenina-guanina (CAG) - ripetuta più 
volte, nota come espansione di triplette. Nel codice genetico, CAG rappresenta 
l’amminoacido glutammina, per cui una serie di queste triplette porta alla produzione di 
una catena di glutammina nota come tratto poliglutamminico (o tratto polyQ), mentre la 
parte ripetuta del gene prende il nome di regione polyQ. Generalmente le persone sane 
presentano meno di 36 ripetizioni CAG nella regione polyQ. Al contrario, una sequenza di 
36 o più triplette comporta la produzione di una proteina che ha caratteristiche diverse.
 I pazienti affetti da malattia di Huntington soffrono tipicamente di sintomi fisici, 
psichiatrici e cognitivi. L’insorgenza dei sintomi della malattia si può verificare in qualsiasi 
età (esiste anche una forma giovanile della malattia), ma più frequentemente in età adulta 
tra i 30 e i 40 anni. Se i movimenti appaiono bruschi e con una distribuzione casuale 
(còrea), essi suggeriscono una diagnosi di malattia di Huntington. Questi movimenti 
anomali tendono a peggiorare nel tempo. In uno stadio avanzato si assiste ad una loro 
diminuzione e alla chiara apparizione di altri sintomi quali parkinsonismo, distonia e 
rigidità. Nelle prime fasi, i pazienti presentano anche un deficit del sistema delle funzioni 
esecutive, della memoria a breve termine e dell’abilità visuo-spaziale.  In questa fase si 
riscontrano anche cambiamenti di personalità e nelle facoltà cognitive che, come nel caso 
dei disturbi motori, si deteriorano gradualmente. Le disabilità cognitive, inoltre, tendono a 
peggiorare nel tempo, fino a portare ad uno stato di demenza. Sono state anche riportate 
manifestazioni neuropsichiatriche come apatia, ansia, impulsività e depressione, con un 
conseguente impatto negativo sulla vita sociale e sulle relazioni interpersonali. Le fasi 
successive della malattia sono invece caratterizzate da bradicinesia, spasticità, disartria, 
disfagia ed incontinenza. Le complicanze, come la polmonite, le malattie cardiache, e i 
danni fisici da cadute, riducono l’aspettativa di vita di circa 20 anni a partire dall’esordio dei 
sintomi.
 Dal 1993, anno della scoperta della mutazione del gene HTT, sono stati pubblicati più 
di 13.000 articoli scientifici allo scopo di comprendere i meccanismi fondamentali della 
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malattia. Nonostante i notevoli progressi nello studio della malattia di Huntington, ad oggi 
non esiste ancora una cura che prevenga o rallenti i suoi sintomi. La lentezza della 
progressione della malattia di Huntington richiede spesso studi clinici lunghi e costosi. 
Inoltre, il numero di pazienti disponibili a partecipare a tali studi è limitato, traducendosi in 
un numero circoscritto di trattamenti testabili di volta in volta.
 Pertanto, una delle sfide più importanti per la ricerca scientifica è lo sviluppo di 
farmaci più efficaci al fine di ridurre la gravità di alcuni dei suoi sintomi. I modelli animali 
sono pertanto indispensabili per la comprensione dei meccanismi che causano la malattia 
e al fine di sostenere le prime fasi di sviluppo dei farmaci. 
 Diversi modelli animali transgenici sono stati sviluppati in seguito alla scoperta del 
gene HTT e della mutazione che causa la malattia. Sono stati sviluppati numerosi modelli 
animali tra cui vermi nematodi, Drosophila melanogaster, topi, ratti, maiali, pecore e 
scimmie, che esprimono il gene mutante e presentano una progressiva neurodegenerazione 
e sintomi simili alla condizione. Ogni modello ha punti di forza e punti deboli e il loro uso 
combinato è importante per la ricerca preclinica focalizzata sui meccanismi della malattia 
e sulle potenziali terapie. In particolare, i modelli di ratto della malattia di Huntington sono 
versatili, specialmente se si considera l’elevato numero di test disponibili che consentono 
la valutazione delle caratteristiche motorie, cognitive e psichiatriche della malattia. Gli 
studi sui ratti che enfatizzano un’attenta analisi comportamentale sono stati sviluppati 
come modelli efficaci ed economici che completano e si aggiungono ai risultati ottenuti 
dagli studi clinici. Il ratto transgenico BACHD è l’ultimo modello di ratto di malattia di 
Huntington ed esprime l’intero gene dell’huntingtina umano con 97 ripetizioni CAG-CAA 
sotto il controllo del gene del promotore umano e di tutti i suoi elementi regolatori. Tale 
costrutto è specificatamente valido in quanto identico a quello umano (validità di 
costrutto). Il modello di ratto BACHD è particolarmente rilevante in quanto manifesta 
profili comportamentali (fenotipi) motori, psichiatrici e cognitivi simili a quelli visti nei 
pazienti con la malattia di Huntington (validità di aspetto). Inoltre, dal punto di vista 
neuroanatomico e istologico, i modelli animali mostrano atrofia e perdita neuronale 
selettiva e dipendente dall’età, inclusioni nucleari e citoplasmatiche. La sua validità 
predittiva è attualmente impossibile da stabilire in quanto non esiste ancora una cura per 
la malattia di Huntington. 
 Nonostante l’ampio utilizzo della linea di ratti BACHD negli ultimi anni, gli studi 
condotti finora non hanno indagato i movimenti fini e grossolani e gli endofenotipi 
psichiatrici come comportamento sociale, impulsività ed ansia. Lo scopo di questa tesi 
è l’indagine di questi domini comportamentali che sono necessari per la diagnosi 
precoce dei primi sintomi della malattia e per il monitoraggio del suo sviluppo, in modo 
che eventuali terapie possano essere più efficaci nel prevenire la progressiva neuro-
degenerazione.
 Spesso i pazienti e diversi modelli di topi transgenici presentano problemi con la 
cognizione ancora prima dell’inizio di qualsiasi problema motorio. Viceversa, i ratti 
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transgenici BACHD mostrano un progressivo peggioramento dell’attività motoria nel test 
Rotarod già in giovane età. Sono state riportate anche attività alterate nel PhenoMaster, 
nel test open field e nell’andatura. Questi risultati suggeriscono come sia necessaria 
un’indagine più approfondita dei vari aspetti della funzione motoria nei ratti BACHD. Nel 
capitolo 2 è stata studiata la relazione tra movimenti fini e grossolani e il peggioramento 
dell’attività motoria dei ratti BACHD nel test Rotarod. I nostri animali transgenici hanno 
esibito le stesse prestazioni viste in studi precedenti, confermando come questo modello 
presenti anomalie motorie rispetto al gruppo controllo (genotipo wild-type, WT). Nei 
nostri studi abbiamo valutato i movimenti fini e grossolani dei ratti tramite il pasta 
handling test (test di manipolazione della pasta) e del pellet reaching test (abilità di 
raggiungimento del pellet). Questi test, eseguiti su animali BACHD a 2, 7 e 12 mesi di età, 
non hanno evidenziato deficit nel controllo motorio quando paragonati agli animali 
controllo. Tuttavia, quando i ratti WT e BACHD sono stati valutati per la funzione motoria 
grossolana nell’ holding bar test (test di resistenza della presa di una sbarra), gli animali 
transgenici hanno mostrato una diminuzione della resistenza muscolare. Al contrario, gli 
stessi animali non hanno mostrato alcuna alterazione delle prestazioni nel grip strength 
(test della forza di presa) rispetto agli animali controllo, suggerendo la presenza di una 
forza muscolare inalterata. È interessante sottolineare come, quando testati in una gabbia 
automatizzata, i ratti BACHD abbiano registrato, esclusivamente durante la fase di luce 
(fase di inattività), una minore distanza percorsa, una minore velocità e un minor tempo 
speso sul rifugio, risultante in una minore attività locomotoria.
 I sintomi cognitivi e psichiatrici, tra cui disturbo ossessivo-compulsivo, irritabilità, 
distraibilità, impatto negativo sulla vita sociale, ansia e impulsività, influenzano i pazienti 
ancor prima della comparsa di disturbi motori, e hanno quindi un impatto deleterio 
precoce sulla qualità della vita del paziente. Fino ad ora, il profilo psichiatrico dei ratti 
BACHD è stato esaminato solo in parte, suggerendo come tale linea richieda un’ulteriore 
caratterizzazione per poter paragonare il loro comportamento ai sintomi dei pazienti. 
Pertanto, nel capitolo 3 è stato condotto uno studio longitudinale per identificare 
l’insorgenza di disturbi del comportamento sociale degli animali BACHD a 2, 4, 8 e 12 mesi 
di età. I ratti BACHD hanno mostrato cambiamenti nel comportamento sociale dipendenti 
dall’età quando sono stati riuniti con il compagno di gabbia dopo un periodo di isolamento 
di 24 ore. Nel test di social interaction (interazione sociale), i ratti BACHD hanno mostrato 
un play behavior (comportamento giocoso) anormale e una riduzione del comportamento 
sociale attivo rispetto agli animali controllo. Nel three-chamber test (test sociale con tre 
camere), i ratti BACHD hanno esibito un lieve deficit di preferenza per la novità sociale 
contrariamente ad un interesse sociale invariato. Sono state anche condotte indagini 
molecolari, rivelando come gli animali BACHD esposti al test di interazione sociale 
mostrino una diminuzione dell’espressione dell’mRNA del fattore neurotrofico cerebrale 
BDNF (brain-derived neurotrophic factor) nello striato ventrale nonchè un’espressione 
striatale inalterata dei recettori della dopamina D1 e D2.
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Nel capitolo 4 i ratti controllo e BACHD sono stati testati nella camera di Skinner per 
valutare la loro impulsività. Alta impulsività, scarsa valutazione del rischio e mancata 
inibizione di azioni appropriate sono spesso associate a cambiamenti della personalità 
riscontrabili nei pazienti affetti da malattia di Huntington. Di conseguenza, abbiamo 
indagato due diversi aspetti del comportamento impulsivo che sono la scelta impulsiva e 
l’azione impulsiva. Quando sono stati sottoposti al test del delay discounting (sconto del 
ritardo, DD), i ratti BACHD hanno mostrato alti livelli di scelta impulsiva a favore di 
ricompense ‘’smaller, sooner” (‘’più piccole ma prima”) rispetto a ricompense “larger, later” 
(“più grandi ma più tardi”). Inoltre, i ratti BACHD hanno esibito un’assenza di inibizione 
comportamentale, come indicato da risposte immediate e premature nell’ottenere le 
ricompense quando sottoposti al “Differential Reinforcement of Low Rate of Responding 
task” (DRL-5 e -10).
 Una delle manifestazioni neuropsichiatriche meno studiate della malattia di 
Huntington è l’ansia, nonostante essa si manifesti in un rilevante numero di pazienti. Nel 
capitolo 5 abbiamo condotto uno studio longitudinale per valutare il comportamento 
ansioso nei ratti BACHD e WT a 2, 4, 8 e 12 mesi di età. In questo capitolo, sono stati 
utilizzati test comportamentali classici e innovativi per valutare i diversi tratti di 
comportamento ansioso tra cui la valutazione del rischio. I ratti sono stati soggetti ai test 
di elevated plus maze (labirinto elevato), light-dark box (test di luce-buio), e il light spot 
(test del punto di luce, LS) nel Phenotyper, una gabbia automatizzata. Contrariamente ai 
pazienti, i ratti BACHD hanno mostrato una leggera diminuzione dell’ansia in tutti i test, 
suggerendo come questo modello si presti meno alla ricerca di potenziali trattamenti dei 
disturbi correlati all’ansia.
 Nel capitolo 6 abbiamo discusso i risultati della ricerca condotta e abbiamo proposto 
diverse direzioni per future ricerche. 
 In conclusione, questa tesi include una serie di studi incentrati sulla caratterizzazione 
di diversi aspetti del profilo psichiatrico e motorio di questo modello animale di malattia 
di Huntington, al fine di associarli e paragonarli ai sintomi dei pazienti, nonché a monitorare 
la loro progressione studiando animali di età diverse. I risultati dei nostri studi potranno 
essere utilizzati al fine di progettare studi interventistici mirati che possano portare allo 
sviluppo di trattamenti migliori per le persone affette da malattia di Huntington.
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Vienna etc.. Positions outside academia spread among the following sectors: specialists 
in a medical environment, mainly in genetics, geriatrics, psychiatry and neurology. 
Specialists in a psychological environment, e.g. as specialist in neuropsychology, 
psychological diagnostics or therapy. Positions in higher education as coordinators or 
lecturers. A smaller percentage enters business as research consultants, analysts or head 
of research and development. Fewer graduates stay in a research environment as lab 
coordinators, technical support or policy advisors. Upcoming possibilities are positions in 
the IT sector and management position in pharmaceutical industry. In general, the PhDs 
graduates almost invariably continue with high-quality positions that play an important 
role in our knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please visit:
http://www.ru.nl/donders/graduate-school/phd/
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